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Abstract
Increased signal to noise ratio in high ﬁeld magnetic resonance imaging (MRI) allows
the acquisition of high resolution images and the development of the quantitative
techniques for measuring tissue properties. This detailed information can provide a
better understanding of the structure and function of the healthy brain but, more
importantly, it can also provide methods for explaining pathological processes in
neurodegenerative diseases. The work described in this thesis investigated iron and
myelin content in the brain using 7T MRI.
Multiple sclerosis (MS) is one of the most common demyelinating disseases. White
matter (WM) lesions detected in MS with conventional MRI techniques show poor
correlation with the disease progression. In this work investigation of degeneration of
the WM as well as cortical and deep grey matter (GM) in MS and clinically isolated
syndrome (CIS) suggestive of MS was performed using high resolution quantitative
MRI techniques.
Iron plays an important role in the physiological processes of the healthy brain, but
its excessive accumulation in the particular brain structures accompanies neurode-
generation in Parkinson’s disease (PD). Studies analysing anatomy and quantitative
properties of these structures, in vivo and post mortem, comparing PD patients with
healthy controls are presented in this thesis. Investigation related to iron is sup-
ported by the simulations aimed at understand the eﬀects of tissue microstructure
related to iron on the MR signal.
The presented analyses provide a better understanding of the complex dependencies
of diﬀerent MR contrasts on myelin and iron content.
v
Acknowledgements
I would like to thank my supervisors, Professor Penny Gowland and Professor
Richard Bowtell, for the constant guidance and motivation, and a lot of patience for
working to the very last minute.
Thanks to all my colleagues, whose advice helped me complete this work and allowed
me to learn new things.
Thanks to all of my friends, especially to Agnieszka and Aleks, for being always
there for me, regardless of the distance.
Dziękuję moim rodzicom za nauczenie mnie rozpoznawania właściwych celów i ws-
parcie w dążeniu do nich moją włąsną drogą. Dziękuję mojemu rodzeństwu, Oli i
Jachowi.
vi
1
Introduction
The nuclear magnetic resonance (NMR) phenomenon, was ﬁrst discovered in 1945
by Purcell [5] and Bloch [1], who were awarded the Nobel Prize in 1952. The
application of magnetic ﬁeld gradients for distinguishing between NMR signal from
diﬀerent locations within the sample was proposed by Lauterbur [3] and Mansﬁeld
[4] in 1973. In 1974 the technique of using the NMR signal for image formation by
applying gradients for slice selection was invented by Mansﬁeld [2]. These discoveries
led to the development of MRI, the method of non-invasive imaging of a human body,
which in 2003 brought the Nobel Prize for Physiology or Medicine to Mansﬁeld and
Lauterbur.
Over the years MRI has become a widely applied diagnostic technique in medicine.
While for the MR systems used clinically the most popular magnetic ﬁeld strengths
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remain 1.5T and 3.0T (considered a high ﬁeld), there is a substantial advantage of
using the ultra high ﬁelds (7T and higher) for research purposes and potentially
clinically, especially in the neuroimaging domain. The signal to noise ratio (SNR)
increases with an increase in ﬁeld strength allowing a higher spatial resolution to
be achieved in MRI and the development of new quantitative imaging techniques
for measuring detailed properties of tissue. This precise information can lead to
better understanding of the physiological processes occurring in the healthy and
diseased brain, and eventually to the establishment of new methods for diagnosing
and monitoring the progression of various neurodegenerative diseases.
1.1 Thesis overview
This thesis presents several studies focusing on the investigation of tissue properties
in healthy control (HC) subjects and in patients with Parkinson’s disease (PD) or
multiple sclerosis (MS), related to iron and myelin.
Chapter 2 introduces the principles of NMR and MRI, including the advanced
techniques used in the following experimental chapters and safety aspects of MR
imaging.
Simulations described in Chapter 3 investigate the eﬀect of shape and concentration
of oriented inclusions of high magnetic susceptibility on the MR signal generated by
the sample, providing a better insight into the mechanisms underlying T 2 -w image
contrast used for the estimation of iron content in the experimental chapters of this
thesis.
Chapter 4 gives an overview of the diﬀerent forms of iron that are present in
the human brain and their functions in physiological processes. It also provides
information about the role of iron in the pathology underlying PD and MS, and
about the use of MRI for measuring iron content for better understanding, and
possibly diagnosing and monitoring these diseases.
Two studies analysing the substantia nigra (SN) are presented in Chapter 5. The
ﬁrst focuses on the SN substructures and their importance in PD, using both in
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vivo and post mortem (PM) MRI data compared with PM histology. The second
investigates healthy brain stem tissue, PM and in vivo, in order to quantify iron and
myelin content.
Chapter 6 presents three studies related to white matter (WM) and grey matter
(GM) degeneration in MS and clinically isolated syndrome (CIS) suggestive of
MS. The extent of the penumbra around WM lesions in CIS patients is analysed
using diﬀerent MRI modalities, GM lesion detection in MS is performed with high
resolution MR images and iron content in the SN and red nucleus (RN) is quantiﬁed
in CIS and MS patients, compared with HCs using iron sensitive MRI measures.
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2
Nuclear Magnetic Resonance
and Magnetic Resonance Imaging
This chapter provides a brief introduction to nuclear magnetic resonance (NMR)
and magnetic resonance imaging (MRI). The ﬁrst section explains the theoretical
principles of NMR focusing on hydrogen nuclei, the second describes how this
phenomenon can be used to obtain images reﬂecting the properties of tissue.
These topics have been widely described in the literature [1, 2, 4, 11, 16, 21–
23, 29, 33, 37]. The third section characterises the advanced MRI techniques used
in the experimental part of the thesis.
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2.1 Nuclear Magnetic Resonance
Nuclear magnetic resonance (NMR) occurs when atomic nuclei, placed in a strong
magnetic ﬁeld, absorb and re-emit electromagnetic waves at the resonant frequency.
Measurement of the generated signal can provide accurate information about the
properties and molecular environment of the sample. The special role of the
hydrogen nucleus arises from its high abundance in tissues (water, fat) and large
magnetogyric ratio (see Table 2.1.1).
2.1.1 Spin, magnetic momentum and precession
One of the main characteristics of atomic nuclei is spin angular momentum (spin).
This quantum mechanical property, classically visualised as spinning of the nucleus
around its own axis, is described by a vector S = hSx; Sy; Szi of magnitude:
jSj = ~
p
I(I + 1); (2.1)
where I is the spin quantum number taking integral or half integral values and
~ = 1:0546  10 34Js is Planck’s constant divided by 2. The particle can be
in 2I + 1 possible quantum states, which values of the spin angular momentum
along the longitudinal axis Sz, are speciﬁed by the second quantum number
mz =  I; I + 1; : : : ; I:
Sz = ~mz: (2.2)
For hydrogen, 1H, the spin quantum number I = 1
2
and mz can take one of two
values:  1
2
or 1
2
as shown in Figure 2.1.1.
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Sz
Sxy
mz=-
1/2
mz=
1/21/2h
-1/2h
Figure 2.1.1: The z-component of the spin angular momentum, for quantum states of a nucleus
with I = 12 (1H).
According to classical physics, a spinning, positively charged nucleus (containing
protons) produces a magnetic ﬁeld, yielding a magnetic moment  = hx; y; zi
parallel ( > 0, most of the nuclei) or anti-parallel ( < 0) to the spin:
 = S; (2.3)
where  is the magnetogyric ratio. The values of  for nuclei commonly used in
NMR are listed in Table 2.1.1.
nucleus spin quantum number I natural abundance (%)  (MHz/T)
1H 1/2 1̃00 42.58
13C 1/2 1.1 10.71
14N 1 99.6 3.08
31P 1/2 1̃00 17.25
23Na 3/2 1̃00 11.27
Table 2.1.1: Properties of commonly used nuclei, from [22].
The behaviour of the spin in the presence of an external magnetic ﬁeld B0 is
described by using the equation of motion:
d
dt
= B0: (2.4)
Assuming that the magnetic ﬁeld B0 is applied in the z-direction, the change of the
magnetic moment  is then perpendicular to both Bz and , so that equation 2.4
8
has solution:
x(t) = x(0) cos(Bzt) + y(0) sin(Bzt) (2.5a)
y(t) = y(0) cos(Bzt)  x(0) sin(Bzt) (2.5b)
z(t) = z(0): (2.5c)
This precessional movement occurs in the clockwise direction for nuclei with  > 0,
as shown in Figure 2.1.2, at the Larmor frequency:
!0 = B0: (2.6)
Figure 2.1.2: Precessional movement of a spin in presence of the external magnetic ﬁeld B0
According to quantum mechanics, the applied magnetic ﬁeld, B0, causes diﬀerent
quantum states to have diﬀerent energies:
E =  zB0 =  ~mzB0: (2.7)
This phenomenon is called Zeeman splitting (Figure 2.1.3) and the energy separation
between the two states given by:
E = ~B0: (2.8)
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E∆E
0 B0
E=1/2hγ
E=-1/2hγ
Figure 2.1.3: Zeeman Splitting, energy levels for the 1H nuclei.
In the presence of an external magnetic ﬁeld, B0, the magnetic moments of the nuclei
tend to align with the ﬁeld direction. Quantization of the spin only allows particular
values of the z-component of the magnetic moment. From equations (2.6) and (2.8)
we can derive, that in order to change the energy level proton need to absorb/lose
the energy of a photon whose frequency exactly matches the Larmor frequency.
2.1.2 Bulk magnetization and Boltzman statistics
In the absence of an external magnetic ﬁeld, the magnetic moments  of the nuclei
in a tissue sample have an isotropic distribution of directions (all equally possible).
When placed in a magnetic ﬁeld B0 (aligned along the z-direction), their alignment
produces a net magnetization M along the z-direction, which is vector sum of the
magnetic moments (Figure 2.1.4).
Figure 2.1.4: Net magnetization M of the sample placed in the external magnetic ﬁeld B0.
The behaviour of the magnetization vector can be described by using an equation
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of motion which is analogous to (2.4):
dM
dt
= MB0: (2.9)
From quantum mechanics, the relative populations of the spins in diﬀerent energy
states, aligned parallel (low energy) and anti-parallel (high energy) to B0, depend
on the energy diﬀerence between the states and the thermal energy of the sample
and can be described by Boltzmann statistics:
N "
N # = e
 E
kT ; (2.10)
where k = 1:381  10 23J=K is Boltzman’s constant and T is the absolute
temperature of the sample in Kelvin. As the nuclei precess with diﬀerent phases,
transverse components of their magnetic moments cancel each other, but because
there are slightly more spins with low energy (aligned parallel to the ﬁeld), a
net magnetization M = hMx;My;Mzi is generated in the z-direction. The net
magnetization caused by the interaction of the spins with the external magnetic
ﬁeld B0 is known as the equilibrium magnetization M0 and it is given by:
M0 =
~2B0
4kT
; (2.11)
where  is the proton density (number of protons per unit volume). For hydrogen
nuclei in a 7T magnetic ﬁeld and T  310K (body temperature) the population
diﬀerence is equal to 7ppm. Greater magnetic ﬁeld strength increases the bulk
magnetization and therefore enhances the MR signal.
2.1.3 RF excitation
Classical physics is suﬃcient to describe the behaviour of the sample containing
a large number of nuclei . As a static longitudinal component of the M vector is
generally too small in magnitude to be detected directly as a direct current (DC) ﬁeld
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by standard means, the MR signal is detected from the oscillating electromagnetic
ﬁeld caused by the transverse magnetization, which in the equilibrium state is
equal to 0. A magnetic ﬁeld, B1(t), of much smaller magnitude than B0, but
oscillating with the Larmor frequency !0, is applied to the sample to produce
transverse magnetisation. In consequence some of the magnetic moments ﬂip and
start precessing with the same phase, which produces net vector, M, rotating in
the xy plane. As the Larmor frequency is in the radio frequency (RF) range, this
process is called RF excitation and B1 forms the RF pulse. The magnetic ﬁeld B1
can be considered as a sum of two ﬁelds counter-rotating with Larmor frequency:
B1(t) = B1(^i cos!0t+ j^ sin!0t) +B1(^i cos!0t  j^ sin!0t) = 2B1i^ cos!0t: (2.12)
as illustrated in Figure 2.1.5.
y
x
B1(icosω0t+jsinω0t)
B1(icosω0t−ysinω0t)
B1(t)
−ω0
ω0
^^
^ ^
Figure 2.1.5: The two components of the magnetic ﬁeld, B1, rotating in the clockwise and
anti-clockwise directions.
Taking into account both magnetic ﬁelds, static B0 and time varying B1, and
neglecting the component rotating anticlockwise as being oﬀ resonance, the equation
of motion (2.13) is given by:
dM
dt
= M (Bzk^+B1(^i cos!0t  j^ sin!0t)): (2.13)
In order to simplify the mathematical description of the excitation process, the
rotating frame of reference can be used in place of the laboratory frame. It rotates
with the Larmor frequency, so that in the rotating frame the ﬁeld B1 becomes
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stationary. The conversion of the coordinate system from the laboratory frame
(x; y; z) to the rotating frame (x0; y0; z0) is therefore performed as following:
x0 = x cos(!t)  y sin(!t) (2.14a)
y0 = x sin(!t) + y cos(!t) (2.14b)
z0 = z: (2.14c)
Figure 2.1.6 shows both, laboratory frame with the M vector under the inﬂuence of
the oscillating B1 ﬁeld and the same process simpliﬁed in the rotating frame.
B1
y
M
x
B0
ω0
ω0
z
B1
y'
M
x'
B0
θ
z'
Figure 2.1.6: Behaviour of the magnetization vectorM in the laboratory frame (left) and the
rotational frame (right).
The equation of motion (2.13) converted to the coordinates of the rotating frame of
reference takes the form:
dM
dt
= MB1x0: (2.15)
The magnetization vector rotates around the x0 axis with the frequency:
!1 =  B1 (2.16)
producing an oscillating magnetic ﬁeld which can be detected with an RF coil.
The ﬂip angle  through which the vector M is tilted relative to the z-direction
depends on the duration of the RF pulse  :
 = B1: (2.17)
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Two special cases of the ﬂip angle can be described:  = 90, when M is fully
rotated into the transverse plane, (Mxy = M0), and  = 180, when M is inverted,
(Mz =  M0).
2.1.4 Relaxation and Bloch equations
After the RF pulse is switched oﬀ, the system starts returning to the equilibrium
state as a result of the interactions between nuclei and molecules. This process is
called relaxation. Gradual loss of the phase coherence by the precessing nuclei causes
transverse relaxation, which produces a reduction of the transverse component Mxy
of the vector M. Transfer of the energy from the nuclei to its surrounding results
in longitudinal relaxation, recovery of the longitudinal magnetization Mz. As the
relaxation rates depend on the molecular environment of the nuclei, they provide
a source of tissue contrast in MR images. The equation of motion incorporating
relaxation processes described by the Bloch equation is given by:
dM
dt
=  (MB)  (Mz  M0)k
T1
  Mxi+Myj
T2
; (2.18)
where B is total external magnetic ﬁeld. In the absence of an applied ﬁeld, the
solutions for the components of the magnetization vector are:
Mx(t) = e
 t=T2 (Mx(0) cos!0t+My(0) sin!0t) (2.19a)
My(t) = e
 t=T2 (My(0) cos!0t Mx(0) sin!0t) (2.19b)
Mz(t) = Mz(0)e
 t=T1 +M0(1  e t=T1) (2.19c)
where t refers to the time after the RF pulse was switched oﬀ and T1 and T2 are the
longitudinal and transverse relaxation constants, respectively. Just after applying
the 90 RF pulse, the magnetization components have values Mz(0) = My(0) = 0,
Mx(0) = M0 and the solution for the equilibrium state is: Mx(1) = My(1) = 0,
Mz(1) = M0.
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Longitudinal (spin-lattice) relaxation
Applying an RF pulse disturbs the longitudinal magnetization from the equilibrium
state . After switching oﬀ theB1-ﬁeld spins start losing thermal energy gradually via
exchange with surrounding atoms and molecules (the lattice). Finally the system
comes back to the equilibrium state and its longitudinal magnetization reaches a
value of M0. This longitudinal relaxation process follows the exponential recovery
curve described by equation (2.19c).
The time scale of the longitudinal relaxation is deﬁned by T1, a longitudinal
relaxation constant, which diﬀers between diﬀerent types of tissue, and changes
with the main magnetic ﬁeld strength, as shown in Table 2.1.2. T1 depends on the
type and mobility of molecules in which the nucleus is found. It is generally short
for fat and short for water that is bound to macromolecules. Table 2.1.2 shows
typical values of T1 for diﬀerent types of tissue. If molecular motion is matched
to the Larmor frequency then dipole-dipole interactions cause relaxation (via spin
ﬂips).
tissue 1.5T 3.0T 7.0T
white matter (WM) 65616 101019 122036
cortical grey matter (cGM) 118869 172393 2132103
deep grey matter (dGM) 93834 138152 163368
cerebrospinal ﬂuid (CSF) 407065 447285 4425137
blood 154023 1914114 2587283
Table 2.1.2: Summary of the T1 values in ms measured for diﬀerent types of tissue of human
body temperature (37), in diﬀerent ﬁeld strengths, based on [35]. Values for deep grey matter
nuclei (dGM) are an average of the measurements taken for: Caudate, Thalamus, Putamen
and Globus Pallidus.
Figure 2.1.7 (left) presents T1 recovery curves for diﬀerent types of tissue. These
diﬀerences are utilized to obtain tissue contrast in MR images.
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M0
T1 relaxation curve
M0
T2* relaxation curve
Figure 2.1.7: T1 (left) and T 2 (right) relaxation curves plotted for three diﬀerent tissue types:
white matter (WM), cortical grey matter (cGM) and deep grey matter (dGM), based on the
values from Tables 2.1.2 and 2.1.3 for a 7T magnetic ﬁeld.
Transverse (spin-spin) relaxation
As a result of applying the RF pulse, spins in the sample start to precess with
the same phase and transverse magnetization is generated. The magnitude of the
transverse component of the M vector depends on the degree of phase coherence
between the spins. Therefore dephasing resulting from the local and large scale
static and ﬂuctuating magnetic ﬁeld variations cause transverse relaxation.
The time scale of the relaxation related to the local magnetic ﬁeld variations due to
the spin interactions is described by the transverse magnetization constant, T2. The
exponential decay of the magnitude of the signal can be described by the equation:
Mxy = M0e
 t=T2 (2.20)
derived from the solutions of the Bloch equation (2.19a) and (2.19b). This process
occurs more rapidly than the longitudinal relaxation and depends on the type of
tissue, the size of molecule: being shorter for protons bound to less mobile molecules
(large, connected to the cell membranes). T2 relaxation is due to oscillating ﬁelds,
an exchange with location of diﬀerent frequency, or static ﬁelds and diﬀusion.
Therefore, due to the very short T2, proteins and other macromolecules are not
detectable directly in MRI (see Section 2.3.3).
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Large-scale variations of the magnetic ﬁeld caused by susceptibility diﬀerences (see
section 2.3.5) and magnetic ﬁeld inhomogeneities also cause signal dephasing. This
eﬀect is approximated by an exponential decay with a time constant T 02. The
summed contribution of local and large scale dephasing factors is expressed as:
R =
1
T 2
=
1
T2
+
1
T
0
2
; (2.21)
where the T 02 eﬀect is static in time and hence reversible. Values of T 2 for diﬀerent
tissue types measured in diﬀerent ﬁeld strengths are presented in Table 2.1.3 and
the T 2 relaxation curve is plotted in Figure 2.1.7.
tissue 1.5T 3.0T 7.0T
white matter (WM) 66.21.9 53.21.2 26.81.2
cortical grey matter (cGM) 840.8 661.4 33.21.3
deep grey matter (dGM) 57.22.4 37.42.4 181.8
Table 2.1.3: Summary of the T 2 values in ms measured for diﬀerent types of tissue of human
body temperature (37), in diﬀerent ﬁeld strengths, based on [32]. Values for deep grey matter
nuclei (dGM) are an average of the measurements taken for Caudate and Putamen.
2.1.5 Signal detection
Transverse magnetization produced when longitudinal magnetization is rotated by
the application of an RF pulse starts producing an electromagnetic ﬁeld oscillating
around the x-axis, as described in Section 2.1.3. The induced change in the magnetic
ﬂux generates an electromotive force (according to the Faraday Law), which can
be detected using a receiver coil. After switching oﬀ the RF pulse the relaxation
process described in Section 2.1.4 begins, causing a free induction decay (FID)
signal, oscillating with the Larmor frequency, !0, according to the Bloch equation
(2.18). The FID signal is ampliﬁed to be detectable and demodulated using two
phase sensitive detectors with 90 phase shift between their reference signals of
frequency !ref . This allows separation of imaginary and real components of the
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signal corresponding to Mx and My, respectively:
Mx(t) = M0 sin  sin(!t+ )e
 t=T 2 (2.22a)
My(t) = M0 sin  cos(!t+ )e
 t=T 2 (2.22b)
where ! = !0 !ref ,  is a reference phase and  is the ﬂip angle of the RF pulse.
Plots of the real and imaginary components of the signal are shown in Figure 2.1.8.
T
∗
2
t
Imaginary component
T
∗
2
t
Real component
Figure 2.1.8: Imaginary and real components of the FID signal, according to the equations
(2.22a) and (2.22b). The T 2 decay envelope is plotted with grey solid line.
The complex signal is given by the equation:
S(t) = M0 sin e
 t=T 2 ei(!t+); (2.23)
assuming Mz = M0 before pulse.
Combination of RF pulses into sequences allows measurement of the relaxation
constants T1 and T2, described in Section 2.1.4, providing the information about
tissue characteristics.
Inversion recovery: T1 measurement
The method commonly used to measure the T1 of a sample is the inversion recovery
sequence, presented schematically in Figure 2.1.9.
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INVERSION RECOVERY
180◦ 90◦ 180◦
RF
M0
1-2exp(- T I
T1
)
-M0
1-exp(- T R
T1
)
FID
TR
TI
Figure 2.1.9: Diagram illustrating the inversion recovery sequence.
The 180 pulse is applied, inverting the longitudinal magnetization vector to  M0.
Magnetization starts recovering, but after the inversion time (TI) another 90 pulse
ﬂips the partially recovered magnetisation into the transverse plane, and an FID
is generated. In order to measure T1 values this sequence needs to be performed
repeatedly, with varying TI values. The repetition time (TR) between two 180
pulses has to be long enough to allow recovery of the magnetisation. The measured
signal is proportional to the product of two recovery curves which can be derived
from the Bloch equation (2.19c):
S(TR) /M0(1  2e TI=T1 + e TR=T1): (2.24)
Spin echo: T2 measurement
As was previously described in Section 2.1.4, transverse relaxation depends not only
on local properties of the sample described by the T2 time constant, but also on
large-scale static magnetic ﬁeld inhomogeneities related to T 02. However, the static
T 02 eﬀects can be reversed and hence the measurement of the T2 value due to time
varying processes is possible using the spin echo sequence introduced by Hahn in
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1950 [15]. This is illustrated in Figure 2.1.10.
SPIN ECHO
90◦
refocusing pulse
180◦ 180◦
RF
FID
T
∗
2
T
∗
2
T2
M0
τ τTE
TR
Figure 2.1.10: Diagram illustrating the spin echo sequence.
Application of the 90 pulse brings all the spins to precess in phase creating a
transverse magnetization, which afterwards decays with T 2 due to dephasing. The
180 refocusing pulse applied after time,  , inverts the magnetisation, which start
to precess in the opposite direction and rephase. After the echo time (TE) of 2 ,
the signal attenuation related to T 02 eﬀects is fully reversed and the remaining loss of
phase coherence due to the T2 processes can not be regained. The signal measured
after time TE, which is called a spin echo is given by:
S(t) /M0e TE=T2 : (2.25)
Multiple measurements are required to measure the T2 values of the sample, which
can be performed by repeating a 90-180 sequence with diﬀerent TEs or by adding
subsequent 180 pulses. The second method is less susceptible to diﬀusion and ﬁeld
inhomogeneity eﬀects.
More introduction about the diﬀerent techniques for measuring speciﬁc
characteristics of tissue can be found in Section 2.3.
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2.2 Magnetic Resonance Imaging
This section presents the principles underlying the use of the NMR phenomenon to
acquire images of the sample, describes basic imaging techniques and introduces the
MRI equipment.
2.2.1 Spatial encoding
Section 2.1 described the formation and detection of the NMR signal from an entire
volume of the sample. Obtaining a 3D image requires measurement of the signal
values corresponding to particular locations within the sample. This is performed
using a gradient of the z-component of the magnetic ﬁeld in three orthogonal
directions:
G = Gxx+Gyy +Gzz =
dBz
dx
x+
dBz
dy
y +
dBz
dz
z: (2.26)
Application of the gradient aﬀects the magnetic ﬁeld experienced by the spins along
the gradient’s direction and the precessional frequency at the position r = (x; y; z)
is given by:
!(r) = (B0 +G  r): (2.27)
The gradients must also have transverse components (eg. dBx
dx
), but assuming that
the B0 is applied in the z-direction, the transverse components of the gradient ﬁelds
can be neglected due to their minor eﬀect on the resonant frequency of the spins.
Additional dephasing introduced by the gradient ﬁeld can be reversed using a
gradient with the opposite sign. This mechanism is used to produce a gradient
echo, where RF pulse induced signal is dephased and subsequently rephased by a
bipolar gradient and spins regaining phase coherence generate the echo. An example
sequence involving gradient echo and using gradient ﬁelds for spatial encoding of the
signal is presented in Figure 2.2.4.
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Slice selection
Selective excitation of the sample is achieved by using a gradient ﬁeld whose direction
is perpendicular to the chosen slice (conventionally the z-direction) and simultaneous
application of the RF pulse of appropriate bandwidth, !. Only the spins precessing
with the same frequency as the applied RF pulse are excited and subsequently
produce a signal, therefore a separate RF pulse is required to obtain an image of
each slice. The location of the selected slice is determined by the centre frequency
of the RF pulse, while the slice thickness, z, depends on the bandwidth of the RF
pulse and the strength of the ﬁeld gradient:
z =
!
Gz
: (2.28)
The same bandwidth produces a thinner slice using a stronger gradient, but narrower
bandwidth makes a thinner slice, while using the same gradient, as is illustrated in
Figure 2.2.1.
z
ω
G1G2
∆ω3∆ω1
∆z3
∆z2
∆z1
Figure 2.2.1: Plot illustrating the relation between bandwidth, gradient strength and slice
thickness. The bandwidth !1 gives a thinner slice z2 < z1 using the stronger gradient
G2, but the narrower bandwidth !3 < !1 gives a thinner slice z3 < z2 with the same
gradient.
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Frequency encoding
Another gradient applied after the RF pulse, conventionally in the x-direction, varies
the precessional frequency of the spins according to their position along the x-axis
within the excited slice:
!(x) = (B0 +Gxx): (2.29)
Therefore, the spins precess with the Larmor frequency only in the locations where
x = 0. The measured signal can be decomposed using an inverse Fourier transform
to identify the corresponding locations for the components of diﬀerent frequencies,
as described in the next sections.
Phase encoding
Finally the third gradient is used to encode the signal position along the y-axis. It is
applied after the RF pulse, before the data acquisition, for a short period of time to
aﬀect the frequency of the spins precession. It introduces a phase diﬀerence varying
in the y-direction and increasing with time when the gradient is on. After the
gradient has been switched oﬀ the phase shift between the precessing spins remains
and the phase oﬀset is proportional to the location of the spins along the y-axis:
(y) = Gyyt (2.30)
where t refers to the gradient duration. One phase encoding step corresponds to one
data acquisition and the amplitude of the phase encoding gradient changes between
the steps.
2.2.2 Image reconstruction
The spins’ precessional frequency under the inﬂuence of three gradient ﬁelds G in
the position r is given by the equation (2.27) and the phase accumulated by time t
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can be calculated as:
(r; t) = r 
Z t
0
G(t0)dt0 (2.31)
The signal in the absence of gradients is proportional to the proton density (r),
while when gradients are applied the FID equation (2.23) is given by:
S(t) =
Z
(r)e i(r;t)dr3 =
Z
(r)e ir
R t
0 G(t
0)dt0dr3 (2.32)
where the relaxation terms are ignored and the reference frequency is assumed to
be equal to the Larmor frequency. Substitution using the variable k  (kx; ky; kz)
given by:
k(t) = 
Z t
0
G(t0)dt0; (2.33)
leads to the signal equation:
S(k) =
Z
(r)e ikrdk3: (2.34)
Finally, the inverse Fourier transform of the signal allows the original spin density
value to be obtained in the particular location within the sample:
(r) =
1
23
Z
S(k)eikrdk3: (2.35)
k-space
k-space is an analog Fourier space, in which the signal is acquired, introduced as a
theoretical concept in 1983 [25]. In practice it corresponds to the discrete matrix
storing values of the signal sampled using an analogue to digital converter (ADC).
The matrix consists of Nx columns corresponding to the frequency encoding steps
(sampling points) and Ny rows, one for each of the phase encoding steps repeated
with a diﬀerent amplitude (see Figure 2.2.2). The strongest signals, associated with
the weakest gradients, are recorded in the centre of k-space and are responsible
for the coarse elements of the image (low spatial frequencies), while the weakest
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Figure 2.2.2: The signal in k-space (left) and a corresponding image (right). k-space is
Nx Ny matrix, where columns correspond to the frequency encoding steps and rows to the
phase encoding steps; kx and ky refer to the spacing between the sampling points marked
with the orange circles. Reconstructed image of size FOVx  FOVy contains voxels of size
xy corresponding to the sampling points.
signals correspond to the periphery and correlate with the ﬁne details and the
edges present in the image (high spatial frequencies). To obtain an image, k-space
is Fourier transformed to Cartesian space according to the equation (2.35). This
correspondence is presented in Figure 2.2.2. Increased image resolution (decrease of
x and y) leads to a longer scanning time, as a larger number of the encoding
steps are required for the ﬁxed ﬁeld of view (FOV) in a given direction:
x =
FOVx
Nx
; (2.36)
or a smaller spacing between the signal measurements:
kx =
1
FOVx
; (2.37)
(similarly for y). Obtaining a discrete k-space matrix from an analogue k-space
trajectory can involve diﬀerent sampling strategies. The main pulse sequences
together with their k-space sampling trajectories are presented in the following
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sctions.
2.2.3 Spin versus gradient echo
Section 2.1.5 described the principles of creating a spin echo using two RF pulses 90-
180 (exciting-refocusing) and measuring a generated signal. Alternatively a gradient
echo can be obtained by combining an excitation pulse with a gradient. After the
RF pulse of a ﬂip angle  a negative gradient is applied for a time,  , to dephase
the spins according to their position within the sample. Subsequently a reversed
gradient is applied for the time period 2 to rephase and then dephase the spins.
The gradient echo occurs half way through the duration of the second gradient,
when spins regain their phase coherence.
These two mechanisms combined with the spatial encoding gradients provide two
classes of the sequences commonly used to acquire 3D MR images: spin echo (SE)
and gradient echo (GE) (see Figures 2.2.3 and 2.2.4).
Spin echo imaging
In the spin echo pulse sequence, schematically presented in Figure 2.2.3 together with
the corresponding k-space trajectory, the slice selection gradient Gz is switched on
during both RF pulses. The de-phasing positive gradient is applied in the x direction
after the excitation pulse simultaneously with the phase encoding gradient Gy, which
corresponds to moving in the spatial frequency domain along both kx and ky axes.
The refocusing pulse inverts the phase of the spins by 180 and data acquisition is
performed with the frequency encoding gradient switched on in the same time. The
signal intensity in the spin echo sequence depends on the T2 relaxation constant. To
ﬁll the rest of k-space this process is repeated with varying phase encode gradient
amplitudes.
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SPIN ECHO SEQUENCE
90◦ 180◦ 90◦
RF
Gz
Gxω
Gyφ
echo
TE
TR
kx
ky
Figure 2.2.3: Timing diagram of a spin echo (SE) sequence: RF pulses (red), gradients (blue)
and echo signal (grey), with marked echo time (TE) and repetition time (TR) (left). Gradients
positions marked in light blue correspond to the movement in k-space plotted in the same
colour. The eﬀect of the refocusing pulse is plotted in red and signal sampling trajectory is
indicated by orange circles (right).
Gradient echo imaging
The gradient echo sequence, diagram and k-space trajectory presented in Figure
2.2.4, consists of a  excitation pulse applied together with the slice selecting gradient
Gz. Subsequently the negative pre-phasing gradient applied in the x direction and
accompanied by the phase encoding gradient Gy results in a trajectory from the
centre to the bottom left quarter of the k-space. Further application of the frequency
encoding Gx gradient generates the gradient echo and the signal is sampled. The
sequence is repeated for diﬀerent  phase encode gradient amplitudes to cover other
lines across k-space.
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GRADIENT ECHO SEQUENCE
θ θ
RF
Gz
Gxω
Gyφ
echo
TE
TR
kx
ky
Figure 2.2.4: Timing diagram of a gradient echo (GE) sequence: RF pulse (red), gradients
(blue) and echo signal (grey), with marked echo time (TE) and repetition time (TR) (left).
Gradients positions marked in light blue correspond to the movement in k-space plotted in the
same colour and signal sampling trajectory is indicated by orange circles (right).
As dephasing due to the large scale magnetic ﬁeld variations (ﬁeld inhomogeneities,
susceptibility) is not be reversed by the gradient echo, the signal attenuation follows
the T 2 decay. To minimise this eﬀect, very short TEs (in order of milliseconds) are
often used and gradient echo imaging is generally faster than spin echo imaging due
to the shorter duration of the GE acquisition and lack of a 180 RF pulse which
makes it more straightforward to reduce TR and the ﬂip angle.
2.2.4 2D multi slice versus 3D volume imaging
The slice thickness in 2D multi slice images is limited by the available gradient
strength. In order to obtain thinner slices additional phase encoding gradient can
be applied in the slice direction and 3D Fourier encoding of the whole volume or
separate thick slabs can be performed. The slice thickness in a 3D image is equal
to FOVz=Nz, where Nz is a number of phase encoding steps in the slice selection
direction. An example of a 3D GE sequence is shown in Figure 2.2.5.
28
3D GRE SEQUENCE
θ θ
RF
Gz
Gxω
Gyφ
echo
TE
TR
Figure 2.2.5: Timing diagram of the 3D gradient echo sequence: RF pulse (red), gradients
(blue) and echo signal (grey), with marked echo time (TE) and repetition time (TR) (left).
2.2.5 Signal to noise ratio (SNR)
One of the most important quality characteristics of MRI data is the signal to noise
ratio (SNR). The amount of the MR signal per voxel increases with a voxel size. The
noise is higher for wider bandwidth sampling, but can be decreased by using more
phase encoding steps, which eﬀectively averages the signal in the Fourier transform.
Additional improvements in SNR can be achieved by averaging the values from
several acquisitions obtained under the same conditions, which also increases the
scanning time. These dependences for 2D and 3D sequences are summarised in
Equation (2.38) showing the 3D imaging provides higher SNR:
SNR3D /
p
Nz
xyz
p
NxNyNSAp
BW
=
p
NzSNR2D (2.38)
where Nx, Ny and Nz are numbers of encoding steps in frequency, phase, phase
slice selection direction, respectively, BW represents the bandwidth of an image
and NSA stands for the number of averages.
Using wide slabs in 3D images allows the use of short excitation pulse lengths which
can shorten TE and TR, although additional phase encoding steps make the total
scanning time longer and the sequence is more susceptible to motion artefacts. The
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relation between total scanning times in 2D and 3D sequence can be expressed as:
T3D = Nz Ny  TRNSA = Nz  T2D; (2.39)
for constant TR. In practice in 2D imaging it is usually possible to excite more than
one slice during each repetition time. The maximum number of slices to ﬁt in one
TR is given by:
Nmax =
TR
TE +T
; (2.40)
where T is the additional time necessary to ﬁnish the signal acquisition and switch
the gradients (approximately half of the readout time). Lengthening TR in this way
generally increases the signal as it allows longer for magnetization recovery.
2.2.6 Fast imaging
This section presents several methods for decreasing the scanning time.
Partial Fourier imaging
Partial Fourier imaging is a technique introduced by Feinberg [5], which takes
advantage of the conjugate symmetry of k-space:
S( kx; ky) = S(kx; ky) (2.41)
where  is a complex conjugate. Only the top half of k-space is sampled and is used to
calculate the remaining part. As the number of the phase encoding steps is reduced
to Ny=2, the scanning time is halved, but this also causes a reduction of the signal
to noise ratio by factor of
p
2, because only half of the signal is acquired. In practice
the condition (2.41) is not always valid due to the eﬀects of ﬁeld inhomogeneity and
additional lines of k-space need to be acquired (usually 60-75% in total) to ensure the
validity of the estimations of missing k-space signal. The central region of k-space
(corresponding to the low spatial resolution) can be used to reconstruct the phase
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image, assuming slow spatial phase variation. This method is easy to implement
and is commonly used, but it can cause artefacts if the condition of slowly varying
phase is not fulﬁlled.
Parallel imaging
Another method of shortening the scanning time is parallel imaging [34]. Reducing
the number of sampled lines of k-space by increasing ky would normally cause
aliasing, leading to the generation of wrap around artefact (Figure 2.2.6, middle).
In order to overcome this problem, multiple independent receiver coils with diﬀerent
spatial sensitivity proﬁles are used (Figure 2.2.6, right). Several methods have
been developed to reconstruct the complete image from the raw data by employing
the information about coil sensitivity and one of the most common is Sensitivity
Encoding for Fast MRI (SENSE) introduced by Pruessmann in 1999 [34]. Parallel
imaging is a hardware dependent technique, the maximum reduction of the scanning
time is given by the number of channels in the receiver coil of the MR system, but
in practice depends on the spatial sensitivity of the diﬀerent coil elements.
Figure 2.2.6: The original image (left), wrap around artefact (middle), sensitivity proﬁles of the
receiver coil channels used to obtain the raw data, which allows to reconstruct the complete
image (right).
In 3D imaging additional reduction in the number of k-space lines in the second
phase encoding direction is possible (see Section 2.3).
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Echo planar imaging
Echo planar imaging (EPI) is a technique proposed by Mansﬁeld [26, 27], which
uses multiple gradient echoes to acquire multiple lines of k-space after one excitation
pulse. The eﬃciency of the sampling scheme allows the whole image to be obtained
with a few excitations (multi-shot EPI) or even only one excitation (single-shot
EPI).
ECHO PLANAR IMAGING SEQUENCE
θ θ
RF
Gz
Gxω
Gyφ
TE
TR
echoes
kx
ky
Figure 2.2.7: Timing diagram of an echo planar imaging (EPI) sequence: RF pulse (red),
gradients (blue) and echo signal (grey), with marked echo time (TE) and repetition time (TR)
(left). Gradients positions marked in light blue correspond to the movement in k-space plotted
in the same colour and signal sampling trajectory is indicated by orange circles (right).
The pulse sequence diagram and k-space trajectory of the gradient echo planar
sequence are presented in Figure 2.2.7. Each line of k-space corresponds to one
of the equally spaced gradient echoes generated by Gx, which together constitute
an echo train. Phase encoding is performed by applying the Gy ’blips’ at the time
when Gx = 0, which gradually moves the sampling in the ky direction. As successive
lines of k-space are sampled in opposite directions, reordering of the data is required
before application of the Fourier transform. Mismatch between even and odd lines
of k-space causes the Nyquist ghost artefact, which appears as a version of the object
repeated and shifted by half the ﬁeld of viev of the image. As all the echoes have to
be acquired before the signal has decayed, rapid switching of the gradients is required
to obtain an image of a single slice in a time of order of milliseconds. A relatively
long readout time in EPI enforces low separation of the sampling points in the kx
direction, which causes high sensitivity to the eﬀect of ﬁeld inhomogeneity often
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leading to signal mis-registration appearing in the image as a geometric distortion.
The amplitudes of the successive echoes follow the T 2 decay due to the dephasing
caused by ﬁeld inhomogeneities, which can also cause artefacts. Long readout times
combined with the thick slices can also lead to signal drop-out due to through slice
phase variation. Distortion can be reduced by increasing gradient strength (not
practical) or reducing a number of the k-space lines sampled to shorten the echo
train duration (parallel imaging).
In spite of being susceptible to artefacts, echo planar imaging is a popular technique,
especially in the applications where fast imaging is crucial (e.g. functional MRI
or diﬀusion weighted imaging). In addition to T 2 -weighted contrast, by applying
preparation pulses, EPI can also be used to obtain spin echo T2-weighted or inversion
recovery T1-weighted images.
2.2.7 Hardware and safety
The architecture of an MR system is schematically presented in Figure 2.2.8 and
particular elements are described below with the reference to the Nottingham 7T
Philips Achieva MR scanner used to obtain most of the data in this thesis.
Figure 2.2.8: Schematic illustration of the MR scanner architecture.
Main magnet
The initial longitudinal magnetisation of the sample is generated by the main magnet
which produces a strong, static, homogeneous, magnetic ﬁeld B0. The strength of
this ﬁeld, its temporal stability and spatial uniformity are important features, as they
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aﬀect the quality of the acquired data. Permanent magnets have limited maximum
strength (0.2-0.3T) and are sensitive to temperature ﬂuctuations. Modern high ﬁeld
MR systems therefore use superconducting magnets built from the materials, in
which the resistance drops to zero below a certain transition temperature causing
the electrical current to ﬂow indeﬁnitely, providing a magnetic ﬁeld of high stability.
The required temperature and ﬁeld strength depend on the material type, systems
operating at ﬁelds <9.4T generally use Niobium Titanium Alloy (NbTi, 9.2K, 15T)
while systems operating at ﬁelds >9.4T use Niobium Tin (Nb3Sn, 18.3K, 30T). A
cooling system containing liquid helium is required to maintain a low temperature.
The Nottingham 7T Phillips system contains superconducting magnet (NBTi) which
produces a ﬁeld with inhomogeneity of less than 0.10 ppm in a 25 cm diameter
spherical volume.
Improvements in the main magnetic ﬁeld inhomogeneity can be achieved by active
or passive shimming. Passive shimming involves placing ferromagnetic elements
within the bore, while active shimming employs coils producing additional magnetic
ﬁelds, which cancel spatial variations of the main ﬁeld. Active shimming can be
interactively adjusted for the particular experiment by modifying the shim currents
automatically or manually, based on a magnetic ﬁeld map.
The magnetic ﬁeld outside the bore of the magnet (fringe ﬁeld) can interfere with
the equipment and passive or active shielding is necessary. The Nottingham 7T
scanner is passively shielded by 200 tones of iron.
Gradient coils
Linear magnetic ﬁeld gradients are used for spatial localisation of the signal as
described in Section 2.2.1. Eﬃciency and precision of the signal encoding depends on
the ﬁeld gradient switching time (0.1-1.0ms), strength (10-50mT/m) and linearity.
The gradient in the z-direction can be produced using a Maxwell Pair, a set of
two circular coils with currents ﬂowing in the opposite directions, but the same
magnitude, placed on the axis of the main magnet bore. A Golay Coil can be used
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to generate a transverse gradient.
The waveform controller is a device responsible for generating gradient waveforms,
which are then passed to the ampliﬁers and gradient coils afterwards.
Rapid changes in the magnetic ﬁeld gradients during the imaging process produce
eddy currents in scanner structures generating additional, spatially and temporary
varying magnetic ﬁelds which cause image distortion and signal loss. This problem
can be overcome by active shielding the conducting parts of the magnet from the
gradient ﬁelds [3]. Therefore a gradient coil consists of the inner primary coil and
the outer shield coil to ensure minimal gradient ﬁeld outside the bore of the scanner.
The gradient coils of the 7T Nottingham scanner produce gradient ﬁelds of 40mT/m
and a slew rate (maximum rate of change) of 200mT/m/ms.
Radio-frequency coils
Radio-frequency coils are used to excite transverse magnetisation of the sample and
to receive the resulting signal, as described in Sections 2.1.3 and 2.1.5. The waveform
controller sets the frequency of the synthesiser which generates the receiver frequency
and generates the envelope of the RF pulses.
Experiments presented in this thesis were performed using two diﬀerent RF coils,
each consisting of volume transmit coil and either a 16- or 32-channels receiver coil,
which allow parallel imaging.
Safety
MRI is relatively safe imaging method in comparison to X-ray imaging. No known
long term adverse eﬀects occur due to the main magnetic ﬁeld <10T, however in high
ﬁeld systems short term symptoms have been reported, including vertigo, nausea,
and a metallic taste, particularly associated with rapid head movements close to
the magnet bore [7, 8]. Objects or implants made from ferromagnetic materials
experience a force moving them towards the magnet, and thus can be potentially
dangerous and need special attention.
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Switching the gradients generates rapidly varying, oscillating magnetic ﬁelds, which
induce currents in the human body and may stimulate muscles or nerves, if exceeding
a threshold for peripheral nerve stimulation (PNS, 60-100T/s) [6]. Ear protection
also needs to be used to minimise the eﬀects of the acoustic noise produced by the
gradient coils due to their vibration caused by the rapidly varying current within
the main magnetic ﬁeld. Recommended maximum rate of change of ﬁeld to limit
PNS is 20T/s for pulses longer than 120s and 140dB is considered as a maximum
acoustic noise limit.
The RF ﬁeld induces currents in the tissue causing heating described by the speciﬁc
absorption rate (SAR), which increases with the higher ﬁeld strength, where more
RF power is used. The maximum allowed SAR value is 4W/kg over 5min period.
It is also important to avoid loops of the cables (or skin touching itself) as this
produces current loops which may lead to the skin burns.
Careful patient screening is necessary in order to exclude those with metal implants,
pacemakers, claustrophobia or other possibly hazardous conditions.
2.3 Advanced imaging methods
This section presents an overview of the sequences and quantitative mapping
methods used in the experimental part of the thesis.
2.3.1 FLASH
The Fast-Low Angle SHot (FLASH) sequence, which was introduced in 1986 [13, 14],
also known as Fast Field Echo (FFE, Philips), is a GE sequence (see section 2.2.3)
using very short TRs to reduce scanning time, together with low ﬂip angle pulses
to maximise the signal. If TR  T1, the longitudinal magnetization will not
fully recover between excitations, but it will reach a steady state after multiple
RF pulses. The transverse magnetization remaining after the previous excitation is
often prevented from contributing to the signal using a spoiling (crusher) gradient
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before application of the subsequent RF-pulse, enabling short repetition times.
Alternatively or additionally RF-spoiling can be used, involving variation of the
phase of the successive RF pulses. Dephasing caused by the phase encoding gradient
is refocused by a rewinding gradient applied after signal acquisition in the same TR-
period. The diagram of a basic 2D FLASH sequence with a spoiling gradient applied
in the z-direction is presented in Figure 2.3.1.
2D FLASH
θ θ
RF
Gz
Gxω
Gyφ
echo
TE
TR
Figure 2.3.1: Timing diagram of a 2D FLASH sequence: RF pulse (red), gradients (blue) with
their current positions (light blue) and echo signal (grey), with marked echo time (TE) and
repetition time (TR).
The signal strength in the FLASH sequence can be written as:
S /M0 sin (1  e
 TR=T1)
1  e TR=T1 cos  e
 TE=T 2 ; (2.42)
where  is the ﬂip angle. For a given TR the maximum signal is obtained by using the
Ernst angle, E which fulﬁls the condition: cos E = e TR=T1 . Spoiling the transverse
magnetization makes FLASH images T1-weighted. In order to acquire T 2 -weighting
a relatively long TE  T 2 is chosen. The contrast also can be modiﬁed by adding
magnetization preparation pulses at the beginning of the sequence (see Section:
2.3.2).
FLASH images can be acquired in either 2D or 3D mode. The sequence has low
sensitivity to oﬀ-resonance eﬀects, but the short TR and consequently short readout
time reduces its SNR.
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2.3.2 MPRAGE and T1 mapping
The mechanism of longitudinal relaxation was discussed in Section 2.1.4 and the
principles of inversion-recovery-based T1 measurement were brieﬂy described in
Section 2.1.5. Here the MPRAGE sequence, which was used in this thesis to obtain
T1-weighted images of the brain, is presented. Moreover the method to calculate
maps of the actual T1 values based on these images is described in this section.
MPRAGE
Magnetisation-Prepared RApid Gradient Echo (MPRAGE), also known as Inversion
Recovery Turbo Field Echo (IR-TFE, Philips), which was proposed in 1990 [31] and
is a 3D sequence consisting of a magnetization preparation step using an inversion
recovery pulse and a 3D FLASH sequence. A diagram showing the structure of a
version of the sequence using a spoiling gradient in the x-direction is presented in
Figure 2.3.2.
MPRAGE
180
◦ θ θ θ θ 180◦
RF
Gz
Gxω
Gyφ
TI TR TR TR TD
SSi
Figure 2.3.2: Timing diagram of a 3D MPRAGE sequence: RF pulse (red), gradients (blue)
with their current positions (light blue) and echo signal (grey), with marked echo time (TE)
and repetition time (TR); time points a-d are used in the equations for T1 mapping in the next
section.
The inversion time (TI) is the time after the 180 pulse when the train of FFE
pulses is applied, each in a separate TR. The number of pulses is speciﬁed by
the TFE factor (Philips). The period after the last FFE pulse during which the
magnetization is recovering before application of the next inversion pulse is called
the delay time (TD). The total time between two sucessive 180 pulses is known as
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the Shot-to-Shot interval (SSi) and can be calculated from:
SSi = TI + TR TFE + TD: (2.43)
MPRAGE is a standard anatomical protocol providing T1 weighted images with
good contrast between the brain tissues: WM, GM, CSF. Timings are normally
chosen to approximately null CSF signal and provide good GM/WM contrast.
T1 mapping
Signal intensity in the individual T1 weighted images can be aﬀected by multiple
factors (diﬀerent relaxation times, hardware conditions, etc.) and therefore such
images do not provide quantitative and reproducible measures of T1. Approaches
based on using a series of measurements obtained with varying inversion times allow
more accurate mapping of the longitudinal relaxation times. For the purpose of
this thesis MPRAGE-based T1 mapping method was used [43]. The resulting data
were ﬁtted to a model, by calculating the signal as a function of M0 and T1 and the
ﬂip angle of the inversion pulse, taking into account all the RF pulses and recovery
periods. Figure 2.3.3 presents a diagram showing three time points, before and after
the RF pulse and after the recovery period
θ θ θ
a b c
Figure 2.3.3: Simpliﬁed diagram showing RF pulses of a 3D MPRAGE sequence (red) and
three diﬀerent time points used in the equations below.
The magnetisation M bz just after the RF pulse of ﬂip angle  is calculated using
magnetization Maz just before the pulse using the equation:
M bz = M
a
z cos : (2.44)
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The magnetization after the recovery period t is calculated using the formula:
M cz = M
b
ze
 t=T1 +M0(1  e t=T1) (2.45)
where M0 is the equilibrium longitudinal magnetization, M cz and M bz are values of
magnetisation after and before the recovery period. Flip angles are obtained from
B1 maps [44] and the polarity restoration method [9] is applied to the data before
the calculations. Fitting of the measurements acquired for diﬀerent time points is
performed to obtain an accurate T1 map (for more details see [43]).
2.3.3 MTR, CEST and NOE
Conventional MRI can not detect signal directly from the protons bound in
macromolecules (proteins, cell membranes, myelin) because of their short T2
relaxation times [17]. However the water protons can interact with the bound
protons leading to magnetization transfer (MT) due to either proton exchange or
spin-spin interaction.
H H
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H H
O
H H
O
chemical exchange
spin-spin interactions
Figure 2.3.4: Magnetization exchange between the molecular and free water protons (left); the
absorption lineshapes of macromolecular and water protons and the oﬀ-resonance saturation
pulse (right).
The MT eﬀect is obtained by using oﬀ-resonance RF pulses to saturate selectively
macromolecular protons, which then partially saturate free water protons via
magnetization exchange. This decreases the available longitudinal magnetization
of the free water and results in a detectable signal change in regions where exchange
occurs. This process is illustrated in Figure 2.3.4, together with the absorption
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lineshapes of macromolecular and water protons.
Magnetization transfer is aﬀected by tissue characteristics, allowing investigation of
the concentration and distribution of macromolecules and possible exchange sites.
The eﬀect of MT on the water protons measured for diﬀerent frequencies of the oﬀ-
resonance saturation pulse forms the so called z-spectra [10], which can be used to
study macromolecules indirectly (via the water signal) in order to evaluate relative
concentrations and exchange rates.
MTR
Magnetization transfer imaging (MTI), introduced as a new source of contrast in
MRI in 1989 [42], can be performed with both SE and GE sequences (in 2D and
3D). A short saturation pulse (or a train of pulses) is applied before each excitation
pulse. For quantitative characterisation, the Magnetization Transfer Ratio (MTR)
is calculated voxelwise based on two separate sequences with identical parameters
apart from one including the MT saturation:
MTR =
S0   SS
S0
; (2.46)
where S0 is the voxel intensity in the non-saturated image and SS the intensity of
the corresponding voxel in the MT-saturated one. The schematic diagram of the
MT sequence used in this thesis is presented in Figure 2.3.5.
MTR
∼
1
BW N pulses
TFESA
T
SSI
TFE
N
O
 S
AT
SSI
Figure 2.3.5: Schematic diagram of the pulse sequence, the pulsed saturation acquisition
followed by a no saturation acquisition with the TFE imaging module.
MTR values are dependent on the tissue type and reﬂect the saturation of the water
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protons due to the magnetization exchange and their longitudinal magnetization
recovery. This method is especially useful for increasing the contrast between
ﬂuids and other tissues with signiﬁcant macromolecular content. One of its major
clinical applications is visualisation of MS lesions, diﬀerentiation of their types and
monitoring of their evolution [18].
CEST
Chemical exchange dependent saturation transfer (CEST) is a subtype of MT
measuring magnetization transfer due to the exchange of protons between free
water and macromolecules. An oﬀ-resonance RF pulse is applied with frequency
corresponding to the resonance of particular metabolites or chemical groups of
high chemical exchange rate, such as amide protons (amide proton transfer, APT
imaging). CEST often investigates asymmetries in the z-spectrum by dividing or
subtracting measurements obtained with the saturation on two sides of the water
spectrum balancing the eﬀects of direct saturation of the free water, assuming that
the underlying spectrum is symmetric.
NOE
The Nuclear Overhauser Eﬀect (NOE) [20], another type of MT, occurs by dipole-
dipole interaction between protons of diﬀerent molecules. NOE has recently been
discovered for the MRI ﬁeld [19] as a method providing information about the
magnetization transfer between aliphatic protons bound in proteins, peptides and
lipids and the water pool [38]. Similarity of NOE to the myelin proton spectrum
[19, 41] suggests it may be a good candidate for the quantitative myelin imaging
technique.
High field
As MT experiments require high power saturation pulses, conducting them in the
high magnetic ﬁeld leads to the problems with reaching the SAR limits. Moreover,
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increased inhomogeneity of the static magnetic ﬁeld B0 and RF B1 ﬁeld aﬀects
the eﬀective frequency and extent of the saturation and therefore changes the
contrast in the MT images. Despite the SAR limits and the issues related to ﬁeld
inhomogeneity, MT experiments beneﬁt from using ultra high ﬁeld due to increase
in SNR, longitudinal relaxation of water and chemical shift between the water and
macromolecules (especially important for CEST eﬀects). Details of the method used
for the MT measurements in this thesis are described in [30].
2.3.4 PRESTO
PRinciples of Echo-Shifting with a Train Observation (PRESTO) proposed in 1993
[24] is an Echo shifted (ES) sequence with TE>TR. Figure 2.3.6 shows a diagram
of the 2D PRESTO sequence.
2D PRESTO
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8
Figure 2.3.6: Timing diagram of the 2D PRESTO sequence: RF pulse (red), gradients (blue)
and echo signal (grey), with marked echo time (TE) and repetition time (TR) (left). Gradients
positions marked in light blue correspond to the movement in k-space plotted in the same colour
and signal sampling trajectory is indicated by orange circles (right).
Multiple gradient echoes are created during a single TR and the echo train is shifted
using a special conﬁguration of the slice selection gradient pulses: a negative spoiler
gradient pulse dephases transverse magnetisation after the ﬁrst excitation and a
positive refocusing gradient lobe before the second RF pulse. Consequently no
signal is measured in the ﬁrst TR and transverse magnetization created by the ﬁrst
RF pulse is a source of the signal in the next readout period. The same mechanism
is repeated for the following TRs thus providing a sequence with TE>TR. In the
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frequency encoding (readout) direction an EPI-type echo train (bipolar gradient
lobes) is applied with the additional positive rephasing lobe afterwards, resulting in
zero net dephasing of transverse magnetization by gradients within the TR period.
The phase encoding gradient blips include: prephasing lobe of decreasing magnitude
for the subsequent TRs initiating k-space trajectory, phase encoding blips and a
rewinder of increasing magnitude at the end of each TR.
PRESTO provides T 2 weighted contrast and also used when long TE is necessary
(susceptibility based perfusion imaging, BOLD fMRI). It is a fast sequence as
multiple k-space lines are acquired in one TR and TE>TR. PRESTO can be
performed in either 2D or 3D mode.
2.3.5 Magnetic susceptibility mapping
The magnetic susceptibility  quantiﬁes a material’s ability to magnetize and
depends on the types of magnetic dipole moments due to the electrons’ arrangement
within the material. Paramagnetic materials of susceptibility values  > 0
contain atoms with unpaired electrons and have permanent magnetic moments.
Weaker eﬀects appear in diamagnetic materials of susceptibility  < 0 which
have dipole moments induced in presence of the external magnetic ﬁeld. The
strongest magnetization occurs for ferromagnetic materials with   1 which
contain permanent domains of magnetic moments. Single domain particles mixed
with the background substance are called superparamagnetics and have magnetic
susceptibility intermediate to paramagnetic and ferromagnetic materials. Brain
tissues are generally diamagnetic with jj  1, but susceptibility diﬀerences occur
for example for the paramagnetic deoxyhemoglobin in venous blood, iron (in form
of ferritin or hemosiderin) and the air/tissue interfaces (  0 for air). Therefore,
susceptibility measurement may be especially important in neurodegenerative
diseases, such as Parkinson’s disease or multiple sclerosis, where iron content plays
a role (see Chapter 4).
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Magnetic susceptibility measurment
Local magnetic ﬁeld inhomogeneities due to the dipole ﬁelds cause MR signal phase
variations between the regions of diﬀerent susceptibility values allowing a new type of
MRI contrast. The phase of the MR signal, which corresponds to the accumulated
angle of the precessing magnetization of the sample, is determined by the local
magnetic ﬁeld oﬀset, B, and the echo time TE:
 =  BTE; (2.47)
where  is the magnetogyric ratio. Since the magnetic ﬁeld change depends upon
local magnetic susceptibility diﬀerences, the phase of the MR signal can be used as
a source of information about the magnetic properties of the imaged tissue.
For linear materials (isotropic, homogeneous and linear, i.e. where the magnetization
is proportional to the ﬁeld), ifM is the additional macroscopic magnetization of the
sample, the magnetic ﬁeld, B, can be written as:
B =
1 + 

0M(); (2.48)
where  is the magnetic susceptibility and 0 is the permeability of free space. The
relation between the permeability and susceptibility of the substance is deﬁned as
 = (1 + )0.
Fourier-based susceptibility mapping
The standard method used for investigation of susceptibility diﬀerences in the
brain is susceptibility weighted imaging (SWI) which involves combining phase data
with modulus images to enhance the contrast [12]. However, due to the non-local
relationship between the ﬁeld perturbation and underlying susceptibility distribution
[28] as well as the dependence of phase variations on the angle between the head and
the direction of main magnetic ﬁeld [36], direct susceptibility mapping approaches
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provide a more accurate and precise measure [39].
The magnetic ﬁeld inhomogeneity caused by susceptibility diﬀerences can be
calculated using a Fourier method described in [28] and [36]. For an object of
susceptibility (r) placed in an external magnetic ﬁeld, B0, aligned with the z-axis,
the z-component of the induced magnetization can be expressed as:
Mz(r) = (r)
B0
0r(r)
= (r)
B0
0 (1 + (r))
 (r)B0
0
; (2.49)
where the r = =0 is relative permeability and jj  1 is assumed. The magnetic
ﬁeld perturbation at position r is the sum of dipole ﬁelds generated by the elements
of the Mz(r) distribution and can be calculated in the Fourier domain as:
 ~Bz(k) = ~Mz(k)
0
3
 
1  3 cos2  = B0 ~(k)
3
 
1  3 cos2  ; (2.50)
where~indicates a 3D Fourier transform, k is a vector of coordinates in k-space and
 is the angle between k and the direction of the magnetic ﬁeld. As the value of
cos2  =
k2z
k2x + k
2
y + k
2
z
is undeﬁned for k = 0, which in fact contains the average
value of the ﬁeld,  ~Bz(0) is set to 0. Finally the inverse Fourier transform has to
be applied to calculate Bz(r).
The important advantage of this method is the fact that the Lorenz sphere eﬀect
is automatically considered. The results obtained for spherical and cylindrical
objects have been consistent with analytic expression [28, 36]. Experiments using
MR images of the brain and body as well as phantoms have also conﬁrmed the
accuracy of this approach [39, 40]. This Fourier-based method was used across this
thesis to generate 3D susceptibility maps based on the T2-*w FLASH images. The
same approach was also applied to calculate magnetic ﬁeld variations due to the
susceptibility inclusions in the simulations presented in Chapter 3.
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2.4 Summary
This chapter introduced the theoretical basis of the NMR phenomenon and its
applications for acquiring MR images reﬂecting tissue properties. The following
chapters will present simulations using presented theory and experiments applying
described methods to study human brain.
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3
MR signal simulations for
oriented susceptibility
inclusions
The aim of the simulations was to investigate changes of the NMR signal due to
the presence of inclusions of diﬀerent magnetic susceptibility (introduced in Section
2.3.5) compared to the background substance. Inclusions of ellipsoidal shape, all
oriented in the same direction, were used to model microscopic biological objects
present in tissue of the human brain. Spherical perturbers could correspond to iron
particles or proteins carrying iron, oblate ellipsoidal perturbers to the red blood
cells and prolate ellipsoidal perturbers for example to iron-rich oligodendrocytes.
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Involvement of iron in the physiology of healthy and diseased brain (eg. in
Parkinson’s disease) is not yet fully understood and oligodendrocytes contribute to
myelin creation, crucial for demyelination diseases (eg. multiple sclerosis). Therefore
understanding the signal variations due to the susceptibility inclusions aﬀecting
empirical measurements of the T 2 relaxation rate and phase evolution can be helpful
for better understanding the origins of the contrast in gradient echo images of healthy
and diseased brain.
Previous phase imaging studies [3] suggested, that the presence of NMR invisible
microstructural features does not necessarily aﬀect the phase of the NMR signal in
a way that reﬂects the volume average susceptibility. Motivated by these ﬁndings,
the current study investigated the eﬀects of oriented inclusions which generate no
signal.
The aim of the simulations was to investigate the phase and magnitude of the
signal produced by samples containing oriented ellipsoidal perturbers, in order to
understand how phase relates to average susceptibility in microstructured material
containing NMR invisible oriented inclusions.
3.1 Theory
The eﬀects of inhomogeneities in the magnetic ﬁeld generated by susceptibility
diﬀerences between substances are characterised as static, if diﬀusion eﬀects (related
to molecular motion) are not considered. To investigate the signal behaviour in this
case, two-component models containing objects immersed in a medium of diﬀerent
susceptibility are often used [4, 5, 8].
3.1.1 Field perturbation due to sphere
As an illustration of the eﬀect of a susceptibility inclusion, the case of a sphere was
ﬁrst considered. Assume a spherical object of constant magnetic susceptibility, , is
placed in a z-directed magnetic ﬁeld B0 and centred at the origin. If Bout ! B0 far
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from the sphere and the ﬁeld is ﬁnite at the origin, the magnetic ﬁeld at position r
inside the sphere can be expressed as:
Bin(r) = 3B0
1 + 
3 + 
z^; (3.1)
where z^ is a unit vector in the z-direction. Outside the sphere, the ﬁeld in the
z-direction is a sum of the B0 component and a dipole ﬁeld:
Bout(r) = B0z^+B0

3 + 
a
r
3
(3 cos r^  z^) ; (3.2)
where a is the radius of the sphere, (; r) are spherical polar coordinates of the
considered positions and r^ is a radial unit vector [2]. The change in the magnetic
ﬁeld in the z-direction caused by the presence of the sphere of diﬀerent susceptibility
can be then calculated as:
Bin =
2
3 + 
B0 (3.3)
Bout =

3 + 
a
r
3  
3 cos2    1B0 (3.4)
In reality, the susceptibility inside an object is not constant at the macroscopic
scale and interactions between spins cause a vanishing of microscopic susceptibility
eﬀects, which is known as the Lorentz sphere phenomenon [1]. After taking into
account this fact, and assuming that the sphere is now embedded in a medium of
susceptibility, e, such that  =  e, the changes in the eﬀective magnetic ﬁeld
seen by the nuclear magnetization inside and outside the sphere are deﬁned as:
Bin =
1
3
eB0 (3.5)
Bout =

3
a
r
3  
3 cos2    1B0 + 1
3
eB0: (3.6)
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This indicates that the perturber generates a spatially varying external ﬁeld, while
a uniform ﬁeld oﬀset may be present inside the perturber.
3.1.2 Signal calculation
For N objects of total volume v embedded in a medium of volume V0, the relative
volume fraction is deﬁned as & = v
V
, where V = V0 + v. If the volume fraction is
very small, the signal can be calculated (ignoring contributions from the inside of
the objects) as:
S(t) =

V
Z
V0
e i!(r)tdr; (3.7)
where  is the coeﬃcient representing parameters of the scan (spin density, ﬂip angle,
etc.). This calculation also holds in the case where the objects generate no NMR
signal. Assuming that the results will be presented with respect to the frequency
of the rotating frame !0 = B0 and the external magnetic ﬁeld, B0, is aligned with
the z-axis, the frequency at position r can be written as follows:
!(r) =
X
n
!n(r  rn) = 
X
n
Bzn(r  rn) = Bz(r); (3.8)
where rn is the reference vector deﬁning the position of the n-th object and
Bzn(r   rn) is the z-component of the magnetic ﬁeld created by the n-th object
at point r.
For a random distribution, in which the objects are not overlapping, the average
signal can be calculated using the following formula:
S(t) = (1  &)
NY
n=1
1
V   vn
Z
V vn
e i!n(r rn)tdr (3.9)
where vn is the volume of the n-th object. As the function !n(r   rn) depends
on the geometry of the object, further analytical derivation is performed for the
example case of spherical objects. For the simulations presented in the following
sections, the method described in Section 2.3.5 was used instead of the analytic
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Bz(r) calculation.
3.1.3 Signal behaviour due to spheres
For the n-th sphere of radius an, the frequency can be calculated according to the
following formula:
!n(r  rn) = !s
an
r
3  
3 cos2    1 ; (3.10)
where r = jr  rnj,  is the angle between the z-component of the external magnetic
ﬁeld and the vector r rn. The characteristic frequency shift for the sphere is deﬁned
as:
!s =
B0
3
; (3.11)
where  represents the susceptibility diﬀerence between the sphere and the
medium.
Calculations of the average signal presented in [8] showed that the signal is dependent
on the volume fraction of perturbers, but not on the particular size distribution of the
objects. For the short time limit t!s  1:5 the signal is a quadratic exponentially
decaying function:
S(t) = (1  &)e 0:4&(t!s)2 (3.12)
and for the long time t!s  1:5 is described as an exponential function with an
oscillating part:
S(t) = (1  &)e i!steR20sjt tsj; (3.13)
where the shift from the reference frequency !s = c&!s, where c =  0:15977,
ts =

2
3
p
3
!s
 1
and
R20s =
2
3
p
3
&!s:
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3.1.4 Signal behaviour due to ellipsoids
The ﬁeld perturbations produced by ellipsoidal perturbers are more diﬃcult to
calculate analytically [4], hence the use of a numerical approach for evaluating ﬁeld
perturbations. However some insight can be gained by considering the ﬁeld oﬀsets
produced inside an ellipsoidal perturber, often known as the demagnetizing ﬁeld.
The dependence of the demagnetizing ﬁeld on the shape of an ellipsoidal perturber
can be described using a demagnetizing factor [6], which for an ellipsoid formed by
revolution about the z-axis (a = b, c = qa) are deﬁned as Dxe = Dye = (1 Dze)=2
and:
Dze(q) =
qln(q +
p
q2   1)
(q2   1)3=2  
1
q2   1 ; (3.14)
where the subscripts x, y or z indicates the direction of the applied ﬁeld relative
to the ellipsoid. For randomly distributed and randomly oriented ellipsoids of
revolution the signal has been shown to follow a quadratic exponential decay in
the short time regime (t!s  1) and a linear exponential function in the long time
regime (t!s  1) [4].
3.2 Methods
3.2.1 One perturber
The simulations were ﬁrst run using one perturber, separately for two ellipsoids of
revolution with aspect ratios of 1:1:2 and 1:1:4, and for a sphere. The object was
placed in the centre of the space, in the external magnetic ﬁeld, with the longest
dimension parallel to the ﬁeld direction. The maximum dimension of each object
was set equal to 100 voxels and the overall space was a cube of 5003 voxels. The
external magnetic ﬁeld was set to a value of 7T and the magnetic susceptibility
diﬀerence between the object and the surrounding medium had a value of 10 7.
The Fourier method described in Section 2.3.5 was used to calculate the magnetic
ﬁeld shifts. The complex signal was calculated in each voxel, excluding the inside of
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the object, for TE values in the range of 1-100 milliseconds. A separate simulation
was performed to examine the inﬂuence of the volume fraction (object’s size relative
to the total space considered) on the signal.
3.2.2 Multiple perturbers
The magnetic ﬁeld perturbation due to the susceptibility distribution was calculated
using the Fourier method described in Section 2.3.5. Simulations were run for
randomly positioned inclusions consisting of ellipsoids of revolution with diﬀerent
aspect ratios (a:b:c), as illustrated in Figure 3.2.1, ranging from 1:1:6=needles to
1:1:1=spheres to 6:6:1=pancakes.
c
ab
Figure 3.2.1: Illustration of the ellipsoid aspect ratio a:b:c.
Three sizes of ellipsoid were included in each case (small, medium, large), and the
volume fraction (V F = &) of the inclusions was varied from 1-5%. Small volume
fractions allowed the comparison of the simulated results with previously presented
data [8] and had and additional advantage of simplifying the simulations. All of the
ellipsoids had the same orientation such that axis of revolution was parallel to the
ﬁeld. The dimensions, sizes and volumes of the ellipsoids are summarised in Table
3.2.1; average numbers of perturbers for each volume fraction and for each variant
of the perturber’s dimension ratio are shown in Table 3.2.2.
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small medium large
a:b:c size volume size volume size volume
1:1:6 6 6 36 5429 7 7 42 8621 8 8 48 12868
1:1:5 6 6 30 4524 7 7 35 7184 8 8 40 10723
1:1:4 7 7 28 5685 8 8 32 8453 9 9 36 12173
1:1:3 8 8 24 6434 9 9 27 9161 10 10 30 12566
1:1:2 9 9 18 6089 10 10 20 8309 11 11 22 11117
1:1:1 11 11 11 5575 13 13 13 9171 14 14 14 11513
2:2:1 14 14 7 5747 16 16 8 8578 18 18 9 12215
3:3:1 15 15 5 4712 18 18 6 8143 21 21 7 12931
4:4:1 16 16 4 4289 20 20 5 8378 24 24 6 14476
5:5:1 15 15 3 2827 20 20 4 6702 25 25 5 13090
6:6:1 12 12 2 1206 18 18 3 4071 24 24 4 9651
Table 3.2.1: Summary of the sizes and volumes of the perturbers of diﬀerent dimensions and
ratios, measured as a number of voxels.
vf 1:1:6 1:1:5 1:1:4 1:1:3 1:1:2 1:1:1 2:2:1 3:3:1 4:4:1 5:5:1 6:6:1
1% 141 174 146 138 150 97 144 148 138 164 292
2% 294 350 284 272 303 187 280 303 294 354 592
3% 430 570 423 404 444 281 438 450 432 540 854
4% 567 693 592 540 606 384 586 609 603 710 1150
5% 704 873 722 690 740 472 734 762 766 924 1485
Table 3.2.2: Average (N=5) number of perturbers for the particular volume fraction and
perturber’s dimension ratio.
Inclusions were placed at random positions inside a larger cylindrical region,
not crossing the external boundaries and not overlapping with each other (for
details regarding the overlapping condition see Appendix 1). An external shape
corresponding to an inﬁnite cylinder was chosen to avoid an otherwise necessary
correction of the average phase [3]. The choice of external shape aﬀects only
the average frequency oﬀset and in the case of dilute perturbers does not have a
signiﬁcant eﬀect on the evolution of the signal magnitude. The size of the simulation
space was 5003 voxels and the external cylinder’s radius was equal 230 voxels. Each
ellipsoid’s axis of revolution was aligned with the applied magnetic ﬁeld (B0=7T)
and a susceptibility diﬀerence, , between the inclusions and the matrix of 0.1ppm
was used, yielding a value of  = B0 of 187s 1. The axis of the external cylinder
was also aligned with the ﬁeld direction. The complex MR signal from the whole
region, ignoring contributions from inside the ellipsoids, was calculated for TE values
in the range of 1-100ms. The variations of the phase and log of the signal magnitude
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with TE were ﬁtted using polynomials in two diﬀerent time ranges (0-25ms = short)
and (75-100ms = long). Linear ﬁtting was performed for the phase of the signal in
both time ranges, and for the log of the magnitude, in the long time range only. The
quadratic function was used for the log of the signal magnitude in the short time
range, following previously presented theory [8]. The variation of the amplitudes of
the resulting polynomial coeﬃcients with the volume fraction and ellipsoid shape
was then evaluated.
3.3 Results
3.3.1 One perturber
Figure 3.3.1 presents maps of the magnetic ﬁeld shift calculated using the Fourier
method, together with the masks of the perturbers used. Inside the sphere and
ellipsoids the ﬁeld oﬀset is uniform, outside a characteristic dipole-like ﬁeld appears.
With increasing aspect ratio, the regions of positive ﬁeld shift above and below the
ellipsoid are reduced in extent.
Figure 3.3.1: Magnetic ﬁeld shift due to the susceptibility diﬀerence for a sphere and ellipsoids,
in central x-y (top) and x-z (bottom) plane with overlaid outlines of the perturbers in
transparent-red (left); masks of the corresponding perturbers (right).
Figure 3.3.2 presents maps of phase of the signal obtained for TE = 100ms shown
in central x-y and x-z planes with the outlines of the ellipsoidal perturbers indicated
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in red. Phase wrapping occurs in the regions of large ﬁeld variation.
π π
Figure 3.3.2: The map of phase (radians) of the signal obtained for TE = 100ms, x-y (top)
and x-z (bottom) plane.
The variation of the total signal as a function of TE is presented in the plots in
Figure 3.3.3. Loss of the signal increases with TE due to increased dephasing and
is fasterst for the sphere. At short TEs the phase averages to zero for the sphere.
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Figure 3.3.3: Magnitude (left) and phase (right) of the total signal from a cube surrounding
sphere and two ellipsoids of diﬀerent sizes as a function of TE .
Figure 3.3.4 shows the results calculated for spheres of diﬀerent sizes (volume
fractions), indicating that the signal loss and phase accumulated at long TE both
increase with increasing volume fraction.
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Figure 3.3.4: Magnitude (left) and phase (right) of the total signal calculated from a cube
surrounding a single sphere for diﬀerent volume fractions (1, 5, 10%); volume fraction changes
were produced by increasing the size of the sphere.
3.3.2 Multiple perturbers
Figure 3.3.5 shows a cross section through the structure in the cylindrical region
and the resulting ﬁeld perturbation for ellipsoids of aspect ratio of 1:1:3 and volume
fraction 3%.
Figure 3.3.5: Coronal slice through ﬁeld perturbation (left) and susceptibility distribution
(right) for ellipsoids with an aspect ratio of 1:1:3 and a volume fraction of 3%.
Figure 3.3.6 presents a coronal slice of the map of phase of the signal obtained for
TE = 100ms.
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π π
Figure 3.3.6: The map of phase of the signal obtained for TE = 100ms, in a coronal slice.
Example plots of the log of the magnitude and of the phase of the signal (along
with the polynomial ﬁts in the two regimes) for =0.1ppm for spheres with volume
fractions of 1, 3 and 5% are shown in Figure 3.3.7; similar plots for needles and
pancakes with a volume fraction of 3% are presented in Figure 3.3.8.
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Figure 3.3.7: Signal magnitude (left) and phase (right) variation with TE for spheres with
VF=1, 3, 5%. Polynomial ﬁts are shown for the two regimes.
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Figure 3.3.8: Signal magnitude (left) and phase (right) variation with TE for needles (1:1:2
and 1:1:4) and pancakes (2:2:1 and 4:4:1) with VF= 3%. Polynomial ﬁts are shown for the
two regimes.
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In all cases the natural log of the signal magnitude varied quadratically with TE
(proportional to: const + a2TE2) in the short echo time regime and linearly with TE
(proportional to: const + b1TE) in the long echo time case. The phase was found to
vary linearly with TE in both regimes, but with diﬀerent constants of proportionality
(written as c1 and d1 in the short and long TE regimes, respectively). The dominant
polynomial coeﬃcients were found to scale linearly with volume fraction. Figure
3.3.9 shows the variation of c1=(  V F ) with the demagnetising factor of the
ellipsoids (see Section 3.1).
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Figure 3.3.9: The variation of c1=( V F ) with the demagnetising factor of the ellipsoids.
Figure 3.3.10 shows the variation with the ellipsoid aspect ratio, q, of the other
coeﬃcients in appropriately-scaled, dimensionless forms (a2=(2V F ), b1=(V F )
and d1=( V F )).
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Figure 3.3.10: The variation with the ellipsoid aspect ratio, q, of the coeﬃcients a2=(2V F ),
b1=( V F ) and d1=( V F ).
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3.4 Discussion
The ﬁndings presented in this chapter are in agreement with theory previously
described for spherical, cylindrical [8] and ellipsoidal [4] inclusions. As reviewed
in Section 3.1 the transition between the short and long time regimes occurs at
t!s  1:5. Therefore quadratic evolution of the natural logarithm of signal
magnitude and linear evolution of signal phase were expected in the two diﬀerent
time ranges used for the polynomial ﬁtting since for TE=25ms and 75ms t!s is
approximately equal to 1.56 and 4.68. Importantly, the results indicate that the
measured phase scales linearly with echo time and volume fraction, even in the
regime where the induced phase is  2 close to the oriented inclusions.
The linear variation of phase with Dze in the short-TE regime presented in Figure
3.3.9 was previously predicted from simple analysis of the average ﬁeld in the matrix
[7]. These data indicate that at short TE the measured phase depends strongly on
the shape of the ellipsoids and that pancakes have a larger eﬀect than needles.
In Figure 3.3.10 the coeﬃcient a2, which characterises the variation of the signal
magnitude at short TE, is largest when q  0:5, indicating that slightly pancake-
like ellipsoids oriented in the ﬁeld direction have the strongest eﬀect on signal decay
in the short TE regime. This is in contrast to the case of randomly oriented
ellipsoids for which it has been shown that spheres (q = 1) cause the fastest signal
decay [4]. Figure 3.3.10 indicates that the coeﬃcient, b1, which characterises the
rate of exponential decay of the signal at long TE is approximately constant for
intermediate q-values (0.33 to 2) taking a value of  0:4V F . This is the value
predicted for a random arrangement of point dipoles with an equivalent volume
average magnetic moment [8]. Similarly the coeﬃcient, d1, which describes the
eﬀective angular frequency oﬀset at long TE takes a value of  0:28V F for
intermediate q-values, again as predicted for point dipoles arranged in a cylindrical
volume [8]. In this long-TE regime (TE=75-100 ms, intermediate q) the behaviour
of the signal magnitude and phase is therefore largely independent of the shape
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of the ellipsoids and reﬂects the average susceptibility. This behaviour can be
understood by considering the variation of the signal contributions with distance
from the centre of each ellipsoid. Rapid phase variation around a needle nulls
the signal out to a radius that is approximately 3
p
TEq 2(2) 1, times the z-
dimension of the ellipsoid (for pancakes q 2 is replaced with q). If this radius is
larger than the extent of the ellipsoid then the region which generates a signiﬁcant
signal experiences a purely dipolar ﬁeld and so the behaviour can be adequately
described using a distribution of dipoles. For the maximum value of TE  18:7
considered here, this condition is satisﬁed for 0:34 < q < 1:7, as illustrated in Figure
3.4.1 (top row) for TE=100ms and 7 diﬀerent ellipsoid aspect ratios. Additional
simulations indicated that increasing TE expands the range of q-values for which
simple dipolar behaviour holds. Figure 3.4.1 shows the phase variation (middle and
bottom row) for TE=100, 200 and 300ms.
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Figure 3.4.1: The map of phase of the signal obtained for ellipsoids of diﬀerent aspect ratios (q
values) in TE=100ms (top), TE=200ms (middle) and TE=300ms; outline of the perturber
marked in red and radius of 3
p
TEq 2(2) 1 (q > 1) or 3
p
TEq(2) 1 (q < 1) in yellow.
3.5 Conclusions
Numerical simulations of the NMR signal in the presence of ellipsoidal inclusions
have provided insight into the eﬀect of the shape and concentration of oriented,
inclusions of high susceptibility, on the contrast in phase and T 2 -weighted images.
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The ellipsoidal perturbers used in the presented simulations can potentially
correspond to various paramagnetic biological objects found in the human brain,
such as red blood cells, iron particles and proteins carrying iron, or particulate
contrast agents used in MRI. The signal simulations performed in this study may
therefore improve our understanding of the T 2 -w contrast and its dependence on
the volume fraction, shape, size and distribution of these objects.
The importance of iron in the physiology of the healthy human brain and its
role in the pathological processes underlying neurodegenerative diseases, such as
Parkinson’s disease and multiple sclerosis, are discussed in Chapter 4 of this thesis.
The next two chapters of the thesis presents empirical studies of the properties of the
tissue in healthy and diseased brain using MRI, with a special focus on iron content
changes. The aim of the simulations presented in this chapter was to provide deeper
understanding of how the images used to asses iron concentration may depend on the
microscopic characteristics of the imaged iron stores. However, more work relating
the simulated results to the experiments regarding microscopic structure of the tissue
is required to take a full advantage of these ﬁndings.
References
[1] S. C. Chu, Y. Xu, J. a. Balschi, and C. S. Springer, Bulk magnetic
susceptibility shifts in NMR studies of compartmentalized samples: use of
paramagnetic reagents., Magnetic Resonance in Medicine, 13 (1990), pp. 239–62.
[2] E. M. Haacke, R. W. Brown, M. R. Thompson, and R. Venkatesan,
Magnetic Resonance Imaging. Physical Principles and Sequence Design, John
Wiley & Sons Ltd, Totowa, NJ, 1999.
[3] X. He and D. a. Yablonskiy, Biophysical mechanisms of phase contrast in
gradient echo MRI., Proceedings of the National Academy of Sciences of the
United States of America, 106 (2009), pp. 13558–63.
69
[4] A. L. Sukstanskii and D. A. Yablonskiy, Theory of FID NMR signal
dephasing induced by mesoscopic magnetic ﬁeld inhomogeneities in biological
systems., Journal of Magnetic Resonance, 151 (2001), pp. 107–17.
[5] A. L. Sukstanskii and D. a. Yablonskiy, Gaussian approximation in the
theory of MR signal formation in the presence of structure-speciﬁc magnetic
ﬁeld inhomogeneities. Eﬀects of impermeable susceptibility inclusions., Journal
of Magnetic Resonance, 167 (2004), pp. 56–67.
[6] R. Ulrich, R. W. Glaser, and A. S. Ulrich, Susceptibility corrections in
solid state NMR experiments with oriented membrane samples . Part II : Theory,
Journal of Magnetic Resonance, 164 (2003), pp. 115–127.
[7] S. Wharton, A. Schäfer, and R. Bowtell, Susceptibility Mapping in the
Human Brain Using Threshold-Based k-Space Division, 63 (2010), pp. 1292–1304.
[8] D. A. Yablonskiy and M. E. Haacke, Theory of NMR Signal Behavior in
Magnetically Inhomogeneous Tissues: The Static Dephasing Regime, Magnetic
Resonance in Medicine, 32 (1994), pp. 749–763.
70
4
Role of iron in
neurodegenerative diseases
Non-haeme iron present in the brain has been shown to play a role in the
pathogenesis of various neurodegenerative diseases, such as Parkinson’s disease
(PD), Alzheimer’s disease (AD), multiple sclerosis (MS), Huntington’s disease
(HD), Neuodegeneration with Brain Iron Accumulation Type 1 (formally known
as Hallervorden-Spatz syndrome) and others. The exact role of iron in pathological
processes and in normal physiology is not yet fully understood. Various reviews
summarising the current state of knowledge with regards to the signiﬁcance of iron
in neurodegeneration [7, 36, 64] and use of MRI for iron imaging [28, 60] are available.
Here, a brief summary regarding brain iron is presented, limited to the purpose of
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this thesis, together with possible ways of measuring brain iron content post mortem
(PM) and in vivo. A short discussion of the characteristic of PD and MS is given,
including role of iron in these diseases.
4.1 Brain iron
There are two subtypes of iron in the human body: haeme iron, which is found
in haemoglobin providing tissues with oxygen, and in some enzymes, and non-
haeme iron which plays an important role in many aspects of normal metabolism,
being involved in myelination and neuro-transmission and as a co-factor for tyrosine
hydroxylase (TH), an enzyme required for dopamine synthesis. About 60mg of non-
haeme iron is present in the brain [30], in the form of free ions (Fe2+ and Fe3+), as
a part of low-weight molecular complexes or bound to proteins, of which the most
important are transferrin and ferritin.
Transferrin, which can bind two Fe3+ ions, is responsible for transporting iron from
blood to the brain tissue. Ferritin is a storage protein able to carry within its
core up to 4500 Fe3+ ions in the form of ferrihydrite (5Fe2O3 q9H2O). Storage
of ferrous Fe2+ iron requires oxidation to the ferric Fe3+ form and is not only
important for metabolic processes, but also plays protective role to prevent iron
toxicity, as described below. Ferritin’s protein shell can contain diﬀerent proportions
of two components: light (L)-chain and heavy (H)-chain ferritin; L-rich ferritin is
associated with long term iron storage and H-rich ferritin is present in organs which
utilise iron [57]. An additional iron storage protein, hemosiderin is considered to be a
degeneration product of ferritin, the occurrence of which is connected to hemorrhage
and iron overload diseases.
Neuromelanin (NM), a complex molecular structure forming the dark pigment
present in the substantia nigra and locus coeruleus of the human brain, which also
contains iron [16, 71]. NM binds ferric iron and is generally not fully loaded in
vivo [16]. Iron is also involved in NM creation [71]. Binding of iron to NM may
play a protective role, but may also increase the risk of oxidative damage within the
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dopaminergic neurons in case of increased iron content, for example in PD [24]. Iron
accumulation within the NM cells has been shown to increase in PD [24], however
the amount of NM has been shown to decrease in PD and to increase in normal
ageing [70].
Free ferrous iron can lead to the creation of highly reactive hydroxyl radicals (OH q)
via the Fenton reaction (4.1):
Fe2+ +H2O2  ! Fe3+ +OH  +OH q: (4.1)
Moreover, Fe3+ can be reduced via the Harber-Weiss reaction (4.2):
Fe3+ +O
q 
2  ! Fe2+ +O2; (4.2)
aﬀecting redox cycling of iron [35]. Free iron is therefore considered to be highly
toxic, leading to the oxidative stress, which causes damage and death of the cells
[21].
Iron in the human brain is distributed non-uniformly with the highest concentration
found in the basal ganglia (for detailed review see [28]) and has been shown
to accumulate with age [31]. Increased iron levels were found in various
neurodegenerative diseases [21], for further description regarding PD and MS see
the following sections of this chapter.
4.2 Imaging of brain iron
The method most commonly used to study regional iron content in PM tissue
involves the use of Perls’ stain [54]. This stain is claimed to be sensitive to local
concentration of ferric ions, however recent studies showed that in fact Perls’ is not
speciﬁc to the iron oxidation state, as the chemical compounds used for staining also
react with Fe2+ [47]. This method has some disadvantages; ﬁrst, staining depends
on the way iron is bound and not all the iron is stained (iron bound in NM remains
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unstained). Tissue ﬁxation causes additional problems, depending on the pH of
the formalin, loosely bound iron can be released from ferritin and hemosiderin [47],
which leads to iron leaching [20, 61]. Alternative methods for investigating iron
content in PM tissue include microscopic experiments using frozen, unﬁxed tissue
[51], Mössbauer spectroscopy [19] or high energy X-ray absorption spectroscopy [27].
Iron content in vivo can also be studied using MRI. Of the diﬀerent forms of non-
haeme iron only ferritin and hemosiderin are visible in MRI due to their high
concentrations [59]. Iron present in tissue as a magnetic material reduces T2 and,
to smaller extent, T1 relaxation times and therefore appears hypointense in T2-
w and hyperintense in T1-w images [28]. Strong linear correlation of R2 = 1=T2
with iron concentration has been found in healthy grey matter as well as linear
dependence of iron related R2 on magnetic ﬁeld strength [22, 58, 67]. However
other factors, such as decreased water content reduces the amount of free water
and hence shortens T2 and lead to potential mis-interpretation of the results [28].
Other studies suggested that R02 related to local ﬁeld inhomogeneities reﬂects iron
content better than R2 [22, 53], but its values are relatively small and therefore
diﬃcult to measure accurately. Instead T 2 maps can be used, which contain a T
0
2
contribution as T2*=1/R2=1/R2+1/R
0
2, such maps have been shown to have higher
sensitivity to iron concentration than T2, both post mortem [39] and in vivo [65]. T 02
and in consequence also T 2 measurements may be aﬀected by the background ﬁeld
inhomogeneity and require correction for such eﬀects [53].
It has also been shown in previous work that phase shifts in GE images correlate
with iron concentrations derived from the literature [52]. However phase shifts
have a non local correspondence to the underlying susceptibility distribution. A
new way of visualising iron content by combining phase and magnitude data to
estimate susceptibility values has been proposed, called susceptibility weighted
imaging (SWI) [30]. More recently Fourier-based methods using phase data for
accurate quantitative susceptibility mapping have also been developed [43, 63, 69]
giving results that correlated well with iron content [44, 62, 63, 68].
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Ferritin and haemosderrin were ﬁrst considered to cause MR relaxation by the
outer sphere mechanism: de-phasing of the spins of the diﬀusing water due to the
proximity of the aggregate of magnetic atoms kept away from water (iron within
the protein shell). However this model did not explain the linear magnetic ﬁeld
strength dependence of the transverse relaxation rate, due to the presence of ferritin.
A new approach was proposed, called proton-exchange de-phasing model (PEDM)
explaining this eﬀect by the exchange between structural protons of the hydroxyl
groups (OH) of the surface of hydrous iron oxide (ferrihydrite) particles and protons
of free water. This model predicts that relaxation rates are higher in lower pH,
where more exchangeable protons exist [25].
As the interpretation of the results of quantitative MRI data acquired in vivo is
non trivial and the contrast obtained depends on tissue microstructure, studies
comparing PM MRI with histology data can provide valuable information about
healthy and diseased human brain [37]; speciﬁcally regarding investigation of the
iron content [4, 46] as presented in Chapter 5.
4.3 Iron in Parkinson’s Disease
Parkinson’s disease (PD) is (after Alzheimer’s disease) the second most common
neurodegenerative disorder [14], aﬀecting up to 1% of the population and with
onset generally occurring in people older than 60 [50]. Post mortem studies of
PD demonstrate selective dopaminergic cell loss in the nigrostratial pathway, in
the substantia nigra pars compacta (SNpc) [18], as well as pathology of such brain
structures as nucleus basalis of Meynert and locus coeruleus [15].
The cause of neurodegeneration in PD is not fully elucidated, but it is potentially
related to mitochondrial dysfunction, oxidative stress or protein mishandling [26].
The increased levels of iron that have been reported in the SN in PD patients [56, 66]
support a role for iron-mediated oxidative stress in PD pathogensis. It has also been
found that environmental chemicals (pesticides) may cause dopaminergic cell death
in PD [3]. There is growing evidence relating the occurrence of PD to genetic factors
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[11].
PD is clinically diagnosed using the UK PD Brain Bank Criteria with fatiguable
bradykinesia as the obligatory criterion along with one of the following: tremor,
rigidity or gait disorder [32]. Diagnosis of PD is further supported by an excellent
L-dopa response, subsequent development of L-dopa related motor ﬂuctuations and
ﬁnally cortical Lewy body depositon leading to dementia and visual hallucination.
Misdiagnosis is especially common in the early stages of the disease (4-17% in
clinical trials and up to 25% in community studies) and a biomarker for PD is
yet to be established [14]. The Uniﬁed Parkinson’s disease rating scale (UPDRS)
[17] is used to asses the clinical status of PD patients and can be used to monitor
disease progression, albeit with limited sensitivity. The rate of conﬁrmation of the
clinical diagnosis by histopathological ﬁndings varies from 80-90% (see the review
paper, [42]), but there are no generally accepted criteria; the most commonly used
is the ﬁnding of degeneration of dopaminergic neurons in the SNpc along with the
presence of proteinaceous inclusions, so called Lewy bodies. To diﬀerentiate PD
from other tremulous syndromes, neuroimaging techniques such as (123I)ioﬂupane
(also called (123I)FP-CIT), DaTSCAN, are becoming more widely used [1, 13].
Chelation treatment has been proposed for binding the excess iron occurring in
PD [49]. Diﬃculties with this approach include the requirement for highly selective
chelators, which should only aﬀect the intracellular reactive labile iron pool, and not
the bound iron that is essential for physiological function, as that could inﬂuence
systemic iron homeostasis. Moreover, chelators need to have the ability to cross
the brain blood barrier (BBB) and the resulting bound products have to be non-
toxic. Some studies have shown that chelation treatment can reverse PD symptoms
in transgenic mice [34], as well as successful chelation treatment in patients with
Friedrich ataxia, another disease where increased iron levels are present [5].
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4.4 Iron in Multiple Sclerosis
Multiple sclerosis (MS) is a chronic, autoimmune, inﬂammatory disease of the central
nervous system (CNS), leading to demyelination and axonal loss, which results in
the formation of lesions (plaques) [33]. MS generally aﬀects young adults (20-45y.o.),
is twice as common in women as men, and has a high prevalence in descendants of
Northern Europeans (Europe and North America) [23]. The main clinical symptoms
of MS include: sensory disturbances (numbness and tingling), visual loss, loss of
muscle control and weakness. Life expectancy after the onset of the disease is
reduced by about 5-15 years.
MS most often starts as a clinically isolated syndrome (CIS), involving an episode of
symptoms suggestive of demyelination, usually aﬀecting the optic nerve, spinal cord,
brain stem or cerebellum [48]. The second episode, occurring within 2-3 years in most
cases, determines the conversion from CIS to MS [33]. The course of the disease can
be progressive or relapsing. The most common type of MS is relapsing-remitting
(RRMS, 85%), then primary progressive (PPMS, 10%) and progressive-relapsing
(PRMS, 5%). Some RRMS patients develop secondary progressive MS (SPMS).
The diagnostic criteria, which were deﬁned by McDonald et al. [45], and recently
revised [55] include clinical assessment supported by laboratory tests (examination of
cerebrospinal ﬂuid (CSF)) and use of MRI for lesion detection. Disease progression
is measured with Expanded Disability Status Scale (EDSS) [38]. There is no cure
for MS, however various disease-modifying therapies are available [23].
As previously mentioned, iron plays an important role in myelination.
Oligodendrocytes responsible for the creation of myelin have high levels of iron and
ferritin, and iron is also found in myelin [8, 9, 41]. Dysfunction of oligodendrocytes
has been proposed as being important in the pathological processes involved in MS
[10]. Elevated levels of ferritin have been reported in patients with progressive MS,
which may be a sign of the defence mechanism for binding iron and preventing
oxidative stress [40]. It was also shown in PM work that iron accumulation occurs
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in the periphery of demyelinated MS plaques [12]. MRI studies conﬁrmed these
results [29] and also found increased iron content in deep grey matter, both in MS
[2] and in CIS [6] patients.
4.5 Conclusions
Considering the importance of iron in the pathogenesis of neurodegenerative diseases
such as PD and MS, in vivo imaging of iron can potentially provide non-invasive
tools for diagnosis, monitoring or better understanding. MRI has proved successful
for both qualitative and quantitative assessment of iron content in the brain. The
following chapters of this thesis will present various studies applying MRI methods
to investigate pathology and possible diagnostic tools related to iron, regarding PD
and MS.
References
[1] N. Bajaj, R. a. Hauser, and I. D. Grachev, Clinical utility of dopamine
transporter single photon emission CT (DaT-SPECT) with (123I) ioﬂupane in
diagnosis of parkinsonian syndromes., Journal of Neurology, Neurosurgery &
Psychiatry, (2013).
[2] R. Bakshi, R. H. B. Benedict, R. A. Bermel, S. D. Caruthers, S. R.
Puli, C. W. Tjoa, A. J. Fabiano, and L. Jacobs, T2 Hypointensity in the
Deep Gray Matter of Patients With Multiple Sclerosis, Archives of Neurology,
59 (2002), pp. 62–68.
[3] R. Betarbet, T. B. Sherer, G. Mackenzie, M. Garcia-osuna, A. V.
Panov, and J. T. Greenamyre, Chronic systemic pesticide exposure
reproduces features of Parkinson’s disease, Nature Neuroscience, 3 (2000),
pp. 1301–1306.
78
[4] A. I. Blazejewska, S. T. Schwarz, A. Pitiot, M. C. Stephenson,
J. Lowe, N. Bajaj, R. W. Bowtell, D. P. Auer, and G. P. A,
Visualization of nigrosome 1 and its loss in PD: Pathoanatomical correlation
and in vivo 7T MRI., Neurology, 81 (2013), pp. 534–540.
[5] N. Boddaert, K. H. Le Quan Sang, A. Rötig, A. Leroy-Willig,
S. Gallet, F. Brunelle, D. Sidi, J.-C. Thalabard, A. Munnich, and
Z. I. Cabantchik, Selective iron chelation in Friedreich ataxia: biologic and
clinical implications., Blood, 110 (2007), pp. 401–8.
[6] A. Ceccarelli, M. a. Rocca, M. Neema, V. Martinelli, A. Arora,
S. Tauhid, A. Ghezzi, G. Comi, R. Bakshi, and M. Filippi, Deep gray
matter T2 hypointensity is present in patients with clinically isolated syndromes
suggestive of multiple sclerosis., Multiple Sclerosis, 16 (2010), pp. 39–44.
[7] J. F. Collingwood and J. Dobson, Nanoscale Iron Compounds Related
to Neurodegenerative Disorders, in Biomedical Nanostructures, K. Gonsalves,
C. Halberstadt, C. T. Laurencin, and L. Nair, eds., no. chapter 18, John Wiley
& Sons, 2008, pp. 461–490.
[8] J. R. Connor, K. L. Boeshore, S. A. Benkovic, and S. L. Menzies,
Isoforms of ferritin have a speciﬁc cellular distribution in the brain., J Neurosci
Res, 4 (1994), pp. 461–5.
[9] J. R. Connor and S. L. Menzies, Relationship of Iron to Oligodendrocytes
and Myelination, Glia, 17 (1996), pp. 83–93.
[10] J. R. Connor, S. L. Menzies, J. R. Burdo, and P. J. Boyer, Iron
and iron management proteins in neurobiology., Pediatric neurology, 25 (2001),
pp. 118–29.
[11] I. P. D. G. Consortium, Imputation of sequence variants for identiﬁcation
of genetic risks for Parkinson’s disease: a meta-analysis of genome-wide
association studies, Lancet, 377 (2011), pp. 641–649.
79
[12] W. Craelius, M. W. Midgral, C. P. Luessenhop, A. Sugar, and
I. Mihalakis, Iron deposits surrounding multiple sclerosis plaques, Archives
of Patholgy & Laboratory Medicine, 106 (1982), pp. 397–399.
[13] R. de la Fuente-Fernández, Role of DaTSCAN and clinical diagnosis in
Parkinson disease., Neurology, 78 (2012), pp. 696–701.
[14] L. M. L. de Lau and M. M. B. Breteler, Epidemiology of Parkinson’s
disease, Lancet Neurology, 5 (2006), pp. 525–35.
[15] K. Del Tredici and H. Braak, Dysfunction of the locus coeruleus-
norepinephrine system and related circuitry in Parkinson’s disease-related
dementia., Journal of Neurology, Neurosurgery & Psychiatry, (2012),
pp. 774–783.
[16] K. L. Double, M. Gerlach, V. Schünemann, A. X. Trautwein,
L. Zecca, M. Gallorini, M. B. Youdim, P. Riederer, and
D. Ben-Shachar, Iron-binding characteristics of neuromelanin of the human
substantia nigra, Biochemical Pharmacology, 66 (2003), pp. 489–494.
[17] S. Fahn and R. Elton, Uniﬁed Parkinson’s disease rating scale, in Recent
developments in Parkinson’s disease, S. Fahn, C. Marsden, M. Goldstein, and
D. Calne, eds., 1987, pp. 153–63.
[18] J. M. Fearnley and A. J. Lees, Ageing and Parkinson’s disease: substantia
nigra regional selectivity, Brain, 114 (1991), pp. 2283–2301.
[19] A. Friedman, J. Galazka-Friedman, and D. Koziorowski, Iron as
a cause of Parkinson disease - a myth or a well established hypothesis?,
Parkinsonism & Related Disorders, 15 Suppl 3 (2009), pp. S212–4.
[20] K. Gellein, T. P. Flaten, K. M. Erikson, M. Aschner, and
T. Syversen, Leaching of trace elements from biological tissue by formalin
ﬁxation., Biological Trace Element Research, 121 (2008), pp. 221–5.
80
[21] B. B. Gelman, Iron in CNS Disease, Journal of Neuropathology and
Experimental Neurology, 54 (1995), pp. 477–286.
[22] N. Gelman, J. M. Gorell, P. B. Barker, R. M. Savage, E. M.
Spickler, J. P. Windham, and R. a. Knight, MR imaging of human
brain at 3.0 T: preliminary report on transverse relaxation rates and relation
to estimated iron content., Radiology, 210 (1999), pp. 759–67.
[23] M. M. Goldenberg, Multiple Sclerosis Review., P & T : a peer-reviewed
journal for formulary management, 37 (2012), pp. 175–84.
[24] P. F. Good, C. W. Olanow, and D. P. Perl, Neuromelanin-containing
neurons of the substantia nigra accumulate iron and aluminum in Parkinson’s
disease: a LAMMA study, Brain Research, 593 (1992), pp. 343–346.
[25] Y. Gossuin, a. Roch, F. Lo Bue, R. N. Muller, and P. Gillis,
Nuclear magnetic relaxation dispersion of ferritin and ferritin-like magnetic
particle solutions: a pH-eﬀect study., Magnetic resonance in medicine : oﬃcial
journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic
Resonance in Medicine, 46 (2001), pp. 476–81.
[26] J. T. Greenamyre and T. G. Hastings, Parkinson’s – Divergent Causes
Convergent Mechanisms, Science, 304 (2004), pp. 1120–1122.
[27] P. D. Griffiths, B. R. Dobson, G. R. Jones, and D. T. Clarke, Iron
in the basal ganglia in Parkinson’s disease. An in vitro study using extended X-
ray absorption ﬁne structure and cryo-electron microscopy, Brain, 122 (1999),
pp. 667–673.
[28] E. M. Haacke, N. Y. C. Cheng, M. J. House, Q. Liu, J. Neelavalli,
R. J. Ogg, A. Khan, M. Ayaz, W. Kirsch, and A. Obenaus, Imaging
iron stores in the brain using magnetic resonance imaging., Magnetic Resonance
Imaging, 23 (2005), pp. 1–25.
81
[29] E. M. Haacke, M. Makki, Y. Ge, M. Maheshwari, V. Sehgal, J. Hu,
M. Selvan, Z. Wu, Z. Latif, Y. Xuan, O. Khan, J. Garbern, and
R. I. Grossman, Characterizing iron deposition in multiple sclerosis lesions
using susceptibility weighted imaging., Journal of magnetic resonance imaging :
JMRI, 29 (2009), pp. 537–44.
[30] E. M. Haacke, Y. Xu, Y.-C. N. Cheng, and J. R. Reichenbach,
Susceptibility weighted imaging (SWI)., Magnetic resonance in medicine :
oﬃcial journal of the Society of Magnetic Resonance in Medicine / Society
of Magnetic Resonance in Medicine, 52 (2004), pp. 612–8.
[31] B. Hallgren and P. Sourander, The Eﬀect Oof Age on the Non-heamin
Iron in the Human Brain, Journal of Neurochemistry, 3 (1958), pp. 41–51.
[32] a. J. Hughes, S. E. Daniel, L. Kilford, and a. J. Lees, Accuracy of
clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study
of 100 cases., Journal of Neurology, Neurosurgery & Psychiatry, 55 (1992),
pp. 181–184.
[33] J. E. Joy and R. B. Johnston, eds., Multiple Sclerosis. Current Status and
Strategies for the Future, National Academy Press, Washington, DC, 2003.
[34] D. Kaur, F. Yantiri, S. Rajagopalan, J. Kumar, J. Q. Mo,
R. Boonplueang, V. Viswanath, R. Jacobs, L. Yang, M. F. Beal,
D. Dimonte, I. Volitaskis, L. Ellerby, R. A. Cherny, A. I. Bush,
and J. K. Andersen, Genetic or Pharmacological Iron Chelation Prevents
MPTP-Induced Neurotoxicity In Vivo : A Novel Therapy for Parkinson ’ s
Disease, 37 (2003), pp. 899–909.
[35] J. P. Kehrer, The Haber-Weiss reaction and mechanisms of toxicity.,
Toxicology, 149 (2000), pp. 43–50.
[36] D. B. Kell, Towards a unifying, systems biology understanding of large-scale
cellular death and destruction caused by poorly liganded iron: Parkinson’s,
82
Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others
as examples., Archives of toxicology, 84 (2010), pp. 825–89.
[37] J. Kolasinski, C. J. Stagg, S. a. Chance, G. C. Deluca, M. M.
Esiri, E.-H. Chang, J. a. Palace, J. a. McNab, M. Jenkinson,
K. L. Miller, and H. Johansen-Berg, A combined post-mortem magnetic
resonance imaging and quantitative histological study of multiple sclerosis
pathology., Brain : a journal of neurology, 135 (2012), pp. 2938–51.
[38] J. F. Kurtzke, Rating neurologic impairment in multiple sclerosis: an
expanded disability status scale (EDSS)., Neurology, 11 (1983), pp. 1444–52.
[39] C. Langkammer, N. Krebs, W. Goessler, E. Scheurer, F. Ebner,
K. Yen, F. Fazekas, and S. Ropele, Quantitative MR Imaging of Brain
Iron : A Postmortem Validation Study, Radiology, 257 (2010), pp. 455–462.
[40] S. M. LeVine, S. G. Lynch, C. N. Ou, M. J. Wulser, E. Tam, and
N. Boo, Ferritin, transferrin and iron concentrations in the cerebrospinal ﬂuid
of multiple sclerosis patients., Brain research, 821 (1999), pp. 511–5.
[41] S. M. LeVine and W. B. Macklin, Iron-enriched oligodendrocytes: a
reexamination of their spatial distribution., Journal of Neuroscience, 26 (1990),
pp. 508–12.
[42] I. Litvan, K. P. Bhatia, D. J. Burn, C. G. Goetz, A. E. Lang,
I. Mckeith, N. Quinn, K. D. Sethi, C. Shults, and G. K. Wenning,
SIC Task Force Appraisal of Clinical Diagnostic Criteria for Parkinsonian
Disorders, Movement Disorders, 18 (2003), pp. 467–486.
[43] T. Liu, P. Spincemaille, L. de Rochefort, B. Kressler, and
Y. Wang, Calculation of susceptibility through multiple orientation sampling
(COSMOS): a method for conditioning the inverse problem from measured
magnetic ﬁeld map to susceptibility source image in MRI., Magnetic Resonance
in Medicine, 61 (2009), pp. 196–204.
83
[44] A. K. Lotfipour, S. Wharton, S. T. Schwarz, V. Gontu,
A. Schäfer, A. M. Peters, R. W. Bowtell, D. P. Auer, P. a.
Gowland, and N. P. S. Bajaj, High resolution magnetic susceptibility
mapping of the substantia nigra in Parkinson’s disease., Journal of Magnetic
Resonance Imaging, 35 (2012), pp. 48–55.
[45] W. I. McDonald, a. Compston, G. Edan, D. Goodkin, H. P.
Hartung, F. D. Lublin, H. F. McFarland, D. W. Paty, C. H.
Polman, S. C. Reingold, M. Sandberg-Wollheim, W. Sibley,
a. Thompson, S. van den Noort, B. Y. Weinshenker, and J. S.
Wolinsky, Recommended diagnostic criteria for multiple sclerosis: guidelines
from the International Panel on the diagnosis of multiple sclerosis., Annals of
neurology, 50 (2001), pp. 121–7.
[46] M. D. Meadowcort, J. R. Connor, M. B. Smith, and Q. X. Yang,
Magnetic Resonance Imaging and Histological Analysis of Beta- Amyloid
Plaques in Both Human Alzheimer’s Disease and APP/ PS1 Transgenic Mice,
J Magn Reson Imaging, 29 (2009), pp. 997–1007.
[47] R. Meguro, Y. Asano, H. Iwatsuki, and K. Shoumura, Perfusion-Perls
and -Turnbull methods supplemented by DAB intensiﬁcation for nonheme iron
histochemistry: demonstration of the superior sensitivity of the methods in the
liver, spleen, and stomach of the rat., Histochemistry and cell biology, 120
(2003), pp. 73–82.
[48] D. H. Miller, D. T. Chard, and O. Ciccarelli, Clinically isolated
syndromes, Lancet Neurology, 11 (2012), pp. 157–69.
[49] R. B. Mounsey and P. Teismann, Chelators in the treatment of iron
accumulation in Parkinson’s disease., International journal of cell biology, 2012
(2012), pp. 1–12.
84
[50] R. L. Nussbaum and C. E. Ellis, Alzheimer’s disease and Parkinson’s
disease., The New England journal of medicine, 348 (2003), pp. 1356–64.
[51] A. E. Oakley, J. F. Collingwood, J. Dobson, G. Love, H. R.
Perrott, and C. M. Morris, Individual dopaminergic neurons show raised
iron levels in Parkinson disease, (2007).
[52] R. J. Ogg, J. W. Langston, E. M. Haacke, R. G. Steen, and J. S.
Taylor, The correlation between phase shifts in gradient-echo MR images and
regional brain iron concentration., Magnetic Resonance Imaging, 17 (1999),
pp. 1141–1148.
[53] R. J. Ordidge, J. M. Gorell, J. C. Deniau, R. A. Knight, and
J. A. Helpern, Assessment of Relative Brain Iron Concentrations Using T2-
Weighted and T2*-Weighted MRI at 3 Tesla, Magnetic Resonance in Medicine,
32 (1994), pp. 335–341.
[54] M. Perls, Nachweis von Eisenoxyd in gewissen Pigmenten, Archiv für
Pathologische Anatomie und Physiologie und für Klinische Medicin, 39 (1867),
pp. 42–48.
[55] C. H. Polman, S. C. Reingold, B. Banwell, M. Clanet, J. a. Cohen,
M. Filippi, K. Fujihara, E. Havrdova, M. Hutchinson, L. Kappos,
F. D. Lublin, X. Montalban, P. O’Connor, M. Sandberg-Wollheim,
A. J. Thompson, E. Waubant, B. Weinshenker, and J. S. Wolinsky,
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald
criteria., Annals of Neurology, 69 (2011), pp. 292–302.
[56] P. Riederer, E. Sofic, W.-d. Rausch, B. Schmidt, G. P. Reynolds,
K. Jellinger, and B. H. Youdim, Transition Metals, Ferritin, Glutathione,
and Ascorbic Acid in Parkinsonian Brains, Journal of Neurochemistry, 52
(1989), pp. 515–520.
85
[57] P. Santambrogio, S. Levi, A. Cozzi, B. Corsi, and P. Arosio, Evidence
that the speciﬁcity of iron incorporation into homopolymers of human ferritin
L- and H-chains is conferred by the nucleation and ferroxidase centres, Biochem
J, 314 (1996), pp. 139–144.
[58] F. Schenck, Imaging of brain iron by magnetic reso nance: T2 relaxation at
diﬀerent ﬁeld strengths, Journal of Neurological Sciences, 134 (1995), pp. 10–18.
[59] J. F. Schenck, Magnetic resonance imaging of brain iron, Journal of the
Neurological Sciences, 207 (2003), pp. 99–102.
[60] J. F. Schenck and E. a. Zimmerman, High-ﬁeld magnetic resonance
imaging of brain iron: birth of a biomarker?, NMR in biomedicine, 17 (2004),
pp. 433–45.
[61] M. Schrag, A. Dickson, A. Jiffry, D. Kirsch, H. V. Vinters, and
W. Kirsch, The eﬀect of formalin ﬁxation on the levels of brain transition
metals in archived samples., Biometals, 23 (2010), pp. 1123–7.
[62] F. Schweser, A. Deistung, B. W. Lehr, and J. R. Reichenbach,
Quantitative imaging of intrinisic magnetic tissue properties using MRI signal
phase: An approach to in vivo brain iron metabolism?, NeuroImage, 54 (2011),
pp. 2789–2807.
[63] K. Shmueli, J. a. de Zwart, P. van Gelderen, T.-Q. Li, S. J. Dodd,
and J. H. Duyn, Magnetic susceptibility mapping of brain tissue in vivo
using MRI phase data., Magnetic resonance in medicine : oﬃcial journal of the
Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance
in Medicine, 62 (2009), pp. 1510–22.
[64] J. Sian-Hülsmann, S. Mandel, M. B. H. Youdim, and P. Riederer,
The relevance of iron in the pathogenesis of Parkinson’s disease., Journal of
neurochemistry, 118 (2011), pp. 939–57.
86
[65] S. Siemonsen, J. Finsterbusch, J. Matschke, a. Lorenzen, X.-Q.
Ding, and J. Fiehler, Age-dependent normal values of T2* and T2’ in brain
parenchyma., AJNR. American journal of neuroradiology, 29 (2008), pp. 950–5.
[66] E. Sofic, P. Riederer, H. Heinsen, H. Beckmann, G. P. Reynolds,
G. Hebenstreit, and M. B. H. Youdim, Increased iron (III) and total
iron content in post mortem substantia nigra of parkinsonian brain, Journal of
Neural Transmission, 74 (1988), pp. 199–205.
[67] J. Vymazal, R. a. Brooks, N. Patronas, M. Hajek, J. W. Bulte,
and G. Di Chiro, Magnetic resonance imaging of brain iron in health and
disease., Journal of the neurological sciences, 134 Suppl (1995), pp. 19–26.
[68] S. Wharton and R. Bowtell, Whole-brain susceptibility mapping at high
ﬁeld: a comparison of multiple- and single-orientation methods., NeuroImage,
53 (2010), pp. 515–25.
[69] S. Wharton, A. Schäfer, and R. Bowtell, Susceptibility Mapping in the
Human Brain Using Threshold-Based k-Space Division, Magnetic Resonance in
Medicine, 63 (2010), pp. 1292–1304.
[70] L. Zecca, R. Fariello, P. Riederer, D. Sulzer, A. Gatti, and
D. Tampellini, The absolute concentration of nigral neuromelanin, assayed
by a new sensitive method, increases throughout the life and is dramatically
decreased in Parkinson’s disease, FEBS Letters, 510 (2002), pp. 216–220.
[71] L. Zecca, D. Tampellini, M. Gerlach, P. Riederer, R. G. Fariello,
and D. Sulzer, Substantia nigra neuromelanin : structure , synthesis , and
molecular behaviour, (2001), pp. 414–418.
87
5
Substantia nigra in healthy and
parkinsonian brain
There is a growing evidence supporting the hypothesis that Parkinson’s disease
(PD), which aﬀects dopamine transporter system involving the substantia nigra (SN)
and other midbrain structures, is related to the dysfunction of iron homeostasis (see
Chapter 4). Numerous MRI studies have investigated in vivo changes of the iron
content of the SN in PD using techniques such as T2-, T 2 -imaging or susceptibility
mapping [7, 23, 37, 45]. This study attempts a quantitative, post mortem (PM)
validation of R2 and susceptibility maps as markers of tissue iron, by comparing
brain stem MR image data acquired at 7T with the histological Perls’ stains as
presented in Section 5.2.
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According to the recent studies T 2 and susceptibility contrast are also aﬀected
by myelin content [34, 36]. Therefore in this work PM and in vivo myelin and
iron distributions in the brain stem were investigated by comparing magnetization
transfer ratio MTR maps, considered to be an MRI myelin marker, but also sensitive
to tissue properties caused by inﬂammation, R2 and susceptibility maps related to
iron and myelin with the solochrome cyanine (SC) stain for myelin and Perls’ stain
for iron (Section 5.2).
Changes of the iron content in the substantia nigra (SN) reported in PD patients
are not uniform [16] and death of the dopaminergic neurons of the SN in PD has
previously been found to occur more rapidly in particular locations within the SN
[8, 9]. These spatial variations in neurodegeneration in the SN gave rise to the
motivation for studying its sub-structures in a search for a potential diagnostic
biomarker of PD (Section 5.1).
5.1 Imaging of nigrosomes of the substantia
nigra
The diagnosis of PD in the UK is based on the UK Parkinson’s Disease Brain
Bank criteria of fatiguable bradykinesia plus tremor, rigidity or gait impairment.
Although the accuracy of diagnosis is high in clinico-pathological studies, the false
positive error rate is 15-25% in community studies and is 4-15% in clinical trials [3].
Nuclear medicine techniques such as dopamine transporter scanning (single photon
transmission scan following Ioﬂupane 123I injection) have a reported sensitivity and
speciﬁcity approaching 95% and are helpful in the assessment of clinically challenging
cases [3]. However they are expensive and there is no direct correlation between the
stage of disease and degree of abnormality on the scans, limiting their use in tracking
disease progression. There is therefore a need for an alternative diagnostic marker
in PD, which can provide tracking of disease progression.
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Nigrosomes
The pathological hallmarks of PD are deposition of Lewy bodies and de-
pigmentation of the substantia nigra (loss of the neuromelanin pigment). The SN is
divided into the pars compacta (SNpc), which is densely packed with neuromelanin-
containing dopaminergic cells, and the pars reticulata (SNpr), which is formed by
loose aggregations of GABAergic medium and large neurons [27]. The majority of
neurons in the SNpc project to the neostriatum (putamen and caudate nucleus)
as nigrostriatal ﬁbres [27]. The SNpr neurons mainly project to the thalamus, the
superior colliculus and the parabrachial pontine reticular formation [27]. Neurons
from striosomes (acetylcholinesterase-poor regions) project to the SNpc and those
from the remaining matrix of striatum project to the SNpr [27]. Five distinct
subgroups of dopamine-containing neurons in calbindin-negative zones within the
SNpc, called nigrosomes, have been identiﬁed by immunostaining for calbindin D28K
[9]. The largest, nigrosome 1, is lens-shaped and situated along the rostral/caudal
axis of the SN in its dorsal part, at caudal and intermediate levels (Figure 8 of
Damier et al [9] and Figure 5.1.5). Post mortem (PM) studies have shown the loss
of dopaminergic neurons in PD to be signiﬁcantly higher in the nigrosomes than in
other subregions of the SN, with the greatest loss (98%) occurring in nigrosome 1
[8]. Further evidence of nigrosome 1 involvement in early stages of the disease would
allow monitoring of these neurodegenerative changes in vivo to determine whether
this biomarker can provide a direct diagnostic tool and a method for studying the
aetiology and progression of PD.
SN boundaries
Many magnetic resonance imaging (MRI) studies have reported PD-associated
changes in the SN [35]. However, delineating the boundaries and sub-structures of
the SN and assessing the features of neurodegeneration in the SN remains challenging
[1]. This is partly because of the limited spatial resolution of conventional MRI, but
also because of the large signal loss caused by the high iron content in the SN region.
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It is sometimes erroneously assumed that the hypointense area in T 2 weighted (T 2 -
w) images corresponds to the SN (e.g. [7, 15, 31]), and variations in the deﬁnition
of the SN anatomy on MRI might explain some of the variability in literature on
MRI changes in the SN of PD patients. Recently developed ultra-high ﬁeld MRI
systems allow the acquisition of very high spatial resolution T 2 -w images providing
detailed morphological information from within the SN. Careful correlation of high
resolution MR data and histology [40] may enable a more precise deﬁnition of the
boundaries and sub-structures of the SN in vivo, and an accurate demonstration of
PD pathology.
MRI of nigrosomes
The morphological features of the SN found in MR images acquired in vivo at
7T were investigated by comparison with post mortem MRI and histochemical
data including Perls’ stain which is sensitive to ferric iron and neuromelanin,
tyrosine hydroxylase (TH) stain which is a marker for dopaminergic cells and
calbindin stain to identify nigrosomes [9]. The results suggest that it is possible
to visualise nigrosome 1 directly in healthy subjects. Given previous histological
evidence of preferential dopaminergic cell loss from the nigrosomes in PD [8], the
study then examined whether the in vivo appearance of nigrosome 1 at 7T could
provide a diagnostic marker to distinguish PD patients from healthy controls (HC).
Furthermore the possibility of visualising nigrosome 1 at 3T using diﬀerent MRI
techniques was investigated. This is important due to the much wider availability
of these scanners.
5.1.1 Materials and methods
Anatomy of the human brain stem
Schematic diagram in Figure 5.1.1 presents the substructures of the brain stem
laying within two planes positioned perpendicularly to the brain stem axis.
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Figure 5.1.1: Diagram showing the substructures of a brain stem on the level of red nucleus
(A) and below it (B); lebeled structures are: substantia nigra (SN), red nucleus (RN), cerebral
peduncle (CP) and nigrosome 1 (N).
This positioning was used in all the MRI scans of the SN used in this thesis. Post
mortem samples obtained to visualise nigrosome 1 were taken on level B, below the
red nucleus (RN).
Processing of the post mortem midbrain samples
Complex processing of the PM tissue samples is described here, involving: scanning,
staining, registration and masking images. This part was common to the methods
for the two studies presented in the current and the subsequent sections of the
chapter.
Three post mortem (PM) midbrains ﬁxed in 10% formalin were obtained from
the Queen’s Medical Centre, Nottingham. Two from subjects with no known
neurological conditions (HC, 67 and 46 y.o.) and one diagnosed with PD (PD,
75 y.o., disease duration 6 years).
The samples were washed in 0.9% saline for 24 hours and placed on an agar bed in a
Perspex sphere, which was then ﬁlled with saline solution. All three midbrains were
scanned on a 7T Phillips Achieva system equipped with a 32 channel receiver coil
(with the exception for the images from the ﬁrst brain, where a 16 channel receiver
was used). Four sequences were used, a high resolution 3D FFE (here referred to as
hr-T 2 -w) sequence allowing identiﬁcation of anatomical details, a lower resolution 3D
FFE (here referred to as lr-T 2 -w) sequence repeated with the sample at 4 diﬀerent
orientations with respect to B0 for robust estimation of susceptibility. A second
healthy midbrain and a parkinsonian one were additionally scanned with 3D FFE
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multi-echo sequence (here referred to as me-T 2 -w) used to obtain R2 maps and an
MT sequence (here referred to as MT-TFE) allowing calculation of the MTR maps.
Details of the scans carried out on each sample are presented in Table 5.1.1 and
relevant parameters of all the scans are summarised in Table 5.1.2.
sample hr-T 2 -w lr-T 2 -w me-T 2 -w MT-TFE coil (channels)
HC1 X X 16
HC2 (a & b) X X X X 32
PD X X X X 32
Table 5.1.1: Summary of the obtained scans and receiver coil types (16 or 32 channels) for
the particular PM samples.
name resolution slices TR/TE/TE FA additional time
hr-T 2 -w 0.3x0.3mm 3D 133 x 0.3mm 46/15ms 15 NSA=20, BW=67.5Hz 10h 22:00
lr-T 2 -w 0.5x0.5mm 3D 288 x 0.5mm 26/12ms 12 BW=337.6Hz 31:54
me-T 2 -w 0.5x0.5mm 3D 200 x 0.5mm 44/5/5ms 16 4 echoes, BW=335.2Hz 44:13
MT-TFE 0.4x0.4mm 3D 75 x 0.4mm 14/6.4ms 8 NSA=8, MTC=no/oﬀ
BW=101.2Hz
2h 19:12
Table 5.1.2: Summary of the parameters of the scans acquired for the PM midbrain samples.
Subsequently, midbrains were sectioned and experienced histopathologists prepared
four diﬀerent stains on the adjacent, 5µm thick, transverse slices cut using a Leica
RM2135 microtome and put onto adhesive microscope slides. Sections were dewaxed
with xylene, washed with alcohol of descending concentrations, and rehydrated in
water. Table 5.1.3 presents summary of all the stains obtained.
name precedure used for
Perls’ Prussian blue iron Fe3+
TH tyrosine hydroxylase dopaminergic cells
CAL calbindin nigrosomes (CAL–) and matrix (CAL+) [8]
SC solochrome cyanine myelin
Table 5.1.3: The summary of stains obtained for the PM tissue samples.
It is important to note that, during the process of section preparation most of the
Fe2+ present in tissue is oxidised to ferric iron (by oxygen in aqueous solutions
and exposure to air) and in consequence is also visualised by Perls’ staining [41].
Therefore in this thesis we will consider Perls’ stain to reﬂect the total iron content
in the tissue rather than just Fe3+.
For Perls’ staining, sections were washed three times, put into a solution of 25ml of
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2%w/v potassium ferrocyanide and 25ml of 2%w/v hydrochloric acid and incubated
at room temperature for 10 minutes. After rinsing thoroughly in water, they were
ﬂooded with 0.1%w/v nuclear fast red for 5 minutes to counterstain and washed
again. For staining with solochrome cyanine (SC), sections were incubated in
solution of 96ml distilled water, 4ml 10%w/v iron alum and 0.2g solochrome cyanin
RS for 30 minutes and then removed and washed thoroughly in water. Afterwards
they were put into a 5%w/v iron alum solution for 10 minutes (removing excess dye
from tissue to accentuate the structure) and then returned to water for 10 minutes
until the cream/white coloured areas within the blue could be seen. At the end
of both histochemical procedures, sections were dehydrated and mounted in DPX
using a Leica CV5030 cover slipper.
Two immunohistochemical staining methods were performed using a Leica Bond
Max automated system and commercially produced Leica solutions. To obtain
calbindin (CAL) stains, sections were heated in a citrate-based antigen retrieval
solution (trade name: Novocastra Bond Epitope Retrieval Solution 1) at pH 6.0
for 20 minutes, washed, placed in a peroxidase inhibitor solution for 5 minutes and
washed. Calbindin antibody was diluted to a concentration of 1/500 with Leica
’Antibody diluent’ and slides were incubated in this for 20 minutes, removed and
washed. For tyrosine hydroxylase (TH) staining of the dopaminergic cells sections
were heated in an EDTA-based antigen retrieval solution (trade name: Novocastra
Bond Epitope Retrieval Solution 2) at pH 9.0 for 30 minutes, washed and incubated
in a peroxide inhibitor for 5 minutes, then washed again. Tyrosine hydroxylase
antibody was diluted with Leica ’Antibody diluent’ to 1/20 and sections were
incubated in this for 30 minutes, removed and washed. Finally CAL and TH sections
were incubated in diaminobenzidine (DAB) solution for 10 minutes, washed and
then DAB-enhanced for 5 minutes, before being washed and counterstained with
haematoxylin. Slides were mounted and covered using Microm DTM 6 coverslipper.
Images of the stained slides were digitized using a Hamamatsu NanoZoomer
microscope camera to enable further processing.
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Susceptibility maps were calculated from the low resolution lr-T 2 -w images with the
k-space threshold method [59] (for more details see Section 2.3.5) and co-registered
to the high resolution hr-T 2 -w scans using the transformation matrices obtained
from the lr-T 2 -w data registration with FLIRT, FSL [30]. MTR maps were created
using method described in Section 2.3.3 and R2 maps were generated by ﬁtting
multi echo me-T 2 -w data, for two brain stems where me-T 2 -w was obtained (see
Table 5.1.1). For the third stem, HC1, an hr-T 2 -w image was used to estimate an
R2-w image, according to the equation m 
logS
TE
, where S corresponds to the values
of the signal in the original image and m is an absolute value of the global minimum
of the resulting map, to give a linear relation between R2-w signals and R2. MTR
and R2 maps were then co-registered to the hr-T 2 -w images. The hr-T 2 -w data and
digitized stains, TH, CAL and SC, were co-registered to the Perls’ stain images using
a semi-automatic method (Medical Imaging NetCDF tools, Montreal Neurological
Institute) based on manually selected landmarks (9 degrees of freedom plus shear),
which compensated for tissue deformation due to sectioning. This transformation
was also applied to the susceptibility, R2 and MTR maps, to bring all the images
into the Perls’ stain space.
The CAL images were converted from RGB to grey scale (using coeﬃcients speciﬁed
by the Rec. 601 standard [4]), for other stains the best separation of positively
and negatively stained regions was obtained based on one chosen channel: blue for
TH and red for SC. The Perls’ images were processed using colour deconvolution
[48] to separate the blue contrast, corresponding to iron, from the brown contrast,
corresponding to neuromelanin. For each sample, a mask outlining the brain stem
was created and manually corrected to remove the background, damaged tissue,
small veins visible in the Perls’ image, and air bubble artefacts. Next, masks of
regions that were high in iron, high in neuromelanin and TH-, SC- or CAL-positive,
were obtained by thresholding the stain images and applying manual correction
to remove obvious artefacts. These masks were overlaid on the MR images and
quantitative MR maps to compare the characteristics of the diﬀerent regions of the
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SN. All the processing steps are summarized in the diagram presented in Figure
5.1.2.
Figure 5.1.2: Image processing steps (on sample from HC2a). The stages were: co-registration
(linear for MRI data and based on landmarks for stains), ’cleanup’ (masking the whole stem,
removing small veins, artefacts etc.), converting to grey scale, thresholding and thus binarizing
the images, and hence making the masks for iron, NM, TH, CAL, SC. The ﬁnal masks were
also corrected to remove remaining artefacts.
Imaging nigrosomes in vivo at 7T
To study diﬀerences between PD patients and healthy controls (HC), 19 subjects
(10 PDs and 9 age-matched HCs, median/interquartile range: HC=65/5 y.o.,
PD=64/5y.o., sex: HC=6F:3M, PD=4F:6M; PD duration=32 years, mean total
UPDRS on medication =2413) were scanned using a 2D FFE sequence with
TE/TR=16/385ms, =40, FOV=180x160x16mm3, 0.35x0.35x1.0mm3 resolution,
10 minutes acquisition. A senior neuroradiologist and neuroradiology training fellow
examined the blinded T 2 -w datasets to classify the subjects according to the presence
or otherwise of a hyperintense ovoid sub-structure within the dorsal/posterior
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hypointense midbrain region, later identiﬁed as nigrosome 1. To classify a dataset
as showing this structure, it had to be visible on both sides of the SN, be present
on at least two adjacent axial slices, be surrounded for more than half its boundary
by hypointensity, not be part of a perivascular space and to extend below the RN.
Imaging iron and neuromelanin in vivvo
Two healthy volunteers (49 and 29 y.o.) were scanned in vivo at 7T to improve
characterisation of nigrosome 1. Ultra-high resolution T 2 -w scans were acquired
using a 3D FFE sequence with TE/TR=15/25ms, ﬂip angle=12, SENSE factor=1,
FOV=180x160x15mm3, 0.3mm isotropic resolution in 21 minutes. A T1-weighted
fast spin echo (FSE) sequence with an oﬀ resonance magnetisation transfer pre-
pulse (here referred to as mt-T1-w) at +1100 Hz, with TE/TR=9.0/2582, NSA=4,
FOV=180x180x7mm3, 0.6mm isotropic resolution was also acquired in 7:47 minutes;
the contrast in a similar scan at 3T has previously been ascribed to neuromelanin
[49, 52]. Images were co-registered using FLIRT, FSL [30]) and visually examined.
Imaging nigrosomes in vivo at 3T
Eight healthy subjects (age: 3311y.o., F/M=4/4) were scanned on a 3T Philips
Achieva scanner using four diﬀerent sequences: (i) high resolution T 2 weighted (T 2 -
w), (ii) Fast Field Echo (FFE), (iii) PRESTO and (iv) T1-weighted scans, with oﬀ
resonance MTC which has been reported to be sensitive to neuromelanin (NM) [53]
(Table 5.1.4).
name resolution slices TR/TE FA additional time
T 2 -w 0.43x0.43mm2 2D 8 x 1.5mm 300/50ms 42 NSA=5, BW=216.8Hz 9:57
FFE 1.0x1.0mm2 3D 40 x 1.0mm 100/35ms 10 EPI=3, BW=23.8Hz 5:06
PRESTO 1.0x1.0mm2 3D 200 x 1.0mm 15/21ms 10 BW=191.2Hz 4:34
NM 0.6x0.6mm2 2D 8 x 2.5mm 699/9ms 90 NSA=4, MTC=oﬀ, BW=416.7Hz 9.23
Table 5.1.4: Summary of the scanning parameters.
One dataset was excluded from the analysis due to insuﬃcient coverage. Two
neuroradiologists independently rated the images using two scales: nigrosome
visibility, 1-3 (deﬁnitely not visible – deﬁnitely visible) and image quality, 1-5 (very
97
low – very high, equal to the quality of the T 2 -w image obtained at 7T). On the
NM scan nigrosome visibility is interpreted as ‘high NM in the region corresponding
to N1’ since the high NM area extends beyond the nigrosome, so delineation of the
nigrosome 1 is not generally possible.
For quantitative comparison, all images were co-registered to the PRESTO data
using FLIRT, FSL [30]. For each dataset two slices of the T 2 -w image, in which
nigrosome 1 was clearly visible, were used to deﬁne circular regions of interest
(ROIs): 4 voxel diameter for nigrosome, 8 voxel diameter for remainder of SN and
for a reference region in the brain stem (care was taken to avoid small veins). These
are shown in Figure 5.1.7 (top middle). ROIs were used to calculate the relative
contrast between the nigrosome and the SN, as well as the contrast-to-noise ratio
(CNR), formed by dividing the contrast by the standard deviation of the signal in
the reference region. A one-way ANOVA test with Tukey-Kramer correction for
multiple comparisons was performed to examine diﬀerences between the contrast
and CNR of the diﬀerent images.
5.1.2 Results
Comparison of histology and 7T post mortem MRI of healthy and
parkinsonian substantia nigra
The results presented in this section were obtained using the high resolution T 2 -
w images and stains (TH, CAL, Perls’) processed using the methods described in
Section 5.1.1. For the four histology samples containing the SN at a level below
the RN (three from HC and one from PD) colour-coded maps of areas of high
iron, NM, TH and CAL were overlapped (Figures 5.1.3 and 5.1.4). In HC samples
superposition of the TH (red) and CAL (blue) masks allowed a CAL- region co-
localised with dopaminergic cells (TH+) inside a larger CAL+ area to be identiﬁed
(Figure 5.1.3, 1st row and Figure 5.1.4); a region with this staining, similar size and
location was previously deﬁned as nigrosome 1 [9].
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Figure 5.1.3: Four samples from three brain stems of two healthy and one parkinsonian subject
(HC1, HC2, PD1) containing the SN at a level below the RN. First four rows show pairs of
superimposed masks: CAL with TH (1st), iron with TH (2nd), iron with CAL (3rd) and iron
with neuromalanin (4th) (the coloured text on the right hand side indicates the meanings of
the colours on the masks). Slice of the 3D MR dataset (5th row, 0.3x0.3x0.3mm3 voxels) and
the same slice with overlapped masks representing the diﬀerent regions (6th row). All masks
and images were co-registered to the Perl’s stain image.
The same area showed low iron (Figure 5.1.3, 2nd row: TH and iron, 3rd row: CAL
and iron, and Figure 5.1.4), and high neuromelanin (Figure 5.1.3, 4th row: iron and
neuromelanin, and Figure 5.1.4), and corresponded to the hyperintense sub-structure
visible in the PM T 2 -w data although PM MRI scans showed more laminar structure
in the SN compared to the in vivo scans (Figure 5.1.3, 6th row).
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Figure 5.1.4: Superimposed masks of TH, CAL, iron and neuromelanin obtained for sample
HC2a with nigrosome 1 indicated by black arrows.
The high iron on the Perls’ stain area (yellow) overlapped with the T 2 -w hypointense
regions in the lateral part of the SN (Figure 5.1.3, 6th row). Regions with high
neuromelanin content do not overlap with regions of high iron (comparing Perl’s
(yellow), TH (red) and NM (purple)), or T 2 -wt hypointensity. For the PD sample
a CAL- zone corresponding to the nigrosome 1 was again present (Figure 5.1.3, 4th
column) and partially overlapped with a larger T 2 -w hyperintense region, although
it was neither TH+ nor high in NM. T 2 -w hypointense areas were similar to, if
slightly more diﬀuse than, those in HC, but high iron areas based on the Perls’ stain
were smaller. TH+ regions were co-localised with high NM and smaller compared
to HCs.
Nigrosome loss in Parkinson’s disease patients in 7T
The hyperintense sub-structure in the dorsal SN corresponding to nigrosome 1 could
generally be detected in vivo in HCs using high resolution (0.35x0.35x1.0mm3),
T 2 -w images acquired in a clinically feasible imaging time (Figure 5.1.5).
Neuroradiologists blinded to the clinical status of the subjects were able to
independently correctly classify 7/8 HC and 10/10 PD on the basis of the presence
or absence of nigrosome 1 (one dataset not of diagnostic quality due to subject
motion). This translates to a sensitivity of detection of PD of 100%, speciﬁcity of
88%, with inter-observer agreement  of 1.
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Figure 5.1.5: Example slices from all of the in vivo 7T T 2 -w scans showing SN in HC and
PD patients. Nigrosome 1 (yellow arrows) is visible in HC images as a hyperintense structure,
except of two cases highlighted by the red borders, one wrongly classiﬁed (2nd row) and one
bad quality dataset (3rd row), but not in any of the PD cases. The last segment shows a
schematic of the substantia nigra highlighting the nigrosome in red.
Iron versus neuromelanin in healthy controls in 7T
The ovoid sub-structure hyperintense in T 2 -w images corresponded to a region of
hyperintensity on mt-T1w FSE images (Figure 5.1.6, right and left co-registered).
101
Figure 5.1.6: Example of two, co-reregistered, high resolution, in vivo 7T images of a healthy
control showing the substantia nigra and nigrosome 1 (white arrow). In the T 2 -w image (left,
0.3x0.3x0.3mm3 voxels) the nigrosome is hyperintense due to its low iron content; in the mt-
T1-w sequence (right, 0.6x0.6x0.6mm3 voxels) the nigrosome is hyperintense due to its high
neuromelanin content.
Imaging of the nigrosomes at 3T
In vivo, high resolution T 2 -w images of HCs at 7T clearly showed a hyperintense
ovoid sub-structure within the dorsal hypointense midbrain region, medial to the
cerebral peduncles, which was identiﬁed as nigrosome 1. However, since 7T scanners
are not widely available, it is important to determine whether this structure can
also be detected at 3T. Diﬀerent 3T scans were therefore compared in terms of their
ability to visualise nigrosome 1. Figure 5.1.7 shows example images for one subject,
including the ﬁltered phase image from the T 2 -w scan.
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Figure 5.1.7: Example slices of all the 3T images showing the nigrosome; top middle: single
slice of T 2 -w image with ROIs: SN (blue, yellow), nigrosome (red, green), reference region
(orange, cyan).
Averaged scores of nigrosome visibility and image quality from the two
neuroradiologists are plotted in Figure 5.1.8, with error bars corresponding to
standard deviation. FFE and PRESTO provided the best images for nigrosome
detection (nigrosome visibility=2.9) and also achieved high image quality scores
(2.7 and 3.0), while the NM scans obtained the highest image quality value (3.2).
Note again the diﬀerent deﬁnition of visibility for the NM image compared to the
other scans.
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Figure 5.1.8: Nigrosome visibility (left) and quality of the images for nigrosome delineation
(right), average scores from two neuroradiologists
Contrast and CNR values are plotted in Figure 5.1.9 with error bars corresponding
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to the interquartile range (IQR).
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Figure 5.1.9: Contrast (left) and CNR (right) between nigrosome and the SN; error bars
represent IQR values.
T 2 -w images had signiﬁcantly higher contrast between nigrosome and the SN than
all of the other images, except the FFE. The FFE produced signiﬁcantly higher
contrast than phase and NM, while PRESTO yielded higher contrast then the NM
sequence (p<0.01). There was no signiﬁcant diﬀerence between CNR values for
T 2 -w, phase, FFE and PRESTO images (p<0.01).
Figure 5.1.10 presents a comparison of 7T and 3T T 2 -w in vivo images, showing
that the nigrosome can also be identiﬁed in the 3T images, though less clearly.
Figure 5.1.10: Example T 2 -w images obtained at 7T (0.35x0.35x1.00mm3 voxels, left), and at
3T (0.43x0.43x1.5mm3 voxels, right) on a healthy subject showing the hyperintense structure
that has been identiﬁed as nigrosome 1 (white arrows) within the hypointense region of the
midbrain.
104
5.1.3 Discussion
Nigrosome as PD diagnostic marker
This study identiﬁed as nigrosome 1, an ovoid, hyperintense feature, embedded
within the dorsal, hypointense, midbrain region of the SN on high resolution in vivo
T 2 -w 7T MRI scans of HCs. This MR feature was recently reported by another
group, who speculated that it might correspond to a nigrosome [31]. PM MRI and
histology data were co-registered to show that this sub-structure has high TH, high
NM and low calbindin content, thus conforming to Damier’s deﬁnition of nigrosome
1 [9]. In the PD sample this calbindin-low region was not high in neuromelanin or
TH positive, conﬁrming the loss of neuromelanin-containing cells in nigrosome 1 as
previously described [8].
Importantly, this small clinical study demonstrated the consistent absence of this
MRI feature in PD patients in vivo; which could be a consequence of neuronal cell
loss, neuromelanin loss, an increase in iron content within the nigrosome, a change
in iron oxidation state, or a combination of these eﬀects. This could be investigated
by studying other patient groups who show iron accumulation without dopaminergic
cell loss in this area. The HC misclassiﬁed by both raters as ‘probable PD’ may have
elevated iron due to other factors or may have presymptomatic PD; about 10% of
elderly HCs show alterations of echogenicity in transcranial sonography consistent
with PD [5].
The diagnostic accuracy achieved in this preliminary study at 7T is comparable with
the dopamine transporter scan, which is used for diagnosis of diﬃcult parkinsonian
cases [11]. However, in contrast to dopamine transporter scanning, MRI-based
techniques do not involve risks of radiation exposure, are more widely available
and more cost eﬃcient, particularly since the preliminary data suggests that now
the nigrosome has been clearly identiﬁed at 7T, it may be possible to identify it on
more widely available, 3T scanners. Motion was not a major problem in this study,
aﬀecting data only from 1/19 subjects. If the T 2 -w scan was the primary outcome
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of a scanning session then the protocol could be modiﬁed to reduce the eﬀects of
motion, for instance by motion tracking or by over acquiring the data [38].
It was also shown that nigrosome 1 can be detected at 3T, and PRESTO and FFE
images were preferred by the neuroradiologists for this identiﬁcation task. T 2 -w
images provided the greatest contrast between nigrosome 1 and surrounding tissue.
The CNR values of FFE and PRESTO images were similar to T 2 -w data, which in
combination with the short scanning (5̃min) make them potentially clinically useful.
Susceptibility weighted images (SWI) created by multiplying the T 2 -w modulus
image by a phase mask did not yield improved results. The low contrast and CNR
values of the NM scan are explained by its speciﬁcity to NM, which is high in the
nigrosome 1 area and much of the rest of the SN.
Iron content
The literature on the change of iron content in the SN in PD is inconsistent. Some
PM studies reported greater age-related increases in iron content in PD than HC,
for ferritin-bound iron [24], total iron and Fe3+ [55]. Mössbauer spectroscopy and
colorimetry based studies found total iron concentration to be unchanged or lower
in PD, with a possible increase in non-ferritin bound iron [17]. In vivo MRI studies
tend to suggest iron accumulation in the SN with age [14] and in PD [26, 37, 44],
but without distinguishing the form of iron; since it is known that the relaxivity of
Fe3+ ferric ions is about 10 times greater than that of iron (II) [21], changes in T 2
could simply reﬂect changes in the oxidation state of iron. The lower iron content
in the Perls’ stain of the PD sample found here, may be due to the ﬁxation time
being longer for the PD sample compared to the HC samples (2 versus 1 year)
[19, 51]. The mismatch between the hypointensity observed on the T 2 -w MRI and
Perl’s stains is interesting (Figure 5.1.3). Since the Perls’ stain is sensitive only to
Fe3+, this could be due to higher iron (II) content in PD brains, which could relate
to the ﬁxation process, but would also be consistent with increased oxidative stress
due to elevated ferrous iron in PD [17].
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SN boundaries
T 2 -w MRI provides excellent contrast in the midbrain due to the high iron content
of this brain area [6, 7, 45]. Previous MR work has mainly focused on localising
and measuring characteristics of the whole SN [7, 42, 43] or distinguishing the SNpc
and SNpr [15, 42], although there has been some inconsistency in the deﬁnition of
boundaries and sub-areas of the SN in both the MR and histological literature. In
many previous MRI studies, the boundaries of the SN and changes in PD have often
been deﬁned with reference to the high-iron, T 2 -w hypointense region [7, 15, 31].
The comparison of the Perls’ stain and PM T 2 -w scan in HC conﬁrmed the expected
sensitivity of T 2 -w MRI to iron, but closer inspection of the histology data shows
that the high-iron region cannot be used to delineate the SN boundary. This
does not aﬀect the validity of previous MRI results regarding changes in the size,
shape or intensity of the high iron region in PD, but questions its interpretation as
corresponding to the SN.
MRI characteristics of the SN sub-structures
Summarising, in HC, the SNpc is mainly depicted as a T 2 -w hypointense, mt-T1-w
hyperintense region, with high iron, low TH and high calbindin, which incorporates a
dorsal T 2 -w hyperintense, low iron, high TH and low calbindin sub-region (nigrosome
1 [9]). As far as the author of this thesis is aware, this is the ﬁrst study to determine
that nigrosome 1 is a low iron structure. The SNpr, located lateral to the SNpc,
overlapped with high iron, T 2 -w hypointense region, but information about the
neuronal projections, from diﬀusion tensor MRI, is needed to exactly deﬁne its
boundaries [42, 43]. The signal characteristics of nigrosome were similar to an area
ascribed to the VTA and depicted as a T 2 -w hyperintense, TH positive, iron negative
region lying adjacent to the RN (VTA, A10 [39]). This area is also hyperintense
on T 2 -w and mt-T1-w scans in vivo, and lies medial to the SNpc. The subthalamic
nucleus was not investigated here since the area studied was limited to the levels
below the RN.
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The PM characteristics of the SN in the PD sample diﬀered in two ways. First the
region of nigrosome 1 was TH negative and low in neuromelanin consistent with loss
of neuromelanin-containing dopaminergic cells. Second the iron content in the Perls’
stain was surprisingly low, which is probably an artefact of the longer ﬁxation time
of the PD sample [19, 51]. The T 2 -w hypointensity was somewhat larger than the
Perls’ stain region, but this loss of iron may also explain why the region including
nigrosome 1 was hyperintense on PM MRI in PD, in contrast to the results observed
in vivo.
Visual comparison of the TH stain, neuromelanin containing cells in the Perls’ stain,
and the mt-T1-w and T 2 -w high resolution in vivo scans provides further evidence
that the mt-T1-w scan is indeed sensitive to neuromelanin [49, 52]. The 7T scan used
here is less speciﬁc to neuromelanin than previously reported at 3T since it shows
hyperintensity in the cerebrospinal ﬂuid, probably due to enhanced inﬂow eﬀects
due to the smaller slab thickness (8mm, 5 slices). The reason why the neuromelanin
rich region is hyperintense on mt-T1-w scans is unclear, but possibly neuromelanin
directly shortens the T1 of both the bound and free proton pools leading to rapid
recovery of MT saturation and an increase in T1-w signal.
Limitations
This study had several limitations. Firstly, the assessment of diagnostic accuracy
is only preliminary, due to the small sample size. Secondly, further quantitative
analyses are necessary to determine whether the nigrosome could provide a non-
invasive biomarker of PD progression, which might be useful in future therapeutic
trials, or for distinguishing idiopathic PD from other parkinsonian conditions.
Thirdly, the low iron content in the Perls’ stain of the PD sample was paradoxical
and indicates that future studies should use PM samples with similar ﬁxation times
[2, 19, 51].
This is the ﬁrst study to identify the sub-structure of the SNpc that is visible on 7T
T 2 -w images [31] as nigrosome 1 [9] and to show that this sub-structure can also be
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detected at 3T. This feature is not observed in PD patients, suggesting that it could
potentially provide a simple, sensitive and speciﬁc diagnostic tool for PD, but future
longitudinal, quantitative studies are needed to show if it can provide a biomarker
of disease progression.
5.2 Origins of MR properties of the brain stem
tissue
In this section quantitative analysis related to the iron and myelin distribution in
the brain stem are presented. Post mortem MRI properties of healthy controls were
related to histology results to provide a better understanding of the MRI tissue
properties. The analyses were further extended to in vivo data obtained at 7T and
3T, using ROIs corresponding to the diﬀerent structures of the brain stem.
The values of R2 and R2 have been shown to linearly correlate with iron content
by several studies in vivo and post mortem [20, 32, 45, 46]. Comparison of
these measures with Perls’ stains has also been performed qualitatively [13] and
quantitatively, showing good correlation between the MRI measures and Perls’ stain
intensity [58]. Similarly quantitative susceptibility values correspond to iron content
in brain tissue [33, 62], however correlation with Perls’ stain have not been yet
shown. MTR is a known MRI myelin marker [50, 61] and some studies have shown
correlations between MTR values and Luxol fast blue myelin stain intensities [50, 56],
but no similar results exist for the solochrome cyanine stain used in this work.
The main aim of this study was to correlate R2, susceptibility and MTR values
of in vivo and ﬁxed PM tissue with Perls’ stain for iron and SC stain for myelin.
Based on the previously published results, it was hypothesized that we would ﬁnd a
positive correlations between MR iron measures (susceptibility and R2) and Perls’
stain, and between MTR and myelin stain were expected. These ﬁndings can be
potentially useful for monitoring neurodegenerative changes occurring in PD and
also allow image optimization for MRI.
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5.2.1 Materials and methods
Three diﬀerent groups of correlations were calculated: PM MR images and stains
were correlated pixel by pixel; for in vivo data ROIs corresponding to the particular
structures of the brain stem were used, as direct pixel-based comparison was
impossible for the images obtained from the diﬀerent samples; ﬁnally similar ROIs
were applied to calculate correlations of the PM data for better comparison with
the results obtained in vivo.
Post mortem
Quantitative analysis regarding iron and myelin were performed using MR data and
stains acquired for three samples of two healthy PM brain stems, HC1, HC2a and
HC2b. Details of the acquisition and preprocessing of MRI and histology data,
including obtaining iron and myelin masks, were described in Section 5.1.1. In order
to normalise the range and distribution of the intensity values within the Perls’
and SC images they were converted to grey scale and histogram equalisation was
applied to each image separately. The number of desired grey levels was chosen to be
similar to the original intensity ranges for all samples. Figure 5.2.1 presents mean
and standard deviation values calculated for the brain stem region of the stains
before and after normalisation. Afterwards the images were inverted so that the
high intensity values correspond to high content of iron for Perls’ and high myelin
content for SC (Figure 5.2.2, right).
HC1 HC2a HC2b
0
100
200
Perls
HC1 HC2a HC2b
0
100
200
SC
Figure 5.2.1: Bar plots corresponding to mean and standard deviation values calculated for
Perls’ (left) and SC (right) stains of three samples using the whole-stem region before (dark)
and after (bright) normalisation.
High resolution R2, susceptibility and MTR maps were correlated with Perls’ and
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SC stained images on a pixel by pixel basis to investigate the iron and myelin
distributions within the samples. The brain stem was analysed using an outlining
mask (whole-stem) to avoid areas aﬀected by artefacts caused by air bubbles. For
studying high-iron regions of the substantia nigra, additional high-Perls masks
obtained by thresholding the Perls’ stains were applied and for analysing high-myelin
regions of a brain stem high-SC masks were used (see Section 5.1.1). Perls’ and SC
stains were also correlated with each other within the whole-stem regions and high-
Perls masks were overlapped with the high-SC masks for comparison.
Histograms of R2 and susceptibility values were plotted for the iron rich region (high-
Perls) and of MTR for the high myelin region (high-SC), together with additional
histograms for the remaining part of the brain stem. The mean and standard
deviation of the MR values within these regions were calculated.
To compare particular brain stem structures, Perls’ and SC stains were analysed
using circular regions of interest (structure-ROIs) drawn on the original Perls’ stains
and overlapped on SC images for: nigrosome 1 (N) [8, 9] (also see Section 5.1),
substantia nigra (SN), ventral tegmental area (VTA), cerebral peduncle (CP) and
periaqueductal tissue (PAT), as shown in Figure 5.2.2.
Figure 5.2.2: Perls’ (iron), SC (myelin) stains of the PM brain stem, original (left) and
converted to grey scale and inverted (right) with overlaid ROIs for N, SN, VTA, CP, PAT.
Mean values calculated for the stains within the structure-ROIs were compared.
Structure-ROIs were overlaid on the co-registered slices of R2, susceptibility and
MTR maps and image values in these ROIs were correlated with Perls’ and SC
intensities (for sample HC1, MTR data were not acquired and the R2-w image was
omitted as having values incomparable with the R2 maps of two other samples due
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to the diﬀerent techniques used, as described in Section 5.1.1).
In vivo
Eight healthy subjects (3311y.o.) were scanned at 3T (one dataset excluded due
to insuﬃcient coverage) and two subjects (29, 49y.o.) were imaged at 7T producing
the following scans: high resolution T 2 weighted (referred to as hr-T 2 -w), PRESTO,
multi-echo gradient echo sequence for R2 quantiﬁcation (referred to as me-T 2 -w),
MT with one oﬀ-resonance pulse using FSE at 3T and a multi-pulse saturation train
with an FFE readout at 7T. Scan details are presented in Table 5.2.1.
name resolution slices TR/TE/TE FA additional time
3T hr-T 2 -w 0.43x0.43mm 2D 8 x 1.5mm 300/50ms 42 NSA=5, BW=216.8Hz 9:57
me-T 2 -w 0.7x0.7mm 2D 35 x 1.5mm 2122/7/10ms 80 5 echoes, BW=173.6Hz 5:16
MT-FSE 0.6x0.6mm 2D 8 x 2.5mm 699/9ms 90 NSA=4, MTC=no/oﬀ
BW=416.7Hz
2x9.23
PRESTO 1.0x1.0mm 3D 200 x 1.0mm 15/21ms 10 BW=191.2Hz 4:34
7T hr-T 2 -w 0.35x0.35mm 2D 20 x 1.0mm 525/16ms 40 BW=67.5Hz 12:00
me-T 2 -w 1.0x1.0mm 3D 129 x 1.0mm 24/5/5ms 11 4 echoes, BW=289.3Hz 7:31
MT-TFE 0.5x0.5mm 3D 40 x 1.0mm 12/6.2ms 8 MTC=no/oﬀ, BW=101.1Hz 11:18
PRESTO 1.0x1.0mm 3D 200 x 1.0mm 13/18ms 10 BW=883.3Hz 3:49
Table 5.2.1: Summary of the scanning parameters for HCs at two ﬁeld strengths.
R2 maps were calculated by ﬁtting the me-T 2 -w data and MTR maps were created
from the MT images using methods described in Section 2.3.3. The example images
for both scans and ﬁeld strengths are presented in Figure 5.2.3. Susceptibility maps
were obtained from the 7T me-T 2 -w data [59].
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Figure 5.2.3: Example slices showing brain stem with the SN in MTR (left, so called
neuromelanin scan for 3T) and R2 (right) images acquired in 7T (top) and 3T (bottom).
Circular structure-ROIs were drawn on the slices of hr-T 2 -w data sets in which
nigrosome 1 was clearly visible (2x1.5mm slices in 3T images and 3x1mm slices
in 7T images) for the following structures: N, SN, VTA, CP, PAT, white matter
(WM) and grey matter (GM) of the medial-temporal lobe; structure-ROIs for the
red nucleus (RN) were placed on higher slices in the 7T data (the 3T scan did not
have suﬃcient coverage). The diameter of the structure-ROIs was 8 voxels for SN,
RN, CP, WM, GM and PAT, and 4 voxels for N and VTA. The example slices of
7T and 3T hr-T 2 -w images with all the structure-ROIs, except of those for RN, are
presented in Figure 5.2.4.
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Figure 5.2.4: Two slices of hr-T 2 -w aquired in 3T (left) and 7T (right) with overlaid ROIs: N,
SN, VTA, CP, WM, GM, PAT and RN (not in the picture).
Structure-ROIs masks, R2, susceptibility and MTR maps were co-registered to
PRESTO images (which had greatest coverage) with FLIRT, FSL [30], to allow
all the images to be transferred to the same space. Mean values calculated for
the structure-ROIs, averaged across all subjects and slices, were compared for
R2, susceptibility and MTR maps obtained in vivo at 3T and 7T and PM at
7T magnetic ﬁeld. In vivo and PM 7T R2, susceptibility and MTR maps were
correlated with Perls’ and SC stains, and stains were correlated with each other, for
the corresponding structure-ROIs.
Gradients of the linear ﬁts for all correlations of the in vivo and PM data were
compared. Those calculated PM for whole-stem were averaged across three samples
(omitting values obtained for R2 images of the HC1 sample).
5.2.2 Results
Correlation across whole stem, PM
Figures 5.2.5 and 5.2.6 show R2 and susceptibility maps (respectively) for all three
PM samples with overlaid masks of whole-stem (red), high-Perls (blue) and high-
SC (green). Additionally, the right column of Figure 5.2.5 shows overlap between
high-SC and high-Perls. MTR maps with overlaid whole-stems (red) and high-SC
(green) are presented in Figure 5.2.7.
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Figure 5.2.5: Images of three samples of two healthy PM brain stems (HC1, HC2a, HC2b);
R2 maps with overlaid whole-stem, high-Perls and high-SC; 3rd column presents overlapped
high-SC and high-Perls.
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Figure 5.2.6: Images of three samples of two healthy PM brain stems (HC1, HC2a, HC2b);
susceptibilty maps with overlaid whole-stem, high-Perls and high-SC.
Figure 5.2.7: Images of two samples from a healthy PM brain stem (HC2a, HC2b); MTR maps
with (1st column) and without (2nd column) overlaid high-SC and whole-stem;
Scatter-plots showing the correlations between R2, susceptibility and MTR versus
Perls’ and SC with linear ﬁts and outliers (2standard deviation) marked in grey
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are presented for one example sample in Figure 5.2.8 and the correlation coeﬃcients
for all the samples are summarised in Table 5.2.2. Similar scatter-plots obtained for
range of values limited by the high-Perls and high-SC masks are presented in Figure
5.2.9.
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Figure 5.2.8: Plotted values of MTR, R2 and susceptibility versus Perls’ and SC stains, and
stains against each other, for HC2b sample within the whole-stem; black lines correspond to
the ﬁtted straight line and outliers (2standard deviation) are plotted in grey.
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Figure 5.2.9: Plotted values of MTR, R2 and susceptibility versus SC and Perls stains, and
stains against each other, for HC2b sample within the high-Perls and high-SC regions; black
lines correspond to the ﬁtted straight line and outliers (2standard deviation) are plotted in
grey.
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HC1 HC2a HC2b
MTR vs Perls 0.00y 0.19
MTR vs SC 0.57 0.76
R2 vs Perls 0.69 0.60 0.65
R2 vs SC 0.33 0.14 0.29
susc vs Perls 0.69 0.63 0.62
susc vs SC -0.04 -0.18 -0.20
R2 vs susc 0.85 0.85 0.74
SC vs Perls 0.19 0.05 0.25
Table 5.2.2: Summary of the correlation coeﬃcients calculated for R2, susceptibility and MTR
maps versus Perls’ and SC stained images in the PM samples for whole-stem; non-signiﬁcant
correlation is indicated with y.
Histograms of R2, susceptibility and MTR, for high-Perls/-SC and the rest of the
brain stem are presented in Figure 5.2.10.
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Figure 5.2.10: Normalised histograms of R2, susceptibility and MTR values within high-Perls,
high-SC and the rest of the stem, for HC2a sample; negative values of MTR were not shown
in the plot, as they corresponded to the background region outside of the brain stem that was
not removed by the mask.
Mean and standard deviation values were calculated within the high-Perls and high-
SC masks and also in the remaining part of the brain stem for all the samples on
R2, susceptiblity and MTR, as summarised in Table 5.2.3.
sample image high-Perls high-SC rest
HC1 R2-w [au] 0.13  0.03 0.47  0.03
susc [ppm] 0.36  0.09 0.06  0.09
HC2a R2 [ms 1] 0.12  0.02 0.05  0.02
susc [ppm] 0.21  0.06 -0.01  0.06
MTR [au] 1.34  0.07 1.28  0.07
HC2b R2 [ms 1] 0.12  0.02 0.05  0.02
susc [ppm] 0.21  0.05 0.00  0.07
MTR [au] 1.27  0.06 1.15  0.08
Table 5.2.3: Summary of the mean and standard deviation R2, susceptibility and MTR values
calculated for all three samples for the regions corresponding to high-Perls, high-SC and whole-
stem.
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Structure-ROIs analysis
Mean values of R2, susceptibility and MTR obtained in vivo at 3T and 7T and PM
at 7T, are presented for all the structures in bar plots in Figure 5.2.11; R2 and MTR
values of all the structures for both ﬁeld strengths in vivo are detailed in Table 5.2.4.
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Figure 5.2.11: Mean values for all the structure-ROIs in R2, susceptibility and MTR maps
obtained in vivo in 3T, in vivo in 7T and PM in 7T.
R2 [s 1] MTR [au]
3T 7T 3T 7T
nigrosome 1 (N) 36.9 3.6 51.0 0.7 0.099 0.10 0.330 0.040
substantia nigra (SN) 53.4 5.1 83.9 7.4 0.095 0.12 0.360 0.020
cerebral peduncle (CP) 25.3 1.3 37.4 10.0 0.104 0.12 0.480 0.010
ventral tegmental area (VTA) 29.9 1.4 44.6 0.9 0.086 0.10 0.354 0.005
periaqueductal tissue (PAT) 25.6 3.3 41.3 2.5 0.096 0.12 0.455 0.007
grey matter (GM) 22.6 1.6 26.2 0.2 0.081 0.09 0.230 0.020
white matter (WM) 27.8 2.2 34.0 4.9 0.095 0.10 0.340 0.090
red nucleus (RN) 77.5 4.0 0.460 0.005
Table 5.2.4: Mean values of R2 and MTR calculated for both ﬁeld strengths across all the
subjects using ROIs: N, SN, CP, VTA, PAT, GM,WM and RN.
Figure 5.2.12 presents a comparison of the mean normalised Perls’ and SC stain
values calculated within the structure-ROIs.
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Figure 5.2.12: Mean values of normalised Perls’ and SC stain intensity calculated within
structure-ROIs.
Correlation of the stains with in vivo and PM MRI is presented in Figure 5.2.13 and
the recorded correlation coeﬃcients are summarised in Table 5.2.5.
150 200 250
0.1
0.2
0.3
0.4
0.5
Perls [normalised]
M
TR
 [a
u]
160 180 200 220
0.1
0.2
0.3
0.4
0.5
SC [normalised]
M
TR
 [a
u]
Perls [normalised]
R2
* [
ms
-1 ]
SC [normalised]
R2
* [
ms
-1 ]
150 200 250
−0.1
0
0.1
0.2
0.3
Perls [normalised]
su
sc
 [p
pm
]
160 180 200 220
−0.1
0
0.1
0.2
0.3
SC [normalised]
su
sc
 [p
pm
]
susc [ppm]
R2
*[m
s-1
]
150 200 250
160
170
180
190
200
210
220
Perls [normalised]
SC
 [n
orm
ali
se
d]
Figure 5.2.13: Plots showing correlation of 7T in vivo  and PM  R2, susceptibility and MTR
values with Perls’ and SC stains, and stains with each other for corresponding structure-ROIs:
N, SN, VTA, CP, PAT; correlation coeﬃcients are presented in Table 5.2.5.
in vivo post mortem
MTR vs Perls -0.45 -0.42
MTR vs SC 0.70 0.97
R2 vs Perls 0.85y 0.96
R2 vs SC -0.52 -0.54
susc vs Perls 0.87 0.98
susc vs SC -0.55 -0.64
R2 vs susc 0.99 0.99
SC vs Perls -0.57
Table 5.2.5: Correlation coeﬃcients for MRI and histology measures of iron and myelin
calculated for post mortem and in vivo MR data; signiﬁcant correlations were indicated with
 and correlation with p=0.07 with y.
A summary of the gradient values from the linear ﬁts from all the plots used in the
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correlation analysis is presented in Table 5.2.6.
in vivo [10 3] post mortem [10 3]
structure-ROIs structure-ROIs whole-stem
MTR [au] vs Perls’ [normalised] -0.95 -0.69 0.22  0.31 APS
MTR [au] vs SC [normalised] 2.63 2.81 1.36  0.40 ASC
R2[ms
 1] vs Perls’ [normalised] 0.51 0.88 0.48  0.01 BPS
R2[ms
 1] vs SC [normalised] -0.55 -0.87 0.16  0.06 BSC
susc [ppm] vs Perls’ [normalised] 2.37 4.53 1.69  0.55 CPS
susc [ppm] vs SC [normalised] -2.60 -5.27 -0.33  0.17 CSC
R2[ms
 1] vs susc [ppm] 221 194 276  20
SC [normalised] vs Perls’ [normalised] -318 176  114
Table 5.2.6: Summary of the gradients of the linear ﬁts for all the correlations presented
in Tables 5.2.2 and 5.2.5; the last column lists the names corresponding to the whole-stem
coeﬃcients, which are used further in the discussion of this section.
5.2.3 Discussion
Two histochemical stains were used in this study: Perls’ was used to investigate iron
content in tissue and solochrome cyanine (SC) was used for myelin. Comparison
of high-Perls and high-SC masks in Figure 5.2.5 revealed their partial overlap in
the region of the pars reticulata of the SN (SNpr). This is possibly caused by lack
the of sharp boundaries between the SNpr and cerebral peduncle (CP), so that CP
myelinated ﬁbres coexist with the high iron region of the SN in its most lateral part.
Further histological investigation should conﬁrm the source of this eﬀect.
MTR and myelin
It has previously been shown that MTR is a marker of the myelin content [50, 61].
MTR mapping is a technique widely used for monitoring demylineation and axonal
damage in neurodegenerative diseases, especially in multiple sclerosis [10, 22, 25, 29]
(also see Sections 6.1 and 6.2). However, other tissue properties related to
inﬂammation have also been reported to aﬀect MTR contrast [18, 54, 57].
Correlation of the PM MTR pixel values with the SC stain intensities across the
whole-stem (Figures 5.2.7, 5.2.8 and Table 5.2.2) conﬁrmed that MTR relates to
the myelin distribution (as measured by the SC stain) in tissue within the healthy
brain stem. Considering the structure-ROIs this correlation was signiﬁcant in PM
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data and tended towards signiﬁcance in vivo (Figure 5.2.13 and Table 5.2.5), which
is expected since the same samples were used for PM MRI/histology, but diﬀerent
samples were used in vivo. The correlation coeﬃcient (R=0.97) was higher than
the value previously reported (R=0.84) by Schmierer at el. [50] for PM MTR and
myelin quantiﬁcation measure based on a Luxol fast blue (LFB) stain. This is
probably due to the high ﬁeld MRI used here. When only the high-SC region
was considered, a trend for a correlation between MTR and SC remained (Figure
5.2.9), suggesting that MTR reﬂects myelin variation even within the narrow range
of myelin concentration values and that SC stain does not reach a level of full
saturation.
There was no signiﬁcant correlation between MTR and the Perls’ stain within
the whole-stem, the high-Perls region (Table 5.2.2, Figures 5.2.8 and 5.2.9) or the
structure-ROIs (Table 5.2.5), suggesting that there is no dependence of the MTR
contrast on iron. This implies that iron does not cause suﬃcient frequency shift
to change MTR signal. However, comparing Figures 5.2.8 and 5.2.13 a trend for a
negative correlation between MTR and Perls’ stain calculated for the structure-ROIs
can be seen, which was not present for the whole-stem. Since this was only seen for
structure-ROIs it could possibly be explained by the choice of ROI representing
structures of the brain stem of either high-iron and low-myelin (N, SN) or the
opposite combination (CP, VTA), as presented in Figure 5.2.12.
Overlaying histograms of MTR values for the high-SC region and the rest of the
stem, showed partial overlap, but two peaks were distinguishable conﬁrming again
the sensitivity of MTR to myelin content represented by the SC stain (Figure 5.2.10,
Table 5.2.3).
R2, susceptibiity and iron
The sensitivity of R2 contrast to the iron content within deep GM (dGM) structures
previously shown both in vivo [20, 45, 46, 60] and post mortem [32] was conﬁrmed
in this study by the signiﬁcant correlations between R2 maps and Perls’ stained
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images found PM within the whole-stem and within structure-ROIs (Figures 5.2.5,
5.2.8 and 5.2.13, Tables 5.2.2 and 5.2.5). Susceptibility values [59] (see Section
2.3.5) also correlated with the intensities of the Perls’ stain, both PM and in vivo,
as expected (Figures 5.2.6, 5.2.8, 5.2.13, Tables 5.2.2 and 5.2.5).
The trends corresponding to the whole-stem correlations were also present in high-
Perls regions suggesting that both R2 and susceptibility are sensitive to the iron
content variation and that the Perls’ stain is not fully saturated within the narrow
range of high-iron concentrations (Figure 5.2.9). Overlaying histograms of R2 and
susceptibility values for high-Perls and the rest of the stem ROIs showed good
distinction of these two regions in terms of R2 and susceptibility values (Figure
5.2.10, Table 5.2.2).
There was no signiﬁcant correlation between the R2 or susceptibility values and the
SC stain representing myelin content for whole-stem (Figures 5.2.5, 5.2.6 and 5.2.8).
However there was a trend for a negative correlation for susceptibility and positive
correlation for R2 (Table 5.2.2), which agrees with the previous results suggesting
opposite eﬀects of myelin on these two measures [34, 36].
R2 and susceptibility maps strongly correlated with each other, in vivo and PM,
conﬁrming that they both reﬂect the same tissue characteristics (Figure 5.2.8,
5.2.13). The linear dependence of these measures on the iron content suggested that
within dGM their values are dominated by the eﬀect of iron, which is in agreement
with results of a recent in vivo study [12]. However, stronger correlations found
between susceptibility and Perls’ than betweenR2 and Perls’ (Tables 5.2.2 and 5.2.5),
the signiﬁcance of the in vivo correlation between susceptibility and Perls’ within
the structure-ROIs (Table 5.2.5), and lack of correlation between susceptibility and
SC values even within the high-SC region (Table 5.2.2) may suggest that in dGM
susceptibility reﬂects iron content more accurately than R2.
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In vivo iron and myelin mapping
This study conﬁrmed that R2 and susceptibility contrast are related to iron and
that MTR corresponds to myelin content in tissue. Table 5.2.6 presents the
gradient values of the lines ﬁtted in the correlation analysis, summarising relations
found between MRI measures and histological markers of iron and myelin content.
Considering the whole-stem correlations as the most reliable indicator (calculated for
the widest range of values and providing signiﬁcant correlations, with one exception)
and assuming that Perls’ and SC are quantitative measures of iron and myelin, then
the coeﬃcients obtained for the linear ﬁts can be used to parametrise the dependence
of MTR, R2 and susceptibility on iron and myelin concentration, represented by xm
and xi, respectively:8>>>>>><>>>>>>:
MTR(xm; xi) = ASCxm + APSxi + A
R2(xm; xi) = BSCxm +BPSxi +B
(xm; xi) = CSCxm + CPSxi + C
(5.1)
where A, B and C represent intercept values of the linear ﬁts combined with a
contribution of the factors diﬀerent than iron and myelin to the contrast. This
approach could potentially provide a method for mapping iron and myelin content
of in vivo, however there are several limitations which need to be overcome. First,
this study focused on brain stem tissue, and the results are therefore valid only for
brain stem structures and it needs to be conﬁrmed that the same relationship holds
in the rest of the brain. To extend these ﬁndings to the whole brain, investigation
regarding other parts of the brain is necessary. Second, the number of PM samples
used here was small and the analysis of more samples is needed to validate these
results. Third, and most importantly, the intensities of the Perls’ and SC stains used
in this study are not truly quantitative measures and can not be easily converted to
iron concentration values.
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MRI properties of the brain stem sub-structures
Comparison of the in vivo and PM, 3T and 7T R2 values in the structure-ROIs
showed that in vivo R2 values were higher at 7T than 3T for all the structures
(especially in high iron areas) as shown by the bar plots in Figure 5.2.11. This
ﬁnding is in agreement with a previous study analysing the dependence of R2
contrast on the ﬁeld strength [47]. Values recorded for the SN and nigrosome 1,
N, were both high, therefore the hyperintense appearance of the nigrosome 1 on
T 2 weighted images at 3T and 7T is only an eﬀect of the relative contrast with
the neighbouring SN. Susceptibility values obtained at 7T were high in high iron
structures (N, SN, RN) and close to zero in the remaining structures (relative to
white matter). Susceptibility values were also higher PM than in vivo (except for
the VTA, but for that structure both values were very small). MTR values obtained
in vivo at 3T were low compared to 7T, because of the low MT sensitivity of the
3T sequence, compared to the 7T one, and PM 7T values were lower than in vivo
7T (but higher than 3T in all the structures), presumably due to changes in water
content and proton exchange resulting from ﬁxation.
This comparison also revealed that in high iron (SN and N) regions, 7T PM values of
R2 were higher than those obtained in vivo. The increase of the iron concentration
in a brain with age [28] can not explain this ﬁnding, as in vivo subjects in the study
were not signiﬁcantly younger than PM subject used for analysis (mean 39y.o. vs
46y.o.) compared to the trends of iron increase with age. These regions had also
lower MTR values and higher susceptibility PM, so high R2 PM may be related to
changes in water or myelin content, as well as directly or indirectly to iron. It could
be due to the increase in iron content related to the changes in PM tissue, or due to
increased heterogeneity in iron distribution, which was previously observed in PM
T 2 -w images compared to in vivo (see Figures 5.1.3 and 5.1.7). Another possible
explanation would be a change in tissue absolute susceptibility, which can not be
seen directly in our experimental measurements as only relative susceptibility is
measured, but which can make iron-tissue diﬀerences bigger. Potentially, the results
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may also be aﬀected by the fact that both PM samples used for the calculations were
taken from the same subject. Therefore further investigation involving more samples
and additional high iron structures is necessary to understand origins of this ﬁnding.
5.3 Conclusions
Detailed anatomy of healthy and parkinsonian substantia nigra studied in Section 5.1
used in vivo and post mortem MRI data to identify nigrosome 1, the sub-structure
of the SN suﬀering high loss of the dopaminergic neurons in PD. Further, in vivo
investigation showed that this structure allows classiﬁcation of the PD patients in
7T and possibly also 3T MRI.
The quantitative part of this chapter, Section 5.2, investigated properties of the
healthy brain stem tissue in vivo and post mortem. Analysis focused on iron and
myelin concentrations within the whole stem and within its particular structures
showing correlations between MRI and histology measures. Susceptibility mapping
was found to provide a better correlation with iron content than R2. A potential
approach for in vivo iron and myelin mapping was presented. These ﬁndings could
be used to improve knowledge regarding brain stem tissue changes in Parkinson’s
disease as well as for the optimisation of MRI sequences used for imaging iron and
myelin in deep grey matter.
Future work will include longitudinal and quantitative analysis of nigrosome 1
regarding its possible use as a disease progression marker and on developing in
vivo method of iron and myelin mapping proposed in this study.
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6
White and grey matter
degeneration in Multiple
Sclerosis
Conventional MRI techniques that are sensitive to white matter (WM) lesions, such
as Fluid-Attenuated Inversion Recovery (FLAIR), T2-weighted and post contrast T1-
weighted sequences, have become established methods for diagnosing and monitoring
Multiple Sclerosis (MS) [59]. However, lesions detected using these methods show
poor correlation with the clinical status of the disease and weak predictive value
for its long-term prognosis [6, 36]. New quantitative MRI techniques and increased
spatial resolution provided by high ﬁeld MRI allow the detection of pathology in
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normal appearing WM, as well as cortical and deep grey matter (GM), redeﬁning MS
no longer to be an exclusively WM disease [25]. More comprehensive knowledge of
the involvement of grey matter could improve our understanding of the pathogenesis
of MS and may provide new biomarkers for disease prognosis.
Oligodendrocytes are present in both GM and WM, where they are responsible for
producing myelin, and can contain iron [45]. Increased iron concentration found in
neurodegenerative diseases can therefore be considered a disease marker, but also as
a measure of the neurodegeneration which is directly caused by (due to the toxicity
of free radicals) or mediated by iron (for more details see Chapter 4).
This chapter presents an investigation of the MR markers in MS and clinically
isolated syndrome (CIS) suggestive of MS (see Section 4.4 for more information),
and related to them degeneration of WM as well as cortical and deep GM. The
MRI data were acquired from two ongoing projects; the ﬁrst, including MS and CIS
patients and healthy controls (HCs), scanned with a protocol designed to look at
WM, but with the ﬁeld of view also covering the substantia nigra (SN), provided the
material for studies described in Sections 6.1 and 6.3; the second, focusing on high
resolution cortical imaging in MS patients and HCs, for the study of GM lesions, in
Section 6.2.
6.1 Peri-lesional White Matter changes in CIS
assessed using different MRI modalities
Many MR studies have reported changes in normal appearing white matter (NAWM)
in MS using various MR contrasts such as T1 [65], magnetization transfer ratio
(MTR) [51, 57, 65], R02/T
0
2 [54, 60], diﬀusion weighted imaging [2, 14] and
spectroscopy [2]. However, histological and MR evidence suggests that these changes
are not uniform, but localized close to gross lesions, and involve diﬀerent pathological
processes depending on the distance from the lesion [2, 51]. Therefore the visible
extent of the aﬀected tissue surrounding the lesion might vary depending on the
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MR imaging technique used [65]. Better identiﬁcation of diﬀuse areas of damage in
WM may be important in studying the progression of MS and possible responses to
therapy. The ﬁrst aim of this study was to compare diﬀerent imaging techniques in
terms of their ability to depict peri-lesional changes depending on the distance from
the lesion boundary.
As was described in Section 2.3.3 MTR is a marker of the density of macromolecules
including myelin, but the MT sequence can also be sensitized to NOE, the eﬀect
probably arising from lipids. Therefore MTR may provide a useful tool for accessing
demyelination in close proximity to the WM lesions, with especially good sensitivity
and high resolution in 7T images. T1 maps, also sensitive to the changes in proton
mobility and to some extent to iron, may provide an additional method to measure
myelin loss. The occurrence of the rings of high iron content around the MS lesions
has been shown in histological and MRI studies [17, 30, 32]. Here R2-w images
and quantitative susceptibility maps obtained from the phase component of the
T 2 -w datasets were applied to investigate iron content in peri-lesional tissue. T 2 -
w contrast and susceptibility mapping are considered established markers of iron
content and have been used to measure iron in MS [1, 3, 32]. However, they can
also be aﬀected by myelin content with the opposite eﬀect [44, 46]. Comparison of
these two measures with MTR and T1 values obtained for the tissue surrounding
MS lesions may help to explain ongoing pathological processes, based on the myelin-
and iron-related contrasts.
MS lesions can be classiﬁed according to their appearance in diﬀerent MRI images,
which correspond to time since the lesion occurred and degree of underlying
pathology [53]. MRI characteristics of the changes in peri-lesional NAWM could
potentially provide another way of distinguishing subgroups of lesions based on
diﬀerent pathological processes aﬀecting the tissue. Moreover, investigating this in
CIS patients could lead to a better understanding of the pathological mechanisms
occurring in the early stages of MS and help to develop prognostic methods.
This section compares changes in the peri-lesional NAWM in patients with CIS
137
using myelin and iron sensitive, high resolution 7T images. Fitting functions were
used to investigate the extent of penumbra around the lesion in diﬀerent modalities.
Moreover, an attempt at lesion classiﬁcation based on the diﬀerences in the MR
signal changes around the lesion with the distance from its boundary is presented.
6.1.1 Materials and methods
14 CIS patients (age=37.7±9.1, EDSS mean=2.0±0.9), selected from the project
described in the introductory part of the chapter, were scanned in 7T Philips Achieva
scanner equipped with a 16 channel receiver coil allowing SENSE reconstruction.
Four diﬀerent sequences were used: MT-TFE either with 20 oﬀ-res pulses applied at
+1100Hz for APT and MT sensitivity (MT1), 20 pulses applied at -1100Hz for NOE
and MT sensitivity (MT2), or no saturation (MT0), T1-TFE with seven diﬀerent
inversion times for T1 measurement, high resolution T 2 -w with phase data stored
and MPRAGE optimised to provide maximum contrast between WM and GM.
Details of the scan parameters are summarised in Table 6.1.1
name resolution slices TR/TE FA additional time
MT-TFE 0.860.86mm 2D 201.5mm 11/6.6 ms 8 MTC=no/2oﬀ (1100Hz)
BW=164.3Hz
9:06
T1-TFE 1.251.25mm 3D 581.25mm 6.9/3.2ms 8 TI=0,150,350,650,1050,
1650,2350,
SENSE=2, BW=240.6Hz
14:49
T 2 -w 0.50.5mm 3D 500.5mm 150/20ms 14 4 stacks, SENSE=2,
EPI=3, BW=80.4Hz
8:49
MPRAGE 0.60.6mm 3D 2600.6mm 15/6ms 8 SENSE=2, BW=114.9Hz 12:05
Table 6.1.1: Summary of the parameters of the acquired scans.
Pre-processing
MT1 and MT2 scans were co-registered to the MT0 scans and processed to obtain
MTR1 and MTR2 maps using method described in Section 2.3.3. Moreover,
ASYM maps were calculated as a diﬀerence of MTR2-MTR1, such that they were
assumed to be NOE-weighted. T1 maps were created as presented in Section
2.3.2. Susceptibility maps were calculated from the phase data of the T 2 -w
images via k-space thresholding method (see Section 2.3.5). MPRAGE images were
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bias corrected using SPM (http://www.fil.ion.ucl.ac.uk/spm/) and the other
modalities (MTR, T1, susceptibility maps and T 2 -w) were linearly co-registered to
the MPRAGE using FLIRT, FSL [35] (6 degrees of freedom). One subject was
removed from the analysis due to a mis-registration error. The brain was extracted
from all the images using masks obtained from MPRAGE by applying the BET,
FSL tool [62]. Table 6.1.2 presents a summary of all the quantitative maps and
images obtained from the original scans.
original scan quantitative measures
MT-TFE MTR1 map, ASYM map (assumed to be NOE dominated)
T1-FFE R1 = 1=T1 map
T 2 -w R2-w=1=T 2 -w image, susceptibility map
MPRAGE
Table 6.1.2: Summary of quantitative measures and images obtained from the original scans.
The white matter lesions (WML) were segmented manually on MPRAGE
images using NeuRoi software (http://www.nottingham.ac.uk/scs/divisions/
clinicalneurology/software/neuroi.aspx) by a trained radiologist, giving total
of 237 lesions. Tissue segmentation of MPRAGE images was performed using SPM
package (http://www.fil.ion.ucl.ac.uk/spm/) and resulting WM probability
maps were thresholded to obtain NAWM masks. WM lesions were often classiﬁed
as GM by SPM and therefore dilated lesion masks were added to the NAWM masks.
The masks were then eroded to ensure all GM was removed and applied to the other
images. The ﬁeld of view (FOV) of the ﬁnal results was limited by the data set with
the smallest coverage (MTR) to allow comparison of all the modalities. An example
set of preprocessed images is presented in Figure 6.1.1: MPRAGE, T 2 -w images,
susceptibility, T1, MTR1 and ASYM maps (dominated by NOE eﬀect).
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Figure 6.1.1: Example axial slices of one pre-processed dataset: MPRAGE corrected for bias,
T 2 -w image, susceptibility map (top row), T1, MTR1 and ASYM maps (bottom row), with
overlapped lesions masks marked in red.
For each lesion separately two 3D distance maps were created with ImageJ plugin
[22]: outside and inside of the lesion boundary. They were then combined to make
distances smaller than 0 correspond to the lesion’s inside and positive ones to its
outside. The distances were re-scaled using a voxel size of the source images (0.6mm)
to obtain maps of the distance expressed in millimetres. Figure 6.1.2 presents an
example slice of a combined distance map of one lesion and a diagram illustrating
values of the distance in relation to the lesion’s boundary.
Figure 6.1.2: Example axial slice of a combined 3D distance map with overlapped mask of the
lesion (red), where grey levels correspond to the distance from the lesion’s boundary in mm
(left); diagram illustrating distance values in relation to the lesion’s boundary (right).
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For every lesion, average intensities of each map or image within the distance bins of
1mm width were calculated to obtain peri-lesional proﬁles used for further analysis.
During the calculations T1 and T 2 -w images were inverted to obtain R1 maps and
R2-w images.
WM surrounding one particular lesion can be aﬀected by other lesions located in
the neighbourhood. In the pilot part of this study only the lesions with no other
lesions lying within the particular distance from the lesion boundary were considered.
The main aim was to investigate the general shape of the peri-lesional proﬁles and
the extent of penumbra around the lesion, as measured with diﬀerent modalities.
The second part of the study used an alternative way of addressing the problem
of the neighbouring lesions, the WM regions aﬀected by more than one lesion were
neglected in the analysis, allowing to increase the number of analysed lesions. The
proximal and distal peri-lesional changes were distinguished based on the results of
the pilot part of the study. Peri-lesional proﬁles were compared between diﬀerent
modalities and the attempt to proﬁle-based lesion classiﬁcation was performed.
Lesions with lesion-free neighbourhood
Two lesion-free distances were selected deﬁning two subsets of lesions: (1) these
with a lesion-free neighbourhood within 6mm distance in 3D (45 of 237 lesions) and
(2) these with a lesion-free neighbourhood within 10mm distance in 3D (28 of 237
lesions). For these lesions the function A(1 e x=S1)(1  x
F
)+B, where x represents
distance, was ﬁtted to the peri-lesional proﬁles for 0-6mm in order to parametrize
proximal changes in the rim of the lesion (S1) and any distal changes further away
from the lesion (F ). Parameter constraints were applied, so that S1 2 [0; 6]mm and
F 2 [ 100; 100]mm. Coeﬃcient A represented amplitude and B corresponded to
the signal value for x = 0. Figure 6.1.3 shows proﬁles of an example lesion with
the ﬁtted function and images of the corresponding lesion in all ﬁve modalities. For
plotting purposes R1 images were scaled by factor 103.
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Figure 6.1.3: Proﬁles of the example lesion calculated on R2-w=1/T 2 -w [au], SUSC [ppm],
R1=1/T1 [ms 1  103], MTR1 [au], ASYM [au] with the ﬁtted function A(1  e x=S1)(1 
x
F
) + B and error bars showing standard deviations of the values within each distance bin
(left), and the images of this lesion in ﬁve modalities (right); colours of the images’ labels
correspond to the colours of the plotted proﬁles.
The same function was ﬁtted to the proﬁles averaged across all the lesions from
subsets (1) and (2) to compare how size of the lesion-free neighbourhood aﬀects
parameters of the ﬁt.
Lesions with neighbourhoods’ overlap removed
Lesions masks were dilated by 6mm (10 voxels) isotropically and then the parts of
WM which belonged to more than one dilated lesion, i.e. regions that were within
10mm from two lesions, were removed. As many of the small lesions fell into the
removed regions, this limited the number of lesions considered to 91 of the original
237.
The lesion proﬁles obtained in the pilot part of the study showed that changes
further away from the lesion were sometimes linear in either positive or negative
direction (Figure 6.1.4), apparently independently of proximal changes. However
the ﬁrst model had the eﬀect of coupling the distal and proximal changes, so that
the proximal ﬁtted parameters would be aﬀected by the ﬁt to the distal part, making
it diﬃcult to compare proximal results between lesions. Therefore in the second
model it was decided to split the function ﬁtted to the peri-lesional proﬁles into
two: the proximal-function A(1   e x=S2) + B was ﬁtted to the part of the proﬁle
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within 0-5mm and the linear distal-function Dx +M was ﬁtted to the part within
5-15mm. There was no constraints applied to the parameter D, but S2 2 [0; 15]mm.
The parameter S2 of the proximal-function characterises the distance over which
the tissue signal returns to normal around the lesion boundary, where D of the
distal-function corresponds to signal changes further from the lesion in NAWM and
can be positive or negative. The 5mm transition point was estimated from the
average extent of proximal penumbra calculated in the pilot study. In order to
normalise the resulting sum of square error estimate to allow 2 to be compared
between the ﬁts for diﬀerent modalities, weights were applied equal to the average
standard deviation across all the values used for calculation of the lesion proﬁle in
the particular image. Strictly, the weights would vary with distance since there will
be more voxels included in average at larger radial distances. However given the
biphasic nature of the ﬁt and the underlying biological variability which will also
vary in an unpredictable manner with distance from the lesion, a constant weighting
with distance was assumed here. Figure 6.1.4 presents example proﬁles plotted with
the ﬁtted functions and the images showing the appearance of the corresponding
lesions in all ﬁve modalities. The examples have been chosen to illustrate diﬀerent
sizes of lesions and extents of penumbra around the lesion boundary represented by
the parameter S2.
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Figure 6.1.4: Lesion proﬁles of four example lesions with diﬀerent values of S2 and D
parameters calculated on R2-w=1/T 2 -w [au], SUSC [ppm], R1=1/T1 [ms 1 103], MTR1
[au], ASYM [au] plotted together with the ﬁtted functions: A(1   e x=S2) + B for [0-5]mm
and Dx +M for [5-15]mm and error bars showing standard deviations of the values within
each distance bin (left), and images of the same lesions (right); colours of the images’ labels
correspond to the colours of the plotted proﬁles.
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The ﬁtted functions were visually assessed and compared with the corresponding 2
values to deﬁne thresholds, 2=0.1, used to exclude lesions where the quality of the
ﬁts was insuﬃcient for at least one modality. As a result, analysis of the coeﬃcients
of the ﬁtted functions were performed only for 75 lesions in case of the proximal-
function (0-5mm) and 91 lesions in case of the distal-function (5-15mm), which
probably reﬂects increased biological and physical noise, as well reduced number
of degrees of freedom at lower radii. Values of S2 for each image were plotted
against the lesion size and mean intensity inside the lesion to investigate possible
correlations. S2 and D coeﬃcients were correlated between the diﬀerent modalities
to investigate possible relations between the lesion proﬁles of diﬀerent sequences.
Values of S2 reaching an upper boundary of the deﬁned constraints, S2 = 15, were
removed from the plots, as representing ﬂat per-lesional proﬁles corresponding to
the lack of penumbra.
Clustering of the lesion profiles
Based on the fact that distances around the lesions over which the MR signal is
aﬀected were smaller in some lesions than in the others and that the characteristic
distance (S2) of the proﬁle also diﬀered between lesions, an attempt to distinguish
subsets of lesions having similar characteristics was performed. Raw, unﬁtted
peri-lesional proﬁles were divided into the clusters using agglomerative hierarchical
clustering method. The algorithm computes a matrix of values of distance between
each pair of the elements from the given set and iteratively merges the closest
values into clusters until the required number of classes is reached. The complete-
link version of the method was applied, where the maximum distance between the
elements is compared. In this case the correlation between two proﬁles was used as
the inter-proﬁle distance measure to perform classiﬁcation separately for the whole
proﬁles 0-15mm and the proﬁles limited to the ﬁrst 5mm, with required number
of clusters C being 2,3 or 4. Figure 6.1.5 shows three example classiﬁcation trees
calculated for 15mm correlation between proﬁles, where the bottom level represents
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the original set of proﬁles subsequently combined into the bigger clusters, moving
up towards the root of the tree.
SUSC R1 MTR1
Figure 6.1.5: The example classiﬁcation trees calculated for SUSC, R1 andMTR1 using 15mm
correlation between proﬁles; the bottom level represents the original proﬁles, joined into the
bigger clusters towards the root of the tree.
For each variant of the classiﬁcation a co-occurrence matrix was created to count
the numbers of lesion proﬁles falling into each cluster for every pair of modalities.
The average proﬁles of lesions divided into the two classes (for classiﬁcation with
C=2) were plotted together for the comparison, with the error bars corresponding
to the inter-class standard deviation. Classiﬁcation based on each type of the image
was used to group proﬁles.
Inter-modality scatters of lesion profiles
The agreement between diﬀerent modalities measuring properties of the tissue
around the lesions was investigated by plotting lesion proﬁles against each other
for every pair of images, so that the points corresponded to the values at diﬀerent
distances from a lesion boundary. A straight line was ﬁtted to the points using an
iterative procedure to exclude outliers: the data point lying furthest away from the
ﬁtted line was excluded if its removal improved the norm of residuals of the ﬁt by
at least 30%.
The gradients of the resulting ﬁtted lines for each pair of modalities were averaged:
(1) across all the lesions, (2) across the lesions of each subject, (3) across the 2 classes
of lesions found using clustering of the 15mm proﬁles. For variant (3) additional
one-way ANOVA testing with Tukey-Kramer correction for multiple comparisons
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was performed to test diﬀerences between the groups corresponding to four possible
combinations of classes to which two considered modalities belong.
6.1.2 Results
Lesions with lesion-free neighbourhood
The average proﬁles of two lesion groups used in the pilot study, with 6mm and
10mm lesion-free neighbourhood, were very similar, as shown in Figure 6.1.6.
Figure 6.1.6: Average proﬁles calculated on R2-w [au], SUSC [ppm], R1 [ms 1103],MTR1
[au], ASYM [au] for the lesions with lesion-free neighbourhood within 6mm (left) and 10mm
(right); dashed lines indicate standard deviations of the values across the lesions.
Summary of the coeﬃcients of the function ﬁtted to the averaged proﬁles for all the
modalities is presented in Table 6.1.3.
proximal recovery distal gradient
S1 [mm] F [mm]
lesion-free 6mm 10mm 6mm 10mm
R2-w [au 105] 1.9 1.8 23.9 25.8
SUSC [ppm] 0.8 0.8 99.5 90.0
MTR1 [au] 1.3 1.3 48.5 37.7
R1 [ms 1  103] 1.2 1.2 32.5 29.0
ASYM [au] 1.4 1.2 44.6 28.4
mean 1.30.4 1.30.4 49.829.5 42.227.1
Table 6.1.3: Coeﬃcients of the function A(1 e x=S1)(1  x
F
)+B ﬁtted to the lesions proﬁles
averaged across all lesions with 6mm and 10mm lesion-free neighbourhood; mean and standard
deviation values calculated across all the modalities (bottom row).
Signal recovery close to the lesion boundary represented by S1 and changes far from
the lesion represented by F were similar in both groups. Values of S1 coeﬃcient
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suggested that WM lying at least 2mm away from the lesion boundary in MPRAGE
(on which lesions were originally segmented) can be considered as NAWM. Moreover
S1 was generally higher for R2 and lower for SUSC. Slightly higher F values for the
group where there was only a 6mm lesion-free region around the lesion may be due
to WM peripheral to the lesions being still aﬀected by other lesions lying further
away.
Lesions with neighbourhoods’ overlap removed
Table 6.1.4 presents number of lesions used in the main study and their total volume
for each of the analysed subjects.
subject A B C D E F G H I J K L M total
lesion count 9 9 2 2 2 11 4 2 10 10 13 10 7 91
lesion vol [mm3] 156 1532 57 33 3324 416 85 181 4979 865 1657 434 139 13857
Table 6.1.4: Summary of numbers and total volumes of the lesions for all the subjects.
There was no systematic correlation between S2 ﬁtted to the ﬁrst 5mm of the
lesion proﬁle and mean intensity within the lesion calculated for the same modality
and between the parameter S2 and size of the lesion (see Appendix 2, Figures
A.1and A.2, respectively). Neither S2 nor D coeﬃcients, characterising the signal
changes close to and far from the lesion boundary (respectively), correlated between
diﬀerent sequences (Figures A.3 and 6.1.7). However, there was a trend for positive
correlation between D values measured on images related to myelin (MTR1, ASYM,
R1) and on images related to iron (R2, SUSC), and to negative correlation between
myelin- and iron-dependent modalities.
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Figure 6.1.7: The coeﬃcient D of the function ﬁtted to the second part of the lesion proﬁles
5-15mm plotted for all the combinations of the pairs of the images with the ﬁtted straight
lines plotted in black.
Clustering of the lesion profiles
Co-occurrence matrices calculated for each classiﬁcation, for the number of clusters
C=2,3,4, and for both 5 and 15mm, did not show any particular overlap between the
classes in the pairs of modalities (see Appendix 2, Table A.1). Similarly, plots of the
lesion proﬁles, averaged across two classes determined by the clustering based on the
15mm correlation, for each of ﬁve modalities revealed poor inter-classes separation
(see Appendix 2, Figure A.4).
Inter-modality scatters of lesion profiles
Figure 6.1.8 presents plots of one modality proﬁle against another (so that each
point represents a diﬀerent distance from lesion boundary) for an example lesion,
with a ﬁtted straight line and any outliers that were removed to improve the ﬁt
marked in black.
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Figure 6.1.8: Correlations of the proﬁles of the example lesion with the ﬁtted ﬁrst degree
polynomial and outliers removed to improve the ﬁt marked in black.
Table 6.1.5 summarises means and standard deviations of the gradient values of the
ﬁtted lines across all the lesions and the most frequent gradient signs. Large standard
deviations from the average values of the gradients across the lesions corresponded
to high variation of the correlation between the lesion proﬁles.
correlation gradient mean  std –/+ gradient
SUSC [ppm] / R2-w [au] -4000  22000 – (62%)
MTR1 [au] / R2-w [au] 23000  46000 + (69%)
R1 [ms 1] / R2-w [au] 80  90 + (81%)
ASYM [au] / R2-w [au] 15000  25000 + (84%)
MTR1 [au] / SUSC [ppm] -2.9  4.0 – (75%)
R1 [ms 1] / SUSC [ppm] -4.5  5.8 10 3 – (80%)
ASYM [au] / SUSC [ppm] -6.4  15.0 10 1 – (71%)
R1 [ms 1] / MTR1 [au] 1.2  1.0 10 3 + (91%)
ASYM [au] / MTR1 [au] 0.3  0.2 + (95%)
ASYM [au] / R1 [ms 1] 150  170 + (89%)
Table 6.1.5: Summary of the gradients of plotted proﬁles of one modality against another
averaged across all the lesions (mean and standard deviation) and the most frequent gradient
direction (positive/negative, –/+) among all the lesions with a percentage.
Mean values of the gradient across all the lesions diﬀered between the subjects as
shown in Figure 6.1.9. High variation of the gradient values for diﬀerent lesions
within each subject (standard deviation) was also observed.
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Figure 6.1.9: Mean values and standard deviation of the gradient values calculated across all
the subject’s lesions for all the correlations of the lesion proﬁles.
Figure 6.1.10 shows bar plots of the mean values of the gradients grouped based on
the classiﬁcation of the 15mm proﬁles into C=2 clusters. Each bar corresponds to
one of four possible combinations of the classes to which correlated images belong.
One-way ANOVA with Tukey-Kramer correction for multiple comparisons did not
ﬁnd any signiﬁcant diﬀerences between the groups.
151
1/1 2/1 1/2 2/2
−4
−2
0
2
SUSC [ppm]/R2*w [au]
1/1 2/1 1/2 2/2
−1
0
1
MTR1 [au]/R2*w [au]
1/1 2/1 1/2 2/2
−100
0
100
200
R1 [ms
−1
]/R2*w [au]
1/1 2/1 1/2 2/2
−2
0
2
4
ASYM [au]/R2*w [au]
1/1 2/1 1/2 2/2
−10
−5
0
5
MTR1 [au]/SUSC [ppm]
1/1 2/1 1/2 2/2
−15
−10
−5
0
R1 [ms
−1
]/SUSC [ppm]
1/1 2/1 1/2 2/2
−3
−2
−1
0
1
ASYM [au]/SUSC [ppm]
1/1 2/1 1/2 2/2
−1
0
1
2
R1 [ms
−1
]/MTR1 [au]
1/1 2/1 1/2 2/2
0
0.2
0.4
0.6
0.8
ASYM [au]/MTR1 [au]
1/1 2/1 1/2 2/2
−200
0
200
400
ASYM [au]/R1 [ms
−1
]
4x10
4 x104
6
3
x10-3x10-35
2x10
5
Figure 6.1.10: Each of the bar plots corresponds to one of the correlations between the lesion
proﬁles. Each bar represents mean value of the gradient, where correlated images belongs
to the given combination of the classes (1/1, 1/2, 2/1, 2/2). Classiﬁcation was obtained
using clustering of the lesion proﬁles within 15mm with two clusters. There was no signiﬁcant
diﬀerences between the groups.
6.1.3 Discussion
Peri-lesional proﬁles of mean signal intensity values calculated for every bin of
distance from the lesion boundary were used to characterise MR signal changes
around the lesions in CIS patients. Five diﬀerent modalities were used: R2-w images,
susceptibility, MTR, R1 and ASYM maps. The negative values of ASYM found
around the lesions showed that the z-spectrum was asymmetric in a manner that
conﬁrmed the initial assumption that they are NOE (not APT) dominated [52].
The coeﬃcient S1 of the function ﬁtted to the average lesion proﬁles estimated the
extent of penumbra around the lesion, allowing the conclusion that WM lying further
than 2mm from an MPRAGE lesion boundary can be considered to be unaﬀected
by signiﬁcant inﬂammation for all the measures (Figure 6.1.6, Table 6.1.3). Based
on that assumption, the transition value of 5mm was estimated and used to increase
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stability of the ﬁt by splitting lesion proﬁles into two parts: proximal to the lesion,
where MR signal changes rapidly over the distance from the lesion boundary and
distal to the lesion, where slower, approximately linear, signal change was observed.
This result also suggested that lesions appear smaller in MPRAGE than in other
analysed modalities indicating diﬀerences in their sensitivity to the same underlying
biological changes.
S1 value obtained for the average R2-w proﬁle was higher and S1 calculated for
susceptibility proﬁle was lower than the average (Table 6.1.3), indicating diﬀerent
eﬀects of iron and myelin content with the distance around the lesion boundary.
Increasing myelin content around the lesion would cause gradual increase of R2
signal and decrease of the susceptibility values, however a simultaneously occurring
decrease in iron content would cause slowing down of the R2 increase but speeding
up of the susceptibility decrease. The narrow range of change in iron content
accompanied by the wide range of change in myelin content could potentially indicate
existence of iron rings around the lesions. However, the same set of lesion data was
visually reviewed for another study ﬁnding no iron rings in susceptibility maps and
T 2 -w images, which would be expected for the CIS lesions representing an early
stage of the disease. This eﬀect must therefore be related to some other, not fully
understood pathological processes. Possibly, changes in iron content leading to the
creation of iron ring in the future may already occur in lesion proximity, being not
signiﬁcant enough to be visually identiﬁed.
The characteristic distance (S2) of the proximal-function ﬁtted within 0-5mm
from the lesion boundary and corresponding to the range of the MRI detectable
inﬂammation around the lesion was found to be independent of the size of the
lesion as well as mean signal intensity measured within the lesion (Figures A.2 and
A.1). Moreover there was no correlation of the characteristic distance coeﬃcients
(S2) between diﬀerent modalities (Figure A.3). These results indicated that in CIS
patients the area of tissue aﬀected pathological processes was similar for all the
lesions, independent on their appearance in diﬀerent modalities and size calculated
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based on MPRAGE segmentation.
For the distal-function ﬁtted to the 5-15mm part of the lesion proﬁle, D values were
relatively small, both positive and negative, corresponding to the slight increase
and decrease (respectively) of the lesion proﬁle in its distal part (Figure 6.1.7). This
variation could be caused by the transition value chosen for two ﬁtted functions
possibly being too big and a range ﬁtted being too large, so that the direction of the
distal-function might have been driven by the data points which were missed from
the distal-function (and included in the proximal-function).
The coeﬃcients S2 and D of the two functions ﬁtted to the lesion proﬁles did
not provide any information regarding possible sub-sets of lesions or dependence of
diﬀerent imaging measures on each other within the tissue surrounding the lesion.
Another attempt to separate lesion groups based on the peri-lesional characteristics
using an automatic clustering method with diﬀerent conﬁgurations of the parameters
(5mm and 15mm of the proﬁle, expected number of clusters C=2,3,4) also did not
achieve positive results. This can be clearly seen in the co-occurrence matrices
(Table A.1) and in the comparison of the lesion proﬁles averaged within the classes
(Figure A.4), indicating large uniformity or heterogeneity between lesions.
Values of the gradient of the straight line ﬁtted to inter-modality scatters of the
lesion proﬁles (Figure 6.1.8) conﬁrmed a high variation of the characteristics of the
peri-lesional tissue between the particular lesions (Table 6.1.5), subjects (Figure
6.1.9) and the classes obtained using the clustering method (Figure 6.1.10). No
signiﬁcant diﬀerences were found between the mean gradient values calculated for
the groups obtained by clustering.
However, the signs of the straight line gradients, as summarised in Table 6.1.5,
together with the percentage of the sign’s occurrence reﬂected the general tendencies
in the relations between the modalities within the peri-lesional tissue. The gradients
for R1, MTR1 and ASYM had positive direction in at about 90% of lesions, which
would be expected as all three measures reﬂect myelin content. All of them had
negative gradient values where plotted against SUSC but positive compared with
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R2-w (range of about 70-80%), which is likely to relate to the opposite dependence
of SUSC and R2 on myelin [44, 46]. The negative gradient between SUSC and R2-w
would provide a conﬁrmation of this ﬁnding, however it was true for only 62% of
the lesions suggesting more complex contrast mechanisms, most likely related to
the variable iron content in the peri-lesional region and the mixed eﬀects of iron
and myelin in R2. Bar plots in Figure 6.1.9 clearly present the same trends within
the particular subjects. Some indication of the similar trends was also found in
correlations of the D values obtained for diﬀerent images types (Figure 6.1.7). These
results are in agreement with those presented in Section 5.2 of this thesis regarding
brain stem tissue. Application of the proposed in vivo iron and myelin mapping
method to the MS lesion surroundings could possibly provide better understanding
of the pathological processes occurring in tissue around the lesions.
Investigation of the changes in myelin and iron content in a peri-lesional WM for
the group of CIS patients presented in this section, using ﬁve MRI modalities
and several diﬀerent approaches, showed no behaviour indicating diﬀerent types
or classes of lesions or subjects. This lack of clear consistency may be due to either
heterogeneity or uniformity of the lesion set. Uniformity may be caused by the
early stage of the disease, where little recovery of lesion happening and therefore
distinguishing lesion types based on the diﬀerences in pathology is not yet possible.
On the other hand, the complex nature of the underlying pathological processes
can cause high variation of the measures applied in this study making the lesion set
heterogeneous. However this variation could also potentially result from the noise in
the analysed data. Visual assessment of the lesions proﬁles and the ﬁtted functions
(see Figure 6.1.4) and relatively low 2 values suggested the ﬁts were good and
that it would more likely be caused by the biological heterogeneity of the lesions
and therefore MRI characteristics. In future, Monte Carlo simulations propagating
the measured physical noise would make it possible to determine the origin of the
variation observed in the ﬁts.
It is possible that the negative results obtained were related to over-ﬁtting the data.
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However this was more likely to be a problem for the model in the pilot part of the
study where, although the number of degrees of freedom in the ﬁts was generally
larger, the components of the model were coupled such that noise in one part of the
proﬁle would have aﬀected the ﬁt in all of it. Furthermore by splitting the model
into two components and ﬁtting the signals separately, the problems of multiple
comparisons become larger reducing the power of the study.
Other potential limitation of this study was the application of a geometrical measure
of distance from the lesion boundary, while degeneration in the brain tissue might
potentially spread along the WM tracts. However, given the short range of the
distance considered, 15mm, the geometrical approximation seems sensible.
A future extension of this study would compare CIS lesions with lesions present
in more advanced forms of MS in order to investigate diﬀerences in lesions
characteristics. Moreover longitudinal monitoring of the same lesion combined with
information about the potential conversion of the patient from CIS to MS will be
performed. It would also be interesting to analyse tissue characteristic within the
lesions in relation to the area of inﬂuence of the lesion around the lesion’s boundary.
Finally, the application of the iron and myelin mapping method proposed in Section
5.2 could possibly provide a better understanding of pathological processes occurring
in the tissue surrounding lesions.
6.2 Detection of grey matter lesions in MTR
and MPRAGE images
The majority of MRI studies of MS examine changes in white matter, although
histopathological ﬁndings suggest that cortical lesions are very common in MS and
might provide additional information regarding its pathogenesis [9, 38]. The most
recent studies conﬁrm that cortical lesions occur on early stages of the disease, are
associated with the cognitive and physical impairment [12] and, rather than WM
lesions, should be considered as a predictor of the disease progression [10, 13].
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It was decided to extend the study described in section 6.1 to study the variations
in NAGM about GM lesions. GM lesions are diﬃcult to detect on MR due to their
small size and the low levels of cortical myelin, however recently some success has
been reported using T 2 -weighted [48], FLAIR [39] and MPRAGE images at 7T and
double inversion recovery (DIR) [63] or phase-sensitive inversion recovery (PSIR)
[61] at 3T. Increased ability to detect GM lesions has been shown for the standard
clinical protocols such as T2-w, T1-w and FLAIR in 7T compared with 3T [21].
This section presents a pilot part of the ongoing project comparing of the detection
of GM lesions on high resolution 7T MTR maps and MPRAGE images.
6.2.1 Materials and methods
Eight MS (7 RRMS, 1 SPMS) patients (age mean=489) and four healthy controls
(HC) (age mean=338) were recruited from Nottingham University Hospital Trust
in accordance with local ethics committee approval and scanned on 7T Philips
Achieva scanner using a 32-channel receive coil with SENSE reconstruction. The
protocol included a high resolution MPRAGE sequence with a tailored inversion
pulse to reduce eﬀects of B1 inhomogeneities [34], optimised to produce maximum
contrast between white and grey matter required for accurate tissue segmentation,
and a MT-TFE acquisition with 20 oﬀ-resonance sinc pulses was applied to obtain
saturation (bandwidth=300Hz, oﬀ-resonance=-1.0kHz (3.4ppm), 21ms between
each pulse) and a Turbo-Field echo readout. Additionally T 2 -w images were acquired
with a 3D-FFE spoiled gradient echo sequence. Detailed parameters of all the scans
are summarised in Table 6.2.1
name resolution slices TR/TE/TI FA additional time
MPRAGE 0.5x0.5mm 3D 280 x 0.5mm 15/7/1070ms 8 BW=95.3Hz 11:20min
MT-TFE 0.5x0.5mm 3D 80 x 1.0mm 12/6.4ms 8 MTC=no/oﬀ, BW=100.7Hz, SSi=10s 8:45min
T 2 -w 0.5x0.5mm 3D 180 x 0.5mm 150/20ms 16 4 stacks, BW=79.6Hz 9:37min
Table 6.2.1: Summary of the parameters of the acquired scans.
Preprocessing of the data was performed by Dr. Olivier Mougin. MPRAGE images
were bias ﬁeld corrected using SPM and the cortical grey matter ribbon (CGMR)
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was segmented using Freesurfer to ensure the observers had no knowledge of any
WM lesions, to attempt to blind them to clinical status. The mask of the CGMR was
dilated by one pixel to compensate for the registration and tissue classiﬁcation errors,
and then manually corrected for any missegmentation (e.g. due to the mixed lesions
laying partially in the WM). Finally the CGMR mask was visually checked to ensure
the reviewers would remain blinded (does not include any WM abnormalities). High
resolution MTR maps were calculated using a method described in Section 2.3.3.
MTR maps and T 2 -w images were co-registered to MPRAGE via FLIRT, FSL [35]
and the CGMR mask was applied to them all.
Two MRI physicists (OM and AB, the author of this thesis), one experienced in GM
lesions segmentation (OM), and one neurologist (NM) reviewed example lesions in
MTR, MPRAGE and T 2 -w images and reached consensus on the lesion deﬁnition.
A tissue abnormality was considered as a lesion if it was hypointense on MTR
and MPRAGE and hyperintense on T 2 -w, lying within the cortex, of the longest
dimension in the x-y plane bigger than 4 voxels, present in at least two consecutive
slices, which was not a result of a partial volume eﬀect or movement artefact on the
cortex boundaries. This deﬁnition was then applied by AB to manually segment
lesions, separately in MTR and MPRAGE images and additionally on 4 randomly
chosen T 2 -w scans (2 controls and 2 MS) using ITKSnap software. The image sets
were all presented in random order to prevent the observer using mutual information
between two modalities when ﬁnding lesions. Segmentation was reviewed post-hoc
by OM comparing raw images (i.e. including also WM) of all three modalities to
conﬁrm lesion identiﬁcation and to separate cortical and mixed lesions (i.e. those
that lie in both GM and WM). Numbers of lesions identiﬁed for each subject were
counted. Masks of the local normal appearing GM (LNAGM) surrounding each
lesion were obtained by subtracting two masks created by dilating the lesions masks
by 2 and then 9 voxels. Contrast between the LNAGM and lesion was calculated
for each lesion on MTR and MPRAGE (normalised by dividing by the mean of
LNAGM).
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6.2.2 Results
Figure 6.2.1 presents a CGMR of the example subject masked on MPRGE, MTR
and T 2 -w as it was presented to the observer performing lesions segmentation task.
Figure 6.2.1: Example CGMR masked on MPRAGE, MTR and T 2 -w images.
Figure 6.2.2 shows examples of both lesion types in MPRAGE and MTR.
Figure 6.2.2: Example lesions in MPRAGE (top row) and MTR (bottom row). Cortical lesions
detected only in MTR or only in MPRAGE and mixed lesions detected in both images.
Figure 6.2.3 and Table 6.2.2 summarize the number of detected lesions, and show
that GM abnormalities were signiﬁcantly more commonly found in MS patients than
HC.
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Figure 6.2.3: Total number of lesions (combined cortical and mixed) for each HC and MS
subject in MTR versus MPRAGE.
MPRAGE MTR MPRAGE & MTR
cortical mixed cortical mixed cortical mixed
MS (N=8) 79 37 129 22 16 18
HC (N=4) 5 0 12 0 0 0
Table 6.2.2: Summary of the lesion detection in 12 subjects: total number of cortical and mixed
lesions identiﬁed in MTR and MPRAGE images, together with the number of the additional
lesions found post-hoc by the second observer, and number of lesions found in both modalities.
MTR detected almost twice as many cortical lesions as MPRAGE on average, but
was less eﬃcient in case of mixed ones. Relatively few lesions were detected jointly
on both sequences. MTR and MPRAGE contrast between lesion and LNAGM were
plotted in Figure 6.2.4 for both cortical and mixed lesions.
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Figure 6.2.4: Scatter plots of contrast between lesions and LNAGM in MTR and MPRAGE
for lesions detected in MPRAGE, MTR and MPRAGE & MTR. Left: cortical and right: mixed
lesions.
In 4 randomly chosen cases (2 controls and 2 MS) T 2 -w scans were examined and
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showed only 8 lesions in total between them compared to 52 for MTR and 38 for
MPRAGE.
6.2.3 Discussion
Increased rate of detection of intracortical lesions was found for MTR compared to
MPRAGE at 7T, but MPRAGE was more sensitive in detecting mixed leukocortical
lesions. Only very few lesions were detected on HC, which agrees with previous
reports [10, 61] and makes it unlikely that artefacts were misinterpreted as lesions.
Both MPRAGE and MTR were better at detecting cortical lesions than T 2 -w scans,
previously shown to provide a good contrast for GM lesions in the post mortem [58]
and in vivo [48] work. However, the scans used in this study were optimised to detect
small lesions and therefore the T 2 -w images were obtained with 3D sequence of slice
thickness 0.5mm (compared to 1.0mm in [48]) increasing sensitivity to shimming
variations and movement. The high spatial resolution made it possible to localize
the position of the cortical lesions precisely, for instance as purely intracortical,
which was not possible in previous studies using DIR results [27].
Since the cortical levels of myelin are low, demyelination is diﬃcult to detect in
the GM. High speciﬁcity of MTR to demyelination may explain why more lesions
were detected with MTR than with MPRAGE, despite the fact that the MTR
maps are noisier than the MPRAGE images and require intrinsic registration.
Moreover, the pathological processes underlying occurrence of cortical lesions diﬀer
from those causing WM degeneration in MS and are not yet well understood [11, 40].
Demyelination in cortical lesions involves microglial cells and is not associated with
inﬂammation [8, 56]. The longitudinal relaxation time (to which MPRAGE is
sensitive) is related to diﬀerent tissue characteristics compared to MTR, such as
inﬂammation or iron content, which may explain its sensitivity to the mixed lesions.
For a small subset of detected lesions, values of the peri-lesional contrast (Figure
6.2.4), calculated for the same modality in which these lesions were identiﬁed, were
surprisingly low or negative. This was due to the compromises of the contrast
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measure used. LNAGM surrounding the lesion was selected automatically by
dilating the lesion mask, so that in some cases remainings of CSF tissue were also
included in the calculations. This problem can be solved either by correcting CGMR
segmentation to remove all CSF or by selecting a LNAGM based on the proﬁle of
tissue intensity around the lesion. After improvements this method could possibly
assist a future automation of lesion segmentation using contrast diﬀerence to deﬁne
lesion boundary, which could be used in longitudinal MS studies.
This preliminary study proved MTR was superior to MPRAGE for the cortical lesion
detection at 7T and motivated continuation of the project, in which the author of this
thesis is no longer involved, using bigger number of patients and including diﬀerent
protocols for the comparison. This study will compare the results regarding GM
lesions with the clinical progress of the patients on the longitudinal manner and will
relate these results to the changes in white matter, with the special interest in the
regions laying close to the GM lesions. This project can therefore provide better
understanding of the MS as a disease involving degeneration of WM but also, not
yet fully understood, cortical GM pathology.
On the other hand, peri-lesional contrast calculations performed in this pilot study
are potentially promising for further development of automatic or semi-automatic
lesion detection or lesion characterisation.
6.3 Increase in the iron content of the SN and
RN in MS and CIS: a 7T MRI study
Iron deposition in deep grey matter (dGM) structures in the MS has been monitored
using T2- and T 2 -weighted MRI scans [4, 15, 23, 37, 55, 67, 68] or R2 and R2 maps
which provide more quantitative measures [43]. However these NMR relaxation
based parameters are also sensitive to the other tissue properties like myelin content
and water concentration [28] which can also change in MS. Recent studies used
the phase data to obtain information more speciﬁcally related to iron content [32].
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Susceptibility weighted images (SWI) combine phase and T 2 -weighted signals with
the aim of achieving higher sensitivity to iron density [29, 69].
However the phase maps are distorted compared to the underlying susceptibility
distribution in the tissue. This is because there is a non-local relationship between
the susceptibility distribution and the resulting magnetic ﬁeld distortion, which leads
to spatial distortions in both phase and SWI data. Therefore in this work we used
quantitative susceptibility mapping [66] which converts phase data into magnetic
susceptibility maps that are not spatially distorted. We also used T 2 -weighted
magnitude images since the eﬀect of iron on T 2 is mediated by magnetization
dephasing which depends on the spatial distribution of iron as well as the absolute
content; furthermore the use of T 2 -weighted images allowed results to be compared
with previous studies.
Neurodegeneration within the brainstem is common in MS and is associated with
poor prognosis [18, 64], possibly due to the location of the crucial motor and
sensory pathways in the brainstem. Iron accumulation is often associated with
neurodegeneration and MRI changes suggestive of increased iron content have been
consistently reported for most of the dGM structures in MS [1, 15, 69], but results
for the substantia nigra (SN) and red nucleus (RN) remain inconsistent. While some
studies reported a diﬀerence between MS and healthy subjects in both structures
[43, 55, 68], others found increased iron only in the SN [16, 30] or only in the RN
[5] and some studies reported no diﬀerence in either [23, 67].
Changes in the RN and SN may be particularly important in MS. The RN is involved
in motor control; lesions of the RN including demyelinating plaques within it or
aﬀecting its connection to the cerebellum may cause a characteristic rubral tremor
[41]. In addition, involvement of the SN in MS has been demonstrated through
the detection of lesions on transcranial sonography [33] and decreased levels of
proteins associated with myelin, neuronal development and axonal growth indicating
demyelination of the SN [16] have been found in the SN of MS patients.
This study investigated changes in iron deposition in the SN and RN in two groups of
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patients, with Relapsing-Remitting MS (RRMS) and Clinically Isolated Syndrome
(CIS), a condition indicating the earliest clinical stage of demyelinating disease,
hypothesising that iron deposition in the SN and RN might ultimately provide a
marker of clinical progression in MS. Previous MRI studies of iron accumulation in
dGM structures in CIS did not examine SN and RN [1, 15], although we have
recently reported signiﬁcant diﬀerences in iron content of the dGM structures,
caudate nucleus, putamen, globus pallidus, thalamus and pulvinar, between CIS
patients and healthy controls, using phase data from 7TMRI to produce quantitative
susceptibility maps [1]. We acquired the data using a 7T MR scanner, as the
ﬁeld shifts due to magnetic susceptibility perturbations scale with the ﬁeld strength
providing both higher precision in susceptibility maps and increased sensitivity to
iron content in T 2 -w data [68].
The T 2 -w MRI scans were also examined post-hoc in order to identify nigrosome 1,
the largest of the subgroups of dopamine-containing neurons identiﬁed in calbindin-
negative zones within the SNpc [19]. It has previously been shown using histology
data that the nigrosomes suﬀer preferential dopaminergic cells loss in Parkinson’s
disease [20] and recent studies have shown that nigrosome 1 can be detected in vivo
using 7T MRI [7] (also see Section 5.1), and that this structure cannot be seen
in Parkinon’s disease [7, 42]. Therefore the presence of nigrosome 1 was assessed
in CIS and RRMS patients, since in the late stages of MS, the pathology is not
particularly disease speciﬁc, but is similar to that found in other neurogenerative
diseases (Alzheimer’s or vascular changes) [26].
The aim of this work was to asses iron content in the SN and RN of patients with
CIS and RRMS compared to healthy controls (HC), using susceptibility mapping
and T 2 -weighted signals measured at 7T. Ventral (SNv) and dorsal (SNd) parts of
the SN were analysed separately based on the reported changes in iron distribution
in other neurogenerative diseases [24]. Moreover, the eﬀect of CIS on RRMS on the
visibility of nigrosome 1 on MRI scans was also investigated.
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6.3.1 Materials and methods
14 patients with relapsing-remitting multiple sclerosis (RRMS: age=42.411.3,
range 20-56 y.o.) and 21 with clinically isolated syndrome (CIS: age=37.28.8,
range 24-57 y.o.) together with 27 age-matched healthy controls (HC: age=36.48.8,
range 21-58 y.o.) were recruited from Nottingham University Hospital in accordance
with local ethics committee approval. Expanded Disability Status Scale (EDSS)
assessment giving values between 0 and 10 (death due to MS) was performed by a
trained physician for all of the patients.
MR images were acquired on a 7T Philips Achieva scanner with 16-channel receive
coil and head-only volume transmit coil. A T 2 -weighted 3D GRE sequence was
acquired with TR/TE=150/20ms, ﬂip angle 14, SENSE factor 2, EPI factor 3,
number of acquisitions 1, scan time 8.5min. Four interleaved stacks parallel to the
AC-PC line with coverage 192x164x25 mm were acquired for each scan, where the
overlap between stacks was 5mm. Spatial resolution of the data was 0.5x0.5x0.5mm.
Susceptibility maps were generated from the phase data using the k-space threshold
method [66]. For each subject, the 5 slices of each T 2 -w image where both structures
were most visible were chosen and then circular ROIs of diameter 3mm were drawn
using ITKSnap software (http://www.itksnap.org), separately on left and right
RN, ventral and dorsal SN (Figure 6.3.1).
Figure 6.3.1: T 2 -weighted image showing ROIs placed in the SNv (red and green), SNd (orange
and purple) and RN (blue and yellow). The two ROIs in cyan and magenta are WM regions
used for normalisation.
All of the SN ROIs were positioned to avoid touching ventral and medial boundaries
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of the structure. Two further ROIs of diameter 5mm were placed on the white matter
(WM) in the same slices and used to provide reference values for the susceptibility
measurement.
Matlab [49] was used for further processing of the data. Mean values of 1/T 2 -w
(used instead of R2 maps in absence of the multiecho data) and susceptibility were
calculated for SNv, SNd and RN ROIs, averaging the values obtained from the left
and right hand sides. The results were normalised using the mean intensity of the
WM region, taking the diﬀerence between the ROI and WM region for susceptibility
and ratio for the ROI to the WM region for 1/T 2 -w. Moreover the product of
negative logarithm of the normalised T 2 -w signal (which should be linear in 1/T 2
and hence iron concentration) and normalised susceptibility signal (Susceptibility-
T 2 product) was determined for each structure, to increase sensitivity in a similar
manner to the SWI signal but using susceptibility maps to overcome the problems
of non-local phase eﬀects in SWI data.
Presence of nigrosome 1 within the SN was assessed visually by a trained expert,
separately on each side of the SN, using the criteria stated in the previous study [7].
Normality was checked using the Kolmogorov-Smirnov test. One-way ANOVA
test with the Tukey-Kramer correction for multiple comparisons was performed to
examine diﬀerences in susceptibility and 1/T 2 -w values between the CIS, RRMS
patients and HC for each structure. Left and right parts of the structures were
also compared using one-way ANOVA. Scatter plots of susceptibility and 1/T 2 -w
signal were overlaid with ellipses indicating the HC, CIS and RRMS population
distributions ( 1.5 s.d.). Dependence of the 1/T 2 -w, susceptibility and product
values on age was tested for healthy controls and dependence on the EDSS score for
the CIS and RRMS patients.
6.3.2 Results
Mean EDSS results obtained for two groups of patients were 2.80.7 for RRMS and
EDSS=1.6±1.0 for CIS. There was a trend for susceptibility in all of the structures
166
to increase between HC, CIS and RRMS patients (Figure 6.3.2) and the diﬀerences
between HC and RRMS in SNd and RN were signiﬁcant (p<0.05).
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Figure 6.3.2: Mean susceptibility, 1/T 2 -w and product in SNv, SNd and RN for HC, CIS and
RRMS patients.
No diﬀerence was seen in SNv although this may be because the data for this
region was more scattered. The 1/T 2 -w signal in both parts of the SN and RN
was unchanged for CIS patients compared to HC and higher for RRMS patients,
although diﬀerences were not signiﬁcant (Figure 6.3.2). The Susceptibility-T 2 *
product increased separation of the RRMS versus HC (p<0.01) and RRMS versus
CIS groups (p<0.05) in RN, however the diﬀerence between the groups for SNd was
no longer signiﬁcant.
Scatter plots in Figure 6.3.3 show that there is relatively weak correlation between
susceptibility and 1/T 2 -w signal in all ROIs for all subject groups.
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Figure 6.3.3: Scatter plots of susceptibility versus 1/T 2 -w in SNd, SNv and RN. Ellipse indicate
populations of the HC, CIS and RRMS centred at the mean value, outlined by the 1.5 of the
standard deviation and oriented parallel to the best ﬁt slope.
Susceptibility, 1/T 2 -w and the product did not show a signiﬁcant correlation either
with the patients’ EDSS score (Figure 6.3.4) or age for HC and no signiﬁcant
diﬀerences between the left- and right side- structures were found.
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Figure 6.3.4: Values of susceptibility, 1/T 2 -w and product in SNv, SNd and RN plotted against
their EDSS scores.
Examination of the subjects’ scans in order to identify nigrosome 1 did not show
signiﬁcant diﬀerence between the groups as it is presented in Table 6.3.1.
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subjects nigrosome 1
total excl* L+R L/R none %
HC 27 3 21 2 1 87.50
CIS 21 3 16 0 2 88.89
RR 14 1 11 0 2 84.62
872
Table 6.3.1: The summary of identiﬁcation of nigrosome 1 in healthy (HC) subjects and
patients (CIS, RR). *Datasets excluded from the analysis were either of not suﬃcient quality
(4 cases) or not suﬃcient coverage to include lower part of the SN (3 cases).
Seven datasets were excluded, three due to insuﬃcient coverage (did not include
the lower part of the SN containing nigrosome 1) and four due to the quality not
reaching the diagnostic level. Average percentage of subjects with nigrosome 1
present on both sides was equal 872%.
6.3.3 Discussion
Changes consistent with increased iron content in the SNd and RN were found
in RRMS patients compared to HCs using susceptibility mapping at 7T (Figure
6.3.2). There was a trend for the CIS patients to have higher values than HC in
all three ROIs, although the diﬀerences were not signiﬁcant. These results suggest
a relationship between iron deposition and disease progression and agree with the
previous work applying the same quantitative susceptibility mapping method to the
other dGM structures for the same CIS patients [1]. 1/T 2 -w signal did not show
signiﬁcant changes between the patients and HC groups, but there was a trend for
a small change between CIS and RRMS patients (Figure 6.3.2). The diﬀerence
between the trends found for susceptibility and 1/T 2 -w values aﬀected the third
measure we used, the Susceptibility-T 2 product. The values of this product increased
the separation of the RRMS and HC groups in comparison to susceptibility, but did
not show signiﬁcant diﬀerences for the CIS versus HC (as may be expected from the
results on 1/T 2 -w alone) (Figure 6.3.2). Nonetheless, the combined measure of iron
concentration could have an advantage over susceptibility alone in monitoring the
diagnosed MS patients.
The eﬀects of iron accumulation on susceptibility maps and T 2 -w images are
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diﬀerent. Susceptibility will depend on the total iron content within a voxel
[28]. On the other hand T 2 -w signal decay will depend on both the total iron
content of the tissue and also its distribution (ie whether or not the iron is
aggregated into ‘clumps’. Therefore a trend for susceptibility to change in earlier
demyelinating diseases (CIS) than T 2 -w might suggest that iron accumulation is
initially uniform but becomes more heterogeneous later. However susceptibility
and T 2 -w signal also depend on myelin content [28] and hence demyelination may
also explain the observed diﬀerences in the changes in T 2 -w and susceptibility
between groups. Myelin is diamagnetic (negative susceptibility) whereas iron is
paramagnetic (positive susceptibiltiy). Hence, both demyelination and increased
iron content would be manifest as a net increase in susceptibility. In contrast,
myelin generaly reduces T2 so demyelination will cause a decrease in 1/T 2 -w where
as increased iron will cause an increase in 1/T 2 -w. Further work, possibly including
magnetization transfer (MT) measures are required to separate these eﬀects but
either way the early changes may make susceptibility mapping potentially useful
in the future for monitoring progression of CIS. It has been recently reported that
the nigrosome is visible on 7T MRI [7] of healthy controls but not of Parkinson’s
disease patients [7, 42]. Post hoc examination of the data acquired here found no
change in frequency of nigrosome detection between RRMS and CIS patients and
controls (average frequency of detection in data sets with suﬃcient coverage and
image quality was 872%).
Previous results on the accumulation of iron in the SN and RN in MS were
inconsistent. Most of the work was based on the T2-w contrast [5, 15, 23, 37, 55,
67, 68] which is aﬀected not only by the iron content, but also by the other tissue
properties like water concentration or myelin content [28]. Alternatively the phase
component of the signal was used separately [32] or combined with the magnitude
in form of SWI [29, 69] to provide signals more speciﬁc to iron content, but as
discussed above without performing susceptibility mapping (as carried out here) the
phase signal is distorted in a way which is likely to increase scatter in the results.
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Interestingly, in our study greater diﬀerences in susceptibility were found in SNd
compared to SNv. Variation across the SN may partially explain the lack of
consistency in previous results using images acquired at lower ﬁeld strengths, as high
resolution imaging at 7T allowed speciﬁc ROIs to be deﬁned within the SN. It could
also suggest a similar pattern of the iron accumulation in SN to that previously
found in Parkinson’s disease in histology [24] and T 2 -w images [47], which is in
agreement with the gradient of neurodegeneration found SN in PD patients using
MRI [50].
In PD it has previously been shown in histology [19] and in vivo MRI [7, 42] that
iron is preferentially deposited in nigrosome 1 and nigrosome 1 cannot be detected
in vivo in patients. On the other hand, presence of nigrosome 1 at the same rate in
both healthy subjects and patients does not support that hypothesis, as our previous
study showed the absence of this structure in the Parkinson’s patients [7].
The lack of variation in iron content over the age range used in our study (20-58y)
agrees with previous histological measurements [31]. As in previous studies of dGM
iron in MS patients, we also found no correlation between iron and EDSS, possibly
due to a relatively low range of EDSS scores [67, 68].
The quantitative susceptibility mapping used in this work is a robust method
providing a more direct measure of the spatial iron distribution by the actual
susceptibility values overcoming the problem of non-local phase and susceptibility
relationship [66]. Although the susceptibility maps are rather sensitive to noise, the
increase of the signal-to-noise ratio in the images obtained from 7T magnetic ﬁeld
is suﬃcient to acquire good quality data.
Due to the orientation dependence of the susceptibility measurements the choice of
WM as the reference regions may be a limitation of results of this study based on
the susceptibility mapping. However, as CSF is aﬀected by ﬂow, WM is the most
robust choice.
This is the ﬁrst study using quantitative susceptibility mapping to analyse iron
accumulation in SN and RN in CIS and RRMS patients. ‘Future work will include
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R2 and MT measurements to better understand the mechanisms underlying changes
in iron and possibly myelin content found here. Longitudinal data will be analysed
to investigate whether these measures can predict conversion from CIS to RRMS,
which would be important for studying the disease progression.
6.4 Conclusions
This chapter presented three separate studies investigating diﬀerent aspects of the
neurodegeneration in MS, using 7T MRI.
Peri-lesional WM tissue in CIS patients was analysed in Section 6.1, in order to gain
a better understanding of the pathological processes leading to, and underlying,
the disease, by studying iron and myelin coupling in the proximity of the lesions.
However, the results obtained failed to provide more insight into these eﬀects. The
attempt to classify lesions based on the MR characteristics of their surroundings
was not successful, but lesion proﬁle analysis allowed to estimate of the value of
the distance from lesion boundary, where the NAWM can be considered unaﬀected
(2mm for lesion segmented on MPRAGE). Comparison of the proﬁles obtained for
diﬀerent modalities conﬁrmed a high variation of the MR lesion characteristics, but
agreed with the previous results regarding dependence of the particular contrasts on
myelin and iron. Application of the iron and myelin mapping method proposed in
Section 5.2 could provide an additional input for the interpretation of these results.
The second study, presented in Section 6.2, compared MTR and MPRAGE images
in terms of their usability for GM lesion detection in MS patients and found MTR
to be a better sequence for segmentation of purely cortical lesions. Moreover, the
method of calculating peri-lesional contrast used in this study could potentially be
developed into an automatic or semi-automatic lesion segmentation tool.
Section 6.3 described analysis of the iron content and visibility of nigrosome 1 (see
Section 5.1) in the SN and RN, in MS and CIS patients compared to HCs. Increased
iron content was found in patients using susceptibility mapping in the RN and a
dorsal part of the SN, with higher values recorded for RRMS than for CIS suggesting
172
iron accumulation with the disease progresion. There was no evidence of nigrosome
1 loss in MS patients in contrast to the results obtained in Parkinson’s disease(see
Section 5.1).
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7
Conclusions
The work presented in this thesis involved the application of MRI methods to
investigation of the properties of brain tissue in healthy and diseased brain, focusing
on iron and myelin. Chapter 3 presented simulations aimed at producing a better
understanding of the eﬀects of the microscopic characteristics of iron stores on the
MR signal. Subsequently two experimental chapters described studies investigating
two neurodegenerative diseases: Parkinson’s disease (PD) in Chapter 5 and multiple
sclerosis (MS) in Chapter 6.
Simulations presented in Chapter 3 provided insight into the dependence of T 2 -w
contrast on the shape and concentration of oriented inclusions of high susceptibility,
which can potentially correspond to various forms of high-iron biological objects
present in tissue (particles, proteins etc.).
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Qualitative comparison of in vivo and post mortem (PM) MR data with histology
in healthy controls (HCs) and PD patients presented in Chapter 5 led to the
identiﬁcation of nigrosome 1 in T 2 -w images of HCs obtained at 7T. This low-iron
sub-structure lying within the high-iron substantia nigra (SN) was also found to
disappear in in vivo images of PD patients, potentially providing a classifying factor
for distinguishing between patients and HCs. A small study on healthy subjects
proved that nigrosome 1 can also be identiﬁed at 3T and therefore the presence
of this structure could potentially be used in the diagnosis of PD in the clinical
setting.
The second part of the chapter focused on healthy brain stem tissue, including
nigrosome 1, and conﬁrmed magnetization transfer ratio (MTR) as a marker
of myelin content and susceptibility as well as R2 as markers of iron content.
Susceptibility was slightly more sensitive to iron concentration than R2 and they
both were also aﬀected by myelin content, but in opposite senses. These ﬁndings
were used to propose a quantitative method of iron and myelin mapping in in vivo
data.
Chapter 6 described an analysis of neurodegeneration taking place in MS, in white
matter (WM) and grey matter (GM). MR characteristics of the penumbra around
the WM lesions were analysed in patients with clinically isolated syndrome (CIS),
suggestive of MS. The analysed lesions could not be classiﬁed on the basis of their
peri-lesional proﬁles, but the analysis which was performed provided insight into
some lesion features. The dependence of the diﬀerent types of contrast on myelin
and iron content found in Chapter 5 was could be used to explain the results of this
study of peri-lesional WM tissue. The extent of the penumbra which was visible in
the images formed using the diﬀerent modalities was found to be up to approximately
2mm large for the lesion boundary seen on MPRAGE data.
Analysis of GM lesions in MS patients presented in the second part of Chapter 6 led
to the conclusion that MTR provides a better tool for identiﬁcation of the cortical
lesions than MPRAGE image contrast.
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The last part of Chapter 6 described the ﬁnding of increased iron content in the
dorsal part of the SN and in the red nucleus (RN) of CIS and MS patients compared
to HCs, based upon susceptibility mapping. The increase was higher in MS than
in CIS subjects suggesting that iron accumulates with disease progression. The
diﬀerences found using 1/T 2 -w images were not signiﬁcant, which is in agreement
with the conclusion of Chapter 5 about the greater sensitivity of susceptibility than
R2 to iron content. Diﬀerent eﬀects found in susceptibility and 1/T 2 -w contrast
need further investigation. As both modalities are also aﬀected by myelin content,
additional use of an MR marker of myelin (such as MTR) may lead to better
understanding of these dependencies. There was no evidence of nigrosome loss in
MS and CIS patients in contrast to PD studies presented in Chapter 5.
Future work
The simulations part of the thesis will be extended to include comparison of
these results with experiments regarding microscopic tissue structure. Moreover,
simulations incorporating the eﬀect of diﬀusion will be performed.
In order to investigate the possible use of nigrosome 1 as a disease progression
marker, future work should include longitudinal comparisons of PD patients, HCs
and subjects at risk of developing PD. Quantitative approaches should be applied
to measure the rate of nigrosome loss and correlate these results with the stage of
disease development. Application of the in vivo method of iron and myelin mapping
may provide additional information about the disease related changes occurring
in tissue. In parallel, further studies using clinically available 3T data should be
conducted on PD patients and HCs.
Future work regarding peri-lesional WM in CIS will include longitudinal studies
comparing development of the same lesions with time. MS patients will be also
studied along with CIS subjects to investigate WM pathology at diﬀerent stages of
the disease. Moreover, a method of iron and myelin mapping described in Chapter
5 will be applied to the peri-lesional tissue, to provide a better understanding of the
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complex mixture of iron and myelin content changes around lesions.
The continuation of the study analysing GM lesions will include studying bigger
group of patients, comparing appearance of the lesions in wider range of modalities
and relating these results to the WM degeneration as well as to the clinical progress
of the disease. The method of measuring peri-lesional contrast presented here needs
some improvement, but could be potentially used in future studies to assist lesion
segmentation by helping to ﬁnd their boundaries in an automatic or semi-automatic
way.
The study of the deep GM in MS will be extended to use the longitudinal data
acquired for this project obtained with one and two years follow up to investigate
changes of the iron content in dGM structures with the disease progression, especially
in the patients who converted from CIS to RRMS. Moreover diﬀerent quantitative
measures such as MTR and R2 will be applied in the future for better understanding
of iron and myelin content changes in the analysed structures.
186
Appendix 1
In order to check if two ellipsoids overlap the following method was used [1].
Assuming that each ellipsoid is algebraically represented by the general equation
of the second order algebraic surface given as:
Ax2 +By2 + Cz2 +Dxy + Eyz + Fxz +Gz +Hy + Jz +K = 0;
where A, B, C, D, E, F , G, H, J , K are constants. This can be transformed to
the matrix representation:
XSXT = 0;
where
X =

x y z 1

and
S =
1
2
266666664
2A D F G
D 2B E H
F E 2C J
G H J 2K
377777775
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For the ellipsoid we can calculate:
(x  xc)2
a2
+
(y   yc)2
b2
+
(z   zc)2
c2
  1 =
=
1
a2
x2 +
1
b2
y2 +
1
c2
z2   2x
2
c
a2
x  2y
2
c
b2
y   2z
2
c
c2
z +
x2c
a2
+
y2c
b2
+
z2c
c2
  1 =
=
2666666664
1
a2
0 0  x
2
c
a2
0
1
b2
0  y
2
c
b2
0 0
1
c2
 z
2
c
c2
 x
2
c
a2
 y
2
c
b2
 z
2
c
c2
x2c
a2
+
y2c
b2
+
z2c
c2
  1
3777777775
XT = XSXT
Algebraic condition for the separation of two ellipsoids can be formulated as
following:
For given ellipsoids A : XAXT = 0 and B : XBXT = 0 their characteristic equation
is deﬁned as:
f() = det(A+B) = 0
(1) A and B are separated iﬀ f()=0 has two distinct positive roots,
(2) A and B externally touch each other iﬀ f()=0 has positive double root.
In case of discrete coordinates externally touching means heaving common point
(pixel), what may be considered as overlapping.
To calculate roots of the characteristic equation, assume that:
A =
266666664
a11 a12 a13 a14
a21 a22 a23 a24
a31 a32 a33 a34
a41 a42 a43 a44
377777775
; B =
266666664
b11 b12 b13 b14
b21 b22 b23 b24
b31 b32 b33 b34
b41 b42 b43 b44
377777775
;
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and xci is i-th row of the matrix X, where c-th element was removed. Characteristic
equation can be written as following:
f() = det(A+B) =
=
4X
c=1
sgn( 1)c
0BBBB@4a4c

ac1
ac2
ac3

+ 3
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+ a4c
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+ a4c

bc1
ac2
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1CCCCA+
+ 2
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+ a4c

bc1
ac2
bc3
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Appendix 2
The following ﬁgures present additional, negative results of the study described
in Section 6.1. Figures A.1, A.2 and A.3 show correlation scatters of the ﬁtting
coeﬃcients obtained for lesions with neighbourhoods’ overlap removed.
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Figure A.1: Characteristic distance (S2) of the function ﬁtted to the ﬁrst part of the lesion
proﬁles 0-5mm plotted against the lesions mean intensity in all the modalities: R2-w, SUSC,
MTR1, R1, ASYM; the number of the data points for which S2=15mm removed from the
plots is N=11,14,2,3,4, respectively; the ﬁtted straight lines are plotted in black.
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Figure A.2: Plots of the characteristic distance (S2) of the function ﬁtted to the ﬁrst part of
the lesion proﬁles 0-5mm against the lesion size; two data points representing very big lesions
have been removed to provide better clarity of the plots; R2-w, SUSC, MTR1, R1, ASYM;
the number of the data points for which S2 = 15mm removed from the plots is N=11,14,2,3,4,
respectively; the ﬁtted straight lines are plotted in black.
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Figure A.3: The characteristic distance (S2) of the function ﬁtted to the ﬁrst part of the
lesion proﬁles 0-5mm plotted for all the combinations of the pairs of the images with the ﬁtted
straight lines plotted in black; the number of the data points for which S2 = 15mm removed
from the plots is N=11,14,2,3,4, for R2, SUSC, MTR1, R1 and ASYM, respectively;
Table A.1 presents the example set of the co-occurrence matrices resulting from the
C=2 clusters classiﬁcation of the whole 15mm proﬁles. No clear overlap between
the classes in the pairs of modalities was found.
ASYM R1 MTR1 SUSC
1 2 1 2 1 2 1 2
R2 1 3 21 8 16 16 8 9 15
2 8 59 16 51 33 34 25 42
SUSC 1 5 29 10 24 14 20
2 6 51 14 43 35 22
MTR1 1 5 44 11 38
2 6 36 13 29
R1 1 4 20
2 7 60
Table A.1: Co-occurrence matrix for C=2 obtained from the clustering of the whole proﬁles
(within 15mm).
Figure A.4 shows plots of the lesion proﬁles, averaged across two classes
determined by the clustering based on the 15mm correlation, where large error bars
corresponding to the standard deviation of the proﬁle values indicate high intraclass
variance.
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Figure A.4: Average lesion proﬁles calculated for two classes determined by 15mm correlation,
plotted together for the comparison in red and blue. Rows’ labels correspond to the source
images used for the classiﬁcation (clustering modality), and columns represent images from
which the average proﬁles were calculated (comparison modality). In each plot, the x-axis
shows distance in mm.
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